THIOPHENE- OR FURAN-SUBSTITUTED ISOTHIAZOLINE COMPOUNDS AS PESTICIDES Description The present invention relates to thiophene- or furan-substituted isothiazoline compounds which are useful for combating or controlling invertebrate pests, in particular arthropod pests and nematodes. The invention also relates to a method for controlling invertebrate pests by using these compounds and to plant propagation material and to an agricultural and a veterinary composition comprising said compounds.

Invertebrate pests and in particular arthropods and nematodes destroy growing and harvested crops and attack wooden dwelling and commercial structures, causing large economic loss to the food supply and to property. While a large number of pesticidal agents are known, due to the ability of target pests to develop resistance to said agents, there is an on-going need for new agents for combating invertebrate pests, in particular insects, arachnids and nematodes.

Related insecticidal aryl isothiazoline compounds are described in WO 2013/037626. However, this document does not describe compounds having the characteristic sub- stituents and substituents' arrangement as claimed in the present invention. Related insecticidal aryl azoline compounds are further described in WO 201 1/092287, WO 201 1/073444, WO 2010/090344, WO 2009/1 12275 and WO 97/23212. These documents do not describe compounds having the characteristic substituents and substituents' arrangement as claimed in the present invention, either.

It is an object of the present invention to provide compounds that have a good pesticidal activity, in particular insecticidal activity, and show a broad activity spectrum against a large number of different invertebrate pests, especially against difficult to control arthropod pests and/or nematodes.

It has been found that these objectives can be achieved by isothiazoline compounds of the formula I below, by their steroisomers and by their salts, in particular their agriculturally or veterinarily acceptable salts.

Therefore, in a first aspect, the invention relates to isothiazoline compounds of formula I

wherein

X is a heterocyclic radical of formula II

wherein

# is the attachment point to the remainder of the molecule;

A is a group A ¹ , A ² , A ³ or A ⁴ ;

wherein

A ¹ is selected from the group consisting of -C(=NR ⁶ )R ⁸ , -N(R ⁵ )R ⁶ and -CN; A ² is a group of following formula:

wherein

# denotes the bond to the aromatic ring of formula (I);

W is selected from O and S;

Y is selected from hydrogen, -N(R ⁵ )R ⁶ and -OR ⁹ ;

A ³ is a group of following formula: (A ³ )

wherein

# denotes the bond to the aromatic ring of formula (I); A ⁴ is a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or maximally unsaturated heteromonocyclic ring containing 1 , 2, 3 or 4 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, or is a 8-, 9- or 10-membered saturated, partially unsaturated or maximally unsaturated heterobicyclic ring containing 1 , 2, 3 or 4 heteroa- toms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heteromonocyclic or heterobicyclic ring is optionally substituted with one or more substituents R ¹¹ ;

G is O or S;

B ¹ , B ² and B ³ are each independently selected from the group consisting of N and CR ² , with the proviso that at most two of B ¹ , B ² and B ³ are N;

R ¹ is selected from the group consisting of Ci-C4-alkyl, Ci-C4-haloalkyl, C1-C4- alkoxy-Ci-C ₄ -alkyl, Ci-C ₄ -haloalkoxy-Ci-C ₄ -alkyl-, C ₂ -C ₄ -alkenyl, C2-C4- haloalkenyl, C2-C ₄ -alkynyl, C2-C ₄ -haloalkynyl, C3-C6-cycloalkyl, C3-C6- halocycloalkyl and -C(=0)OR ¹⁵ ; each R ² is independently selected from the group consisting of hydrogen, halogen, cyano, azido, nitro, -SCN, -SF ₅ , Ci-C6-alkyl, Cs-Cs-cycloalkyl, C2-C6-alkenyl, C2-

C6-alkynyl, wherein the four last mentioned aliphatic and cycloaliphatic radicals may be partially or fully halogenated and/or may be substituted by one or more radicals R ⁸ ,

-Si(R ¹² ) ₃ , -OR ⁹ , -S(0) _n R ⁹ , -NR ^10a R ^10b ,

phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹¹ , and a 3-, 4-, 5-, 6-

7-, 8-, 9- or 10-membered saturated, partially unsaturated or maximally unsaturated heteromonocyclic or heterobicyclic ring containing 1 , 2, 3 or 4 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heteromono- or heterobicyclic ring may be substituted by one or more radicals R ¹¹ ; R ^3a , R ^3b are each independently selected from the group consisting of hydrogen, halogen, hydroxyl, -C0 ₂ R ^3d , Ci-C ₃ -alkyl, Ci-C ₃ -haloalkyl, C ₂ -C ₃ -alkenyl, C2-C3- alkynyl, Ci-C3-alkoxy, Ci-C3-haloalkoxy, Ci-C3-alkylthio, Ci-C3-haloalkylthio, Ci- C3-alkylsulfonyl and Ci-C3-haloalkylsulfonyl; or

R ^3a and R ^3b together form a group =0, =C(R ^3c ) ₂ , =NOH or =NOCH ₃ ;

R ^3c is independently selected from the group consisting of hydrogen, halogen, is selected from the group consisting of hydrogen, Ci-C6-alkyl and C1-C3- alkyloxy-Ci-C3-alkyl-;

R ^4a and R ^4b are independently selected from the group consisting of hydrogen, halogen, cyano, azido, nitro, -SCN, -SF ₅ , Ci-C6-alkyl which may be partially or fully halogenated and/or may be substituted by one or more radicals R ⁸ , C3-C8- cycloalkyl which may be partially or fully halogenated and/or may be substituted by one or more radicals R ⁸ , C2-C6-alkenyl which may be partially or fully halogenated and/or may be substituted by one or more radicals R ⁸ , C2-C6-alkynyl which may be partially or fully halogenated and/or may be substituted by one or more radicals R ⁸ ,

-Si(R ¹² ) ₃ , -OR ⁹ , -S(0) _n R ⁹ , -NR ^10a R ^10b ,

phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹¹ , and a 3-, 4-, 5-, 6- 7-, 8-, 9- or 10-membered saturated, partially unsaturated or maximally unsaturated heteromonocyclic or heterobicyclic ring containing 1 , 2, 3 or 4 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heteromonocyclic or heterobicyclic ring may be substituted by one or more radicals R ¹¹ ; each R ⁵ is independently selected from the group consisting of hydrogen, cyano, C Cio-alkyl, Cs-Cs-cycloalkyl, C2-Cio-alkenyl, C2-Cio-alkynyl, wherein the four last- mentioned aliphatic and cycloaliphatic radicals may be partially or fully halogenated and/or may be substituted with one or more substituents R ⁸ ; and

-S(0) _n R ⁹ , each R ⁶ is independently selected from the group consisting of hydrogen, cyano, C Cio-alkyl, Cs-Cs-cycloalkyl, C2-Cio-alkenyl, C2-Cio-alkynyl, wherein the four last- mentioned aliphatic and cycloaliphatic radicals may be partially or fully halogen- ated and/or may be substituted by one or more substituents R ⁸ ,

-OR ⁹ , -NR ^10a R ^10b , -S(0) _n R ⁹ , -C(=O)NR ^0a N(R ^0a )R ^0b , -Si(R ¹² ) ₃ , -C(=0)R ⁸ ,

-CH=NOR ⁹ ,

phenyl which may be substituted with 1 , 2, 3, 4, or 5 substituents R ¹¹ , and a 3-, 4-, 5-, 6-, 7-, 8-, 9- or 10-membered saturated, partially unsaturated or maximally unsaturated heteromonocyclic or heterobicyclic ring containing 1 , 2, 3 or 4 heteroatoms or heteroatom groups independently selected from N, O, S, NO, SO and SO2, as ring members, where the heteromonocyclic or heterobicyclic ring may be substituted with one or more substituents R ¹¹ ; or R ⁵ and R ⁶ , together with the nitrogen atom to which they are bound, form a 3-, 4-, 5-, 6-, 7- or 8-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring, where the ring may further contain 1 , 2, 3 or 4 heteroa- toms or heteroatom-containing groups selected from O, S, N, SO, SO2, C=0 and

C=S as ring members, wherein the heterocyclic ring may be substituted with 1 , 2, 3, 4 or 5 substituents independently selected from the group consisting of halogen, cyano, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy,

Ci-C6-alkylthio, Ci-C6-haloalkylthio, Cs-Cs-cycloalkyl, Cs-Cs-halocycloalkyl, C2-C6- alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, wherein the aliphatic or cycloaliphatic moieties in the twelve last-mentioned radicals may be substituted by one or more radicals R ⁸ , and phenyl which may be substituted with 1 , 2, 3, 4 or 5 substituents R ¹¹ ; or R ⁵ and R ⁶ together form a group =C(R ⁸ ) ₂ , =S(0) _m (R ⁹ ) ₂ , =NR ^10a or =NOR ⁹ ;

R ^7a , R ^7b are each independently selected from the group consisting of hydrogen, halogen, cyano, Ci-C6-alkyl, Cs-Cs-cycloalkyl, C2-C6-alkenyl and C2-C6-alkynyl, wherein the four last-mentioned aliphatic and cycloaliphatic radicals may be par- tially or fully halogenated and/or may be substituted by one or more radicals R ⁸ ; each R ⁸ is independently selected from the group consisting of cyano, azido, nitro, - SCN, -SF ₅ , C3-Cs-cycloalkyl, Cs-Cs-halocycloalkyl, Cs-Cs-cycloalkenyl, C3-C8- halocycloalkenyl, where the cycloaliphatic moieties in the four last-mentioned radicals may be substituted by one or more radicals R ¹³ ;

-Si(R ¹² ) ₃ , -OR ⁹ , -OSO2R ⁹ , -S(0) _n R ⁹ , -N(R ^0a )R ^0b , -C(=O)N(R ^0a )R ⁰ ,

-C(=S)N(R ^0a )R ⁰ , -C(=0)OR ⁹ , -CH=NOR ⁹ ,

phenyl, optionally substituted with 1 , 2, 3, 4 or 5 substituents R ¹⁶ , and a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring comprising 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring is optionally substituted with one or more substituents R ¹⁶ , or

two R ⁸ present on the same carbon atom of an alkyl, alkenyl, alkynyl or cycloalkyi group together form a group =0,

=S(0) _m R ¹⁵ N(R ^4a )R ^4b , =NR ^0a , =NOR ⁹ ; or =NN(R ^0a )R ^0b ;

or

two radicals R ⁸ , together with the carbon atoms of an alkyl, alkenyl, alkynyl or cycloalkyi group which they are bonded to, form a 3-, 4-, 5-, 6-, 7- or 8-membered saturated or partially unsaturated carbocyclic or heterocyclic ring, where the heterocyclic ring comprises 1 , 2, 3 or 4 heteroatoms or heteroatom groups independently selected from N, O, S, NO, SO and SO2, as ring members, and where the carbocyclic or heterocyclic ring is optionally substituted with one or more substituents R ¹⁶ ; and

R ⁸ as a substituent on a cycloalkyi ring is additionally selected from the group consisting of Ci-C6-alkyl, Ci-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2- C6-alkynyl and C2-C6-haloalkynyl, where the aliphatic moieties in these six radicals may be substituted by one or more radicals R ¹³ ; and

R ⁸ in the groups -C(=NR ⁶ )R ⁸ , -C(=0)R ⁸ and =C(R ⁸ ) ₂ is additionally selected from the group consisting of hydrogen, halogen, Ci-C6-alkyl, Ci-C6-haloalkyl, C2-C6- alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl and C2-C6-haloalkynyl, where the aliphatic moieties in the six last-mentioned radicals may be substituted by one or more radicals R ¹³ ; each R ⁹ is independently selected from the group consisting of hydrogen, cyano, Ci- Ce-alkyl, Ci-C ₆ -haloalkyl, C ₃ -C ₈ -cycloalkyl, C ₃ -C ₈ -cycloalkyl-Ci-C ₄ -alkyl-, C ₃ -C ₈ - halocycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, where the aliphatic and cycloaliphatic moieties in the nine last-mentioned radicals may be substituted by one or more radicals R ¹³ ,

-Ci-C ₆ -alkyl-C(=0)OR ¹⁵ , -Ci-C ₆ -alkyl-C(=0)N(R ^a )R ,

-Ci-C ₆ -alkyl-C(=S)N(R ^4a )R ^4b , -Ci-C ₆ -alkyl-C(=NR ⁴ )N(R ^4a )R ⁴ ,

-Si(R ¹² ) ₃ , -S(0) _n R ¹⁵ , -S(0) _n N(R ^a )R , -N(R ^0a )R ⁰ , -N=C(R ¹³ ) ₂ , -C(=0)R ¹³ , -C(=0)N(R ^4a )R ⁴ , -C(=S)N(R ^4a )R ⁴ , -C(=0)OR ¹⁵ ,

phenyl, optionally substituted with one or more substituents R ¹⁶ ; and

a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring comprising 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring is optionally substituted with one or more substituents R ¹⁶ ; and R ⁹ in the groups -S(0) _n R ⁹ and -OSO2R ⁹ is additionally selected from the group consisting of Ci-C6-alkoxy and Ci-C6-haloalkoxy;

R ^10a , R ^10b are selected independently from one another from the group consisting of hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, Cs-Cs-cycloalkyl, Cs-Cs-halocycloalkyl, C2- C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, where the aliphatic and cycloaliphatic moieties in the eight last-mentioned radicals may be substituted by one or more radicals R ¹³ ;

-Ci-C ₆ -alkyl-C(=0)OR ¹⁵ , -Ci-C ₆ -alkyl-C(=0)N(R ^a )R , -Ci-C ₆ -alkyl- C(=S)N(R ^a )R , -Ci-C ₆ -alkyl-C(=NR )N(R ^a )R , Ci-C ₆ -alkoxy, Ci-C ₆ - haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio,

-S(0) _n R ¹⁵ , -S(0) _n N(R ^a )R , -C(=0)R ¹³ , -C(=0)OR ¹⁵ , -C(=0)N(R ^a )R , -C(=S)R ¹³ , -C(=S)SR ¹⁵ , -C(=S)N(R ^4a )R ⁴ , -C(=NR ⁴ )R ¹³ ;

phenyl, optionally substituted with 1 , 2, 3, 4 or 5 substituents R ¹⁶ ; and

a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring comprising 1 , 2, 3 or 4 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring is optionally substituted with one or more substituents R ¹⁶ ;

or

R ^10a and R ^10b form together with the nitrogen atom they are bonded to a 3-, 4- , 5-, 6-, 7- or 8-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring, wherein the heterocyclic ring may additionally contain one or two heteroatoms or heteroatom groups selected from N, O, S, NO, SO and

SO2, as ring members, where the heterocyclic ring optionally carries one or more substituents selected from halogen, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio, Cs-Cs-cycloalkyl, Cs-Cs- halocycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, phenyl, optionally substituted with 1 , 2, 3, 4 or 5 substituents R ¹⁶ , and a 3-, 4-, 5-,

6,- or 7-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring comprising 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring optionally carries one or more substituents R ¹⁶ ;

or R ^0a and R ¹⁰ together form a group =C(R ¹³ ) ₂ , =S(0) _m (R ¹⁵ ) ₂ ,

=S(0) _m R ¹⁵ N(R ^4a )R ⁴ , =NR ¹⁴ or =NOR ¹⁵ ; ?11 is independently selected from the group consisting of halogen, cyano, azido, nitro, -SCN, -SF ₅ , Ci-Cio-alkyl, Cs-Cs-cycloalkyl, C2-Cio-alkenyl, C2-Cio-alkynyl, wherein the four last-mentioned aliphatic and cycloaliphatic radicals may be partially or fully halogenated and/or may be substituted with one or more radicals R ⁸ , -OR ⁹ , -NR ^10a R ^10b , -S(0) _n R ⁹ , -Si(R ¹² ) ₃ ;

phenyl, optionally substituted with 1 , 2, 3, 4, or 5 substituents selected independently from R ¹⁶ ; and

a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or maximally unsaturated aromatic heterocyclic ring comprising 1 , 2, 3 or 4 heteroatoms or het- eroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring is optionally substituted with one or more substituents selected independently from R ¹⁶ ;

or two R ¹¹ present on the same ring carbon atom of an unsaturated or partially unsaturated heterocyclic ring may together form a group =0, =S;

=S(0) _m (R ¹⁵ ) ₂ ; =S(0) _m R ¹⁵ N(R ^4a )R ^4b , =NR ¹⁴ , =NOR ¹⁵ , or =NN(R ^4a )R ^4b ;

or two R ¹¹ bound on adjacent ring atoms form together with the ring atoms to which they are bound a saturated 3-, 4-, 5-, 6-, 7-, 8- or 9-membered ring, wherein the ring may contain 1 or 2 heteroatoms or heteroatom groups selected from O, S, N, NR ¹⁴ , NO, SO and S0 ₂ and/or 1 or 2 groups selected from C=0, C=S and C=NR ¹⁴ as ring members, and wherein the ring may be substituted by one or more radicals selected from the group consisting of halogen, Ci-C6-alkyl, C1-C6- haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio, Cs- Cs-cycloalkyl, C3-Cs-halocycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6- alkynyl, C2-C6-haloalkynyl, phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁶ , and a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring may be substituted by one or more radicals R ¹⁶ ; each R ¹² is independently selected from the group consisting of hydrogen, halogen, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, C2-C6-alkenyl, C2- C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, Cs-Cs-cycloalkyl, C3-C8- halocycloalkyl, Ci-C6-alkoxy-Ci-C6-alkyl, Ci-C6-haloalkoxy-Ci-C6-alkyl, and phenyl, optionally substituted with 1 , 2, 3, 4, or 5 substituents R ¹⁶ ; each R ¹³ is independently selected from the group consisting of cyano, nitro,

-OH, -SH, -SCN, -SF ₅ , d-Ce-alkoxy, Ci-C ₆ -haloalkoxy, Ci-C ₆ -alkylthio, Ci-C ₆ - haloalkylthio, Ci-C6-alkylsulfinyl, Ci-C6-haloalkylsulfinyl, Ci-C6-alkylsulfonyl, Ci- Ce-haloalkylsulfonyl, -NR ^14a R ^14b , trimethylsilyl, triethylsilyl, fert-butyldimethylsilyl, - C(=0)N(R ^4a )R ^4b ,

C3-C8-cycloalkyl which may be unsubstituted, partially or fully halogenated and/or may carry 1 or 2 radicals selected from cyano, Ci-C4-alkyl, C3-C4- cycloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy and oxo; phenyl, benzyl, phenoxy, where the phenyl moiety in the three last-mentioned radicals may be unsubstituted or carry 1 , 2, 3, 4 or 5 substituents R ¹⁶ ; and a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring may be substituted by

1 , 2 or 3 substituents R ¹⁶ ;

or

two R ¹³ present on the same carbon atom of an alkyl, alkenyl, alkynyl or cycloalkyl group may together be =0, =CH(Ci-C ₄ -alkyl), =C(Ci-C ₄ -alkyl)Ci-C ₄ -alkyl, =NR ⁷ or =NOR ¹⁷ ;

and

R ¹³ as a substituent on a cycloalkyl ring is additionally selected from the group consisting of Ci-C6-alkyl, C2-C6-alkenyl and C2-C6-alkynyl, wherein the three last- mentioned aliphatic radicals may be unsubstituted, partially or fully halogenated and/or may carry 1 or 2 substituents selected from CN , C3-C4-cycloalkyl, C1-C4- alkoxy, Ci-C4-haloalkoxy and oxo;

and

R ³ in the groups =C(R ¹³ ) ₂ , -N=C(R ¹³ ) ₂ , -C(=0)R ¹³ , -C(=S)R ¹³ and

-C(=NR ¹⁴ )R ¹³ is additionally selected from the group consisting of hydrogen, halogen, Ci-C6-alkyl, C2-C6-alkenyl and C2-C6-alkynyl, wherein the three last- mentioned aliphatic radicals may be unsubstituted, partially or fully halogenated and/or may carry 1 or 2 radicals selected from CN, C3-C4-cycloalkyl, C1-C4- alkoxy, Ci-C4-haloalkoxy and oxo; each R ¹⁴ is independently selected from the group consisting of hydrogen, cyano, Ci- C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio, C1-C6- alkylsulfinyl, Ci-C6-haloalkylsulfinyl, Ci-C6-alkylsulfonyl, Ci-C6-haloalkylsulfonyl, - C(=0)NR ^18a R ^18b , trimethylsilyl, triethylsilyl, fert-butyldimethylsilyl,

Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, wherein the three last-mentioned ali- phatic radicals may be unsubstituted, partially or fully halogenated and/or may carry 1 or 2 radicals selected from CN, Ci-C4-alkoxy, Ci-C4-haloalkoxy, C1-C4- alkylthio, Ci-C4-alkylsulfinyl, Ci-C4-alkylsulfonyl, C3-C6-cycloalkyl which may be substituted by 1 or 2 substituents selected from halogen and cyano; and oxo; Cs-Cs-cycloalkyI which may be unsubstituted, partially or fully halogenated and/or may carry 1 or 2 radicals selected from cyano, Ci-C4-alkyl, Ci-C4-alkoxy, C1-C4- haloalkoxy, Ci-C4-alkylthio, Ci-C4-alkylsulfinyl, Ci-C4-alkylsulfonyl, C3-C4- cycloalkyl, C3-C4-cycloalkyl-Ci-C4-alkyl-, where the cycloalkyl moiety in the two last-mentioned radicals may be substituted by 1 or 2 substituents selected from halogen and cyano; and oxo;

phenyl, benzyl, pyridyl, phenoxy, wherein the cyclic moieties in the four last- mentioned radicals may be unsubstituted and/or carry 1 , 2, 3 or 4 substituents selected from halogen, cyano, nitro, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio, C2-C4-alkenyl, C2-C4- haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, C3-C6-cycloalkyl, C3-C6- halocycloalkyl, and (Ci-C6-alkoxy)carbonyl; and a 3-, 4-, 5- or 6-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring comprising 1 , 2 or 3 heteroatoms or heteroatom groups selected from N , O, S, NO, SO and SO2, as ring members, where the heterocyclic ring is optionally substituted with one or more substituents R ¹⁶ ;

R ^14a and R ^14b , independently of each other, have one of the meanings given for R ¹⁴ ; or

R ^14a and R ^14b , together with the nitrogen atom to which they are bound, form a 3-,

4-, 5-, 6- or 7-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring, wherein the heterocyclic ring may additionally contain 1 or 2 heteroatoms or heteroatom groups selected from N , O, S, NO, SO and SO2, as ring members, where the heterocyclic ring optionally carries one or more substit- uents selected from halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-

C4-haloalkoxy;

or

R ^14a and R ¹⁴ or R ^14b and R ¹⁴ , together with the nitrogen atoms to which they are bound in the group -C(=N R ¹⁴ )N(R ^14a ) R ^14b , form a 3-, 4-, 5-, 6- or 7-membered partially unsaturated or maximally unsaturated heterocyclic ring, wherein the heterocyclic ring may additionally contain 1 or 2 heteroatoms or heteroatom groups selected from N , O, S, NO, SO and SO2, as ring members, where the heterocyclic ring optionally carries one or more substituents selected from halogen, C1-C4- haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy; each R ¹⁵ is independently selected from the group consisting of hydrogen, cyano, trimethylsilyl, triethylsilyl, feri-butyldimethylsilyl, Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, wherein the three last-mentioned aliphatic radicals may be unsubstituted, partially or fully halogenated and/or may carry 1 or 2 radicals selected from C3-C4-cycloalkyl, Ci-C4-alkoxy, C1-C4- haloalkoxy, Ci-C4-alkylthio, Ci-C4-alkylsulfinyl, Ci-C4-alkylsulfonyl and oxo;

Cs-Cs-cycloalkyI which may be unsubstituted, partially or fully halogenated and/or may carry 1 or 2 radicals selected from Ci-C4-alkyl, C3-C4-cycloalkyl, C1-C4- alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, Ci-C4-alkylsulfinyl, Ci-C4-alkylsulfonyl and oxo;

phenyl, benzyl, pyridyl and phenoxy, wherein the four last-mentioned radicals may be unsubstituted, partially or fully halogenated and/or carry 1 , 2 or 3 substit- uents selected from Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy and (Ci-C6-alkoxy)carbonyl;

R ¹⁶ is independently selected from the group consisting of halogen, nitro, cy- ano, -OH, -SH, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, C1-C6- haloalkylthio, Ci-C6-alkylsulfinyl, Ci-C6-haloalkylsulfinyl, Ci-C6-alkylsulfonyl, Ci- C6-haloalkylsulfonyl, Ci-C4-alkylcarbonyl, Ci-C4-haloalkylcarbonyl, C1-C4- alkoxycarbonyl, Ci-C4-haloalkoxycarbonyl, aminocarbonyl, C1-C4- alkylaminocarbonyl, di-(Ci-C4-alkyl)-aminocarbonyl, trimethylsilyl, triethylsilyl, tert- butyldimethylsilyl;

Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, wherein the three last-mentioned aliphatic radicals may be unsubstituted, partially or fully halogenated and/or may carry 1 or 2 radicals selected from cyano, C3-C4-cycloalkyl, Ci-C4-alkoxy, C1-C4- haloalkoxy and oxo;

Cs-Cs-cycloalkyI which may be unsubstituted, partially or fully halogenated and/or may carry 1 or 2 radicals selected from cyano, Ci-C4-alkyl, C3-C4-cycloalkyl, Ci- C4-alkoxy, Ci-C4-haloalkoxy and oxo;

phenyl, benzyl, pyridyl and phenoxy, wherein the four last mentioned radicals may be unsubstituted, partially or fully halogenated and/or carry 1 , 2 or 3 substit- uents selected from Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy and (Ci-C6-alkoxy)carbonyl;

or

two R ¹⁶ present together on the same atom of an unsaturated or partially unsaturated ring may be =0, =S, =N(Ci-C ₆ -alkyl), =NO(Ci-C ₆ -alkyl), =CH(Ci-C ₄ -alkyl) or =C(Ci-C ₄ -alkyl)Ci-C ₄ -alkyl;

or

two R ¹⁶ on two adjacent carbon atoms form together with the carbon atoms they are bonded to a 4-, 5-, 6-, 7- or 8-membered saturated, partially unsaturated or maximally unsaturated ring, wherein the ring may contain 1 or 2 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, and wherein the ring optionally carries one or more substituents selected from halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy;

R ¹⁷ , R ^18a and R ^18b , independently of each other and independently of each occurrence, are selected from the group consisting of hydrogen, Ci-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, wherein the three last-mentioned aliphatic radicals may be unsub- stituted, partially or fully halogenated and/or may carry 1 or 2 radicals selected from CN, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, Ci-C4-alkylsulfinyl, Ci-

C4-alkylsulfonyl, C3-C4-cycloalkyl which may be substituted by 1 or 2 substituents selected from halogen and cyano; and oxo;

C3-C8-cycloalkyl which may be unsubstituted, partially or fully halogenated and/or may carry 1 or 2 radicals selected from cyano, Ci-C4-alkyl and Ci-C4-haloalkyl; phenyl and benzyl; each n is independently 0, 1 or 2; and

each m is independently 0 or 1 ; and the N-oxides, stereoisomers and agriculturally or veterinarily acceptable salts thereof.

The present invention also provides an agricultural composition comprising at least one compound of the formula I as defined herein and/or an agriculturally acceptable salt thereof and at least one liquid or solid carrier.

The present invention also provides a veterinary composition comprising at least one compound of the formula I as defined herein and/or a veterinarily acceptable salt thereof and at least one liquid or solid carrier.

The present invention also provides a method for controlling invertebrate pests which method comprises treating the pests, their food supply, their habitat or their breeding ground or a cultivated plant, plant propagation materials (such as seed), soil, area, material or environment in which the pests are growing or may grow, or the materials, cul- tivated plants, plant propagation materials (such as seed), soils, surfaces or spaces to be protected from pest attack or infestation with a pesticidally effective amount of a compound of formula I or a salt thereof as defined herein. The present invention also relates to plant propagation material, in particular seed, comprising at least one compound of formula I and/or an agriculturally acceptable salt thereof as defined herein. The present invention further relates to a method for treating or protecting an animal from infestation or infection by parasites which comprises bringing the animal in contact with a parasiticidally effective amount of a compound of the formula I or a veterinarily acceptable salt thereof as defined herein. Bringing the animal in contact with the compound I, its salt or the veterinary composition of the invention means applying or ad- ministering it to the animal.

The term "steroisomers" encompasses both optical isomers, such as enantiomers or diastereomers, the latter existing due to more than one center of chirality in the molecule, as well as geometrical isomers (cis/trans isomers).

Depending on the substitution pattern, the compounds of the formula I may have one or more centers of chirality, in which case they are present as mixtures of enantiomers or diastereomers. One center of chirality is the carbon ring atom of the isothiazoline ring carrying radical R ¹ . The invention provides both the pure enantiomers or diastere- omers and their mixtures and the use according to the invention of the pure enantiomers or diastereomers of the compound I or its mixtures. Suitable compounds of the formula I also include all possible geometrical stereoisomers (cis/trans isomers) and mixtures thereof. The term N-oxides relates to a form of compounds I in which at least one nitrogen atom is present in oxidized form (as NO). To be more precise, it relates to any compound of the present invention which has at least one tertiary nitrogen atom that is oxidized to an N-oxide moiety. N-oxides of compounds I can in particular be prepared by e.g. oxidizing the ring nitrogen atom of the isothiazoline moiety and/or of any nitrogen-containing heterocyclic group present in group A with a suitable oxidizing agent, such as peroxo carboxylic acids or other peroxides. The person skilled in the art knows if and in which positions compounds of the present invention may form N-oxides.

The compounds of the present invention may be amorphous or may exist in one ore more different crystalline states (polymorphs) which may have a different macroscopic properties such as stability or show different biological properties such as activities. The present invention includes both amorphous and crystalline compounds of the for- mula I, mixtures of different crystalline states of the respective compound I, as well as amorphous or crystalline salts thereof.

Salts of the compounds of the formula I are preferably agriculturally and veterinarily acceptable salts. They can be formed in a customary method, e.g. by reacting the compound with an acid of the anion in question if the compound of formula I has a basic functionality or by reacting an acidic compound of formula I with a suitable base.

Suitable agriculturally acceptable salts are especially the salts of those cations or the acid addition salts of those acids whose cations and anions, respectively, do not have any adverse effect on the action of the compounds according to the present invention. Suitable cations are in particular the ions of the alkali metals, preferably lithium, sodium and potassium, of the alkaline earth metals, preferably calcium, magnesium and barium, and of the transition metals, preferably manganese, copper, zinc and iron, and also ammonium (NH ⁴⁺ ) and substituted ammonium in which one to four of the hydrogen atoms are replaced by Ci-C4-alkyl, Ci-C4-hydroxyalkyl, Ci-C4-alkoxy, Ci-C4-alkoxy- Ci-C4-alkyl, hydroxy-Ci-C4-alkoxy-Ci-C4-alkyl, phenyl or benzyl. Examples of substituted ammonium ions comprise methylammonium, isopropylammonium, dimethylammo- nium, diisopropylammonium, trimethylammonium, tetramethylammonium, tetrae- thylammonium, tetrabutylammonium, 2-hydroxyethylammonium, 2-(2-hydroxy- ethoxy)ethylammonium, bis(2-hydroxyethyl)ammonium, benzyltrimethylammonium and benzl-triethylammonium, furthermore phosphonium ions, sulfonium ions, preferably tri(Ci-C4-alkyl)sulfonium, and sulfoxonium ions, preferably tri(Ci-C4-alkyl)sulfoxonium. Anions of useful acid addition salts are primarily chloride, bromide, fluoride, hydrogen sulfate, sulfate, dihydrogen phosphate, hydrogen phosphate, phosphate, nitrate, hydrogen carbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate, and the anions of Ci-C4-alkanoic acids, preferably formate, acetate, propionate and butyr- ate. They can be formed by reacting a compound of formulae I with an acid of the cor- responding anion, preferably of hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or nitric acid.

By the term "veterinarily acceptable salts" is meant salts of those cations or anions which are known and accepted in the art for the formation of salts for veterinary use. Suitable acid addition salts, e.g. formed by compounds of formula I containing a basic nitrogen atom, e.g. an amino group, include salts with inorganic acids, for example hydrochloride, sulphates, phosphates, and nitrates and salts of organic acids for example acetic acid, maleic acid, dimaleic acid, fumaric acid, difumaric acid, methane sulfenic acid, methane sulfonic acid, and succinic acid.

The term "invertebrate pest" as used herein encompasses animal populations, such as insects, arachnids and nematodes, which may attack plants, thereby causing substantial damage to the plants attacked, as well as ectoparasites which may infest animals, in particular warm blooded animals such as e.g. mammals or birds, or other higher animals such as reptiles, amphibians or fish, thereby causing substantial damage to the animals infested.

The term "plant propagation material" is to be understood to denote all the generative parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e. g. potatoes), which can be used for the multiplication of the plant. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, shoots, sprouts and other parts of plants, including seedlings and young plants, which are to be transplanted after germination or after emergence from soil. The plant propagation materials may be treated prophylactically with a plant protection compound either at or before planting or transplanting. Said young plants may also be protected before transplantation by a total or partial treatment by immersion or pouring.

The term "plants" comprises any types of plants including "non-cultivated plants" and in particular "cultivated plants".

The term "non-cultivated plants" refers to any wild type species or related species or related genera of a cultivated plant.

The term "cultivated plants" is to be understood as including plants which have been modified by breeding, mutagenesis or genetic engineering including but not limiting to agricultural biotech products on the market or in development (cf.

http://www.bio.org/speeches/pubs/er/agri_products.asp). Genetically modified plants are plants, which genetic material has been so modified by the use of recombinant DNA techniques that under natural circumstances cannot readily be obtained by cross breeding, mutations or natural recombination. Typically, one or more genes have been integrated into the genetic material of a genetically modified plant in order to improve certain properties of the plant. Such genetic modifications also include but are not limited to targeted post-translational modification of protein(s), oligo- or polypeptides e. g. by glycosylation or polymer additions such as prenylated, acetylated or farnesylated moieties or PEG moieties. Plants that have been modified by breeding, mutagenesis or genetic engineering, e. g. have been rendered tolerant to applications of specific classes of herbicides, such as auxin herbicides such as dicamba or 2,4-D; bleacher herbicides such as hydroxyl- phenylpyruvate dioxygenase (HPPD) inhibitors or phytoene desaturase (PDS) inhibitors; acetolactate synthase (ALS) inhibitors such as sulfonyl ureas or imidazolinones; enolpyruvylshikimate-3-phosphate synthase (EPSPS) inhibitors, such as glyphosate; glutamine synthetase (GS) inhibitors such as glufosinate; protoporphyrinogen-IX oxidase inhibitors; lipid biosynthesis inhibitors such as acetyl CoA carboxylase (ACCase) inhibitors; or oxynil (i. e. bromoxynil or ioxynil) herbicides as a result of conventional methods of breeding or genetic engineering. Furthermore, plants have been made resistant to multiple classes of herbicides through multiple genetic modifications, such as resistance to both glyphosate and glufosinate or to both glyphosate and a herbicide from another class such as ALS inhibitors, HPPD inhibitors, auxin herbicides, or AC- Case inhibitors. These herbicide resistance technologies are e. g. described in Pest Managem. Sci. 61 , 2005, 246; 61 , 2005, 258; 61 , 2005, 277; 61 , 2005, 269; 61 , 2005, 286; 64, 2008, 326; 64, 2008, 332; Weed Sci. 57, 2009, 108; Austral. J. Agricult. Res. 58, 2007, 708; Science 316, 2007, 1 185; and references quoted therein. Several cultivated plants have been rendered tolerant to herbicides by conventional methods of breeding (mutagenesis), e. g. Clearfield ^® summer rape (Canola, BASF SE, Germany) being tolerant to imidazolinones, e. g. imazamox, or ExpressSun ^® sunflowers (DuPont, USA) being tolerant to sulfonyl ureas, e. g. tribenuron. Genetic engineering methods have been used to render cultivated plants such as soybean, cotton, corn, beets and rape, tolerant to herbicides such as glyphosate and glufosinate, some of which are commercially available under the trade names RoundupReady ^® (glyphosate-tolerant, Monsanto, U.S.A.), Cultivance ^® (imidazolinone tolerant, BASF SE, Germany) and Lib- ertyLink ^® (glufosinate-tolerant, Bayer CropScience, Germany).

Furthermore, plants are also covered that are by the use of recombinant DNA tech- niques capable to synthesize one or more insecticidal proteins, especially those known from the bacterial genus Bacillus, particularly from Bacillus thuringiensis, such as δ - endotoxins, e. g. CrylA(b), CrylA(c), CrylF, CrylF(a2), CryllA(b), CrylllA, CrylllB(bl ) or Cry9c; vegetative insecticidal proteins (VIP), e. g. VIP1 , VIP2, VIP3 or VIP3A; insecticidal proteins of bacteria colonizing nematodes, e. g. Photorhabdus spp. or Xenorhab- dus spp.; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins, or other insect-specific neurotoxins; toxins produced by fungi, such Streptomy- cetes toxins, plant lectins, such as pea or barley lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin or papain inhibitors; ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin; steroid metabolism enzymes, such as 3-hydroxysteroid oxidase, ecdysteroid-IDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors or HMG-CoA-reductase; ion channel blockers, such as blockers of sodium or calcium channels; juvenile hormone esterase; diuretic hormone receptors (helicokinin receptors); stilben synthase, bibenzyl synthase, chitinases or glucanases. In the context of the present invention these insecticidal proteins or toxins are to be understood expressly also as pre-toxins, hybrid proteins, truncated or otherwise modified proteins. Hybrid proteins are characterized by a new combination of protein domains, (see, e. g. WO 02/015701 ). Further examples of such toxins or genetically modified plants capable of synthesizing such toxins are disclosed, e. g., in EP-A 374 753, WO 93/007278, WO 95/34656, EP-A 427 529, EP-A 451 878, WO 03/18810 und WO 03/52073. The methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, e. g. in the publications mentioned above. These insecticidal proteins contained in the genetically modified plants impart to the plants producing these proteins tolerance to harmful pests from all taxonomic groups of athropods, especially to beetles (Coeloptera), two-winged insects (Diptera), and moths (Lepidoptera) and to nematodes (Nematoda). Genetically modified plants capable to synthesize one or more insecticidal proteins are, e. g., described in the publications mentioned above, and some of which are commercially available such as YieldGard ^® (corn cultivars producing the CrylAb toxin), YieldGard ^® Plus (corn cultivars producing Cry1 Ab and Cry3Bb1 toxins), Starlink ^® (corn cultivars producing the Cry9c toxin), Her- culex ^® RW (corn cultivars producing Cry34Ab1 , Cry35Ab1 and the enzyme Phosphino- thricin-N-Acetyltransferase [PAT]); NuCOTN ^® 33B (cotton cultivars producing the Cry1 Ac toxin), Bollgard ^® I (cotton cultivars producing the Cry1 Ac toxin), Bollgard ^® II (cotton cultivars producing CrylAc and Cry2Ab2 toxins); VIPCOT ^® (cotton cultivars producing a VIP-toxin); NewLeaf ^® (potato cultivars producing the Cry3A toxin); Bt- Xtra ^® , NatureGard ^® , KnockOut ^® , BiteGard ^® , Protecta ^® , Bt1 1 (e. g. Agrisure ^® CB) and Bt176 from Syngenta Seeds SAS, France, (corn cultivars producing the CrylAb toxin and PAT enyzme), MIR604 from Syngenta Seeds SAS, France (corn cultivars producing a modified version of the Cry3A toxin, c.f. WO 03/018810), MON 863 from Monsanto Europe S.A., Belgium (corn cultivars producing the Cry3Bb1 toxin), IPC 531 from Monsanto Europe S.A., Belgium (cotton cultivars producing a modified version of the CrylAc toxin) and 1507 from Pioneer Overseas Corporation, Belgium (corn cultivars producing the Cry1 F toxin and PAT enzyme).

Furthermore, plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the resistance or toler- ance of those plants to bacterial, viral or fungal pathogens. Examples of such proteins are the so-called " pathogenesis-related proteins" (PR proteins, see, e. g.

EP-A 392 225), plant disease resistance genes (e. g. potato cultivars, which express resistance genes acting against Phytophthora infestans derived from the mexican wild potato Solanum bulbocastanum) or T4-lysozym (e. g. potato cultivars capable of synthesizing these proteins with increased resistance against bacteria such as Erwinia amylvora). The methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, e. g. in the publications mentioned above.

Furthermore, plants are also covered that are by the use of recombinant DNA techniques capable to synthesize one or more proteins to increase the productivity (e. g. bio mass production, grain yield, starch content, oil content or protein content), tolerance to drought, salinity or other growth-limiting environmental factors or tolerance to pests and fungal, bacterial or viral pathogens of those plants.

Furthermore, plants are also covered that contain by the use of recombinant DNA techniques a modified amount of substances of content or new substances of content, specifically to improve human or animal nutrition, e. g. oil crops that produce health- promoting long-chain omega-3 fatty acids or unsaturated omega-9 fatty acids (e. g. Nexera ^® rape, DOW Agro Sciences, Canada).

Furthermore, plants are also covered that contain by the use of recombinant DNA techniques a modified amount of substances of content or new substances of content, specifically to improve raw material production, e. g. potatoes that produce increased amounts of amylopectin (e. g. Amflora ^® potato, BASF SE, Germany).

The organic moieties mentioned in the above definitions of the variables are - like the term halogen - collective terms for individual listings of the individual group members. The prefix C _n -C _m indicates in each case the possible number of carbon atoms in the group.

The term halogen denotes in each case fluorine, bromine, chlorine or iodine, in particular fluorine, chlorine or bromine.

The term "alkyl" as used herein and in the alkyl moieties of alkoxy, alkylthio, alkylsulfi- nyl, alkylsulfonyl, alkylcarbonyl, alkoxycarbonyl and the like refers to saturated straight- chain or branched hydrocarbon radicals having 1 to 2 ("Ci-C2-alkyl"), 1 to 3 ("C1-C3- alkyl"),1 to 4 ("Ci-C ₄ -alkyl"), 1 to 6 ("Ci-C ₆ -alkyl"), 1 to 8 ("Ci-C ₈ -alkyl") or 1 to 10 ("Ci- Cio-alkyl") carbon atoms. Ci-C2-Alkyl is methyl or ethyl. Ci-C3-Alkyl is additionally propyl and isopropyl. Ci-C ₄ -Alkyl is additionally butyl, 1 -methylpropyl (sec-butyl), 2- methylpropyl (isobutyl) or 1 ,1 -dimethylethyl (tert-butyl). Ci-C6-Alkyl is additionally also, for example, pentyl, 1 -methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1 - ethylpropyl, 1 ,1 -dimethylpropyl, 1 ,2-dimethylpropyl, hexyl, 1 -methylpentyl, 2- methylpentyl, 3-methylpentyl, 4-methylpentyl, 1 ,1 -dimethylbutyl, 1 ,2-dimethylbutyl, 1 ,3- dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1 -ethylbutyl, 2- ethylbutyl, 1 ,1 ,2-trimethylpropyl, 1 ,2,2-trimethylpropyl, 1 -ethyl-1 -methylpropyl, or 1 - ethyl-2-methylpropyl. Ci-Cs-Alkyl is additionally also, for example, heptyl, octyl, 2- ethylhexyl and positional isomers thereof. Ci-Cio-Alkyl is additionally also, for example, nonyl, decyl and positional isomers thereof.

The term "haloalkyl" as used herein, which is also expressed as "alkyl which is partially or fully halogenated", refers to straight-chain or branched alkyl groups having 1 to 2 ("Ci-C ₂ -haloalkyl"), 1 to 3 ("Ci-C ₃ -haloalkyl"), 1 to 4 ("Ci-C ₄ -haloalkyl"), 1 to 6 ("Ci-C ₆ - haloalkyl"), 1 to 8 ("Ci-C ₈ -haloalkyl") or 1 to 10 ("Ci-Cio-haloalkyl") carbon atoms (as mentioned above), where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as mentioned above: in particular Ci-C2-haloalkyl, such as chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1 - chloroethyl, 1 -bromoethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2- trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2- fluoroethyl, 2,2,2-trichloroethyl or pentafluoroethyl. Ci-C3-haloalkyl is additionally, for example, 1 -fluoropropyl, 2-fluoropropyl, 3-fluoropropyl, 1 ,1 -difluoropropyl, 2,2- difluoropropyl, 1 ,2-difluoropropyl, 3,3-difluoropropyl, 3,3,3-trifluoropropyl, heptafluoro- propyl, 1 ,1 ,1 -trifluoroprop-2-yl, 3-chloropropyl and the like. Examples for Ci-C ₄ - haloalkyl are, apart those mentioned for Ci-C3-haloalkyl, 4-chlorobutyl and the like. "Halomethyl" is methyl in which 1 , 2 or 3 of the hydrogen atoms are replaced by halogen atoms. Examples are bromomethyl, chloromethyl, fluoromethyl, dichloromethyl, trichloromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl and the like. The term "alkenyl" as used herein refers to monounsaturated straight-chain or branched hydrocarbon radicals having 2 to 3 ("C2-C3-alkenyl"), 2 to 4 ("C2-C ₄ -alkenyl"), 2 to 6 ("C ₂ -C ₆ -alkenyl"), 2 to 8 ("C ₂ -C ₈ -alkenyl") or 2 to 10 ("C ₂ -Cio-alkenyl") carbon atoms and a double bond in any position, for example C2-C3-alkenyl, such as ethenyl, 1- propenyl, 2-propenyl or 1-methylethenyl; C2-C4-alkenyl, such as ethenyl, 1-propenyl,

2- propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2- methyl-1-propenyl, 1-methyl-2-propenyl or 2-methyl-2-propenyl; C2-C6-alkenyl, such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1- methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1- pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3- methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-

3- butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl, 1,2- dimethyl-1-propenyl, 1,2-dimethyl-2-propenyl, 1-ethyl-1-propenyl, 1-ethyl-2-propenyl, 1- hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-1-pentenyl, 2-methyl-1- pentenyl, 3-methyl-1-pentenyl, 4-methyl-1-pentenyl, 1-methyl-2-pentenyl, 2-methyl-2- pentenyl, 3-methyl-2-pentenyl, 4-methyl-2-pentenyl, 1-methyl-3-pentenyl, 2-methyl-3- pentenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1-methyl-4-pentenyl, 2-methyl-4- pentenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1,1-dimethyl-2-butenyl, 1,1- dimethyl-3-butenyl, 1,2-dimethyl-1-butenyl, 1,2-dimethyl-2-butenyl, 1,2-dimethyl-3- butenyl, 1,3-dimethyl-1-butenyl, 1,3-dimethyl-2-butenyl, 1,3-dimethyl-3-butenyl, 2,2-dimethyl-3-butenyl, 2,3-dimethyl-1-butenyl, 2,3-dimethyl-2-butenyl, 2,3-dimethyl-3- butenyl, 3,3-dimethyl-1-butenyl, 3,3-dimethyl-2-butenyl, 1-ethyl-1-butenyl, 1 -ethyl-2- butenyl, 1-ethyl-3-butenyl, 2-ethyl-1-butenyl, 2-ethyl-2-butenyl, 2-ethyl-3-butenyl, 1,1,2- trimethyl-2-propenyl, 1-ethyl-1-methyl-2-propenyl, 1-ethyl-2-methyl-1-propenyl, 1-ethyl-

2- methyl-2-propenyl and the like, or C2-Cio-alkenyl, such as the radicals mentioned for C2-C6-alkenyl and additionally 1-heptenyl, 2-heptenyl, 3-heptenyl, 1-octenyl, 2-octenyl,

3- octenyl, 4-octenyl, 1-nonenyl, 2-nonenyl, 3-nonenyl, 4-nonenyl, 1-decenyl, 2-decenyl, 3-decenyl, 4-decenyl, 5-decenyl and the positional isomers thereof.

The term "haloalkenyl" as used herein, which is also expressed as "alkenyl which is partially or fully halogenated", refers to unsaturated straight-chain or branched hydrocarbon radicals having 2 to 3 ("C ₂ -C ₃ -haloalkenyl"), 2 to 4 ("C ₂ -C ₄ -haloalkenyl"), 2 to 6 ("C ₂ -C ₆ -haloalkenyl"), 2 to 8 ("C ₂ -C ₆ -haloalkenyl") or 2 to 10 ("C ₂ -Cio-haloalkenyl") car- bon atoms and a double bond in any position (as mentioned above), where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as mentioned above, in particular fluorine, chlorine and bromine, for example chlorovinyl, chloroallyl and the like. The term "alkynyl" as used herein refers to straight-chain or branched hydrocarbon groups having 2 to 3 ("C ₂ -C ₃ -alkynyl"), 2 to 4 ("C ₂ -C ₄ -alkynyl"), 2 to 6 ("C ₂ -C ₆ -alkynyl"), 2 to 8 ("C2-C8-alkynyl"), or 2 to 10 ("C2-Cio-alkynyl") carbon atoms and one or two triple bonds in any position, for example C2-C3-alkynyl, such as ethynyl, 1-propynyl or 2- propynyl; C2-C4-alkynyl, such as ethynyl, 1 -propynyl, 2-propynyl, 1 -butynyl, 2-butynyl, 3-butynyl, 1 -methyl-2-propynyl and the like, C2-C6-alkynyl, such as ethynyl, 1 -propynyl,

2- propynyl, 1 -butynyl, 2-butynyl, 3-butynyl, 1 -methyl-2-propynyl, 1 -pentynyl, 2-pentynyl,

3- pentynyl, 4-pentynyl, 1 -methyl-2-butynyl, 1 -methyl-3-butynyl, 2-methyl-3-butynyl, 3- methyl-1 -butynyl, 1 ,1 -dimethyl-2-propynyl, 1 -ethyl-2-propynyl, 1 -hexynyl, 2-hexynyl, 3- hexynyl, 4-hexynyl, 5-hexynyl, 1 -methyl-2-pentynyl, 1 -methyl-3-pentynyl, 1 -methyl-4- pentynyl, 2-methyl-3-pentynyl, 2-methyl-4-pentynyl, 3-methyl-1 -pentynyl, 3-methyl-4- pentynyl, 4-methyl-1 -pentynyl, 4-methyl-2-pentynyl, 1 ,1 -dimethyl-2-butynyl, 1 ,1 - dimethyl-3-butynyl, 1 ,2-dimethyl-3-butynyl, 2,2-dimethyl-3-butynyl, 3,3-dimethyl-1 - butynyl, 1 -ethyl-2-butynyl, 1 -ethyl-3-butynyl, 2-ethyl-3-butynyl, 1 -ethyl-1 -methyl-2- propynyl and the like;

The term "haloalkynyl" as used herein, which is also expressed as "alkynyl which is partially or fully halogenated", refers to unsaturated straight-chain or branched hydro- carbon radicals having 2 to 3 ("C ₂ -C ₃ -haloalkynyl"), 2 to 4 ("C ₂ -C ₄ -haloalkynyl"), 3 to 4 ("C ₃ -C ₄ -haloalkynyl"), 2 to 6 ("C ₂ -C ₆ -haloalkynyl"), 2 to 8 ("C ₂ -C ₈ -haloalkynyl") or 2 to 10 ("C2-Cio-haloalkynyl") carbon atoms and one or two triple bonds in any position (as mentioned above), where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as mentioned above, in particular fluorine, chlorine and bro- mine;

The term "cycloalkyl" as used herein refers to mono- or bi- or polycyclic saturated hydrocarbon radicals having 3 to 8 ("Cs-Cs-cycloalkyl"), in particular 3 to 6 ("C3-C6- cycloalkyl") or 3 to 5 ("C ₃ -C ₅ -cycloalkyl") or 3 to 4 ("C ₃ -C ₄ -cycloalkyl") carbon atoms. Examples of monocyclic radicals having 3 to 4 carbon atoms comprise cyclopropyl and cyclobutyl. Examples of monocyclic radicals having 3 to 5 carbon atoms comprise cyclopropyl, cyclobutyl and cyclopentyl. Examples of monocyclic radicals having 3 to 6 carbon atoms comprise cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. Examples of monocyclic radicals having 3 to 8 carbon atoms comprise cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl. Examples of bicyclic radicals having 7 or 8 carbon atoms comprise bicyclo[2.2.1 ]heptyl, bicyclo[3.1 .1 ]heptyl, bicy- clo[2.2.2]octyl and bicyclo[3.2.1 ]octyl. Preferably, the term cycloalkyl denotes a monocyclic saturated hydrocarbon radical. The term "halocycloalkyl" as used herein, which is also expressed as "cycloalkyl which is partially or fully halogenated", refers to mono- or bi- or polycyclic saturated hydrocarbon groups having 3 to 8 ("Cs-Cs-halocycloalkyl" ) or preferably 3 to 6 ("C3-C6- halocycloalkyl") or 3 to 5 ("C ₃ -C ₅ -halocycloalkyl") or 3 to 4 ("C ₃ -C ₄ -halocycloalkyl") car- bon ring members (as mentioned above) in which some or all of the hydrogen atoms are replaced by halogen atoms as mentioned above, in particular fluorine, chlorine and bromine. The term "cycloalkyl-Ci-C4-alkyl" refers to a Cs-Cs-cycloalkyl group ("Cs-Cs-cycloalkyl- Ci-C4-alkyl"), preferably a C3-C6-cycloalkyl group ("C3-C6-cycloalkyl-Ci-C4-alkyl"), more preferably a C3-C4-cycloalkyl group ("C3-C4-cycloalkyl-Ci-C4-alkyl") as defined above (preferably a monocyclic cycloalkyl group) which is bound to the remainder of the molecule via a Ci-C4-alkyl group, as defined above. Examples for C3-C4-cycloalkyl-Ci-C4- alkyl are cyclopropylmethyl, cyclopropylethyl, cyclopropylpropyl, cyclobutylmethyl, cy- clobutylethyl and cyclobutylpropyl, Examples for C3-C6-cycloalkyl-Ci-C4-alkyl, apart those mentioned for C3-C4-cycloalkyl-Ci-C4-alkyl, are cyclopentylmethyl, cyclopen- tylethyl, cyclopentylpropyl, cyclohexylmethyl, cyclohexylethyl and cyclohexyl propyl. Examples for C3-C8-cycloalkyl-Ci-C4-alkyl, apart those mentioned for C3-C6-cycloalkyl- Ci-C4-alkyl, are cycloheptylmethyl, cycloheptylethyl, cyclooctylmethyl and the like.

The term " C3-C6-cycloalkyl-methyl" refers to a C3-C6-cycloalkyl group which is bound to the remainder of the molecule via a methyl group Examples are cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl and cyclohexylmethyl.

The term "C3-C8-halocycloalkyl-Ci-C4-alkyl" refers to a Cs-Cs-halocycloalkyl group as defined above which is bound to the remainder of the molecule via a Ci-C4-alkyl group, as defined above. The term "cycloalkenyl" as used herein refers to monocyclic hydrocarbon radicals with at least one C-C double bond in the ring, which ring is however not aromatic, the hydrocarbon radicals having 3 to 8 ("Cs-Cs-cycloalkyl) carbon atoms. Examples are cy- clopropenyl, such as cycloprop-1 -enyl and cycloprop-2-yl, cyclobutenyl, such as cyclo- but-1 -enyl and cyclobut-2-enyl, cyclopentenyl, such as cyclopent-1 -enyl, cyclopent-2- enyl and cyclopent-3-enyl, cyclopentadienyl, such as cyclopenta-1 ,3-dienyl, cyclpenta- 1 ,4-dienyl and cyclpenta-2,4-dienyl, cyclohexenyl, such as cyclohex-1 -enyl, cyclohex-2- enyl and cyclohex-3-enyl, cyclohexadienyl, such as cyclohexa-1 ,3-dienyl, cyclohexa- 1 ,4-dienyl, cyclohexa-1 ,5-dienyl and cyclohexa-2,5-dienyl, cycloheptenyl, cycloheptadi- enyl, cycloheptatrienyl cyclooctenyl, cyclooctadieny, cyclooctatrienyl and cyclooctatet- raenyl.

The term "halocycloalkenyl" as used herein refers to monocyclic hydrocarbon radicals with at least one C-C double bond in the ring, which ring is however not aromatic, the hydrocarbon radicals having 3 to 8 ("Cs-Cs-halocycloalkyl") carbon atoms, and wherein some or all of the hydrogen atoms are replaced by halogen atoms as mentioned above, in particular fluorine, chlorine and bromine. The term "Ci-C2-alkoxy" is a Ci-C2-alkyl group, as defined above, attached via an oxygen atom. The term "Ci-C3-alkoxy" is a Ci-C3-alkyl group, as defined above, attached via an oxygen atom. The term "Ci-C4-alkoxy" is a Ci-C4-alkyl group, as defined above, attached via an oxygen atom. The term "Ci-C6-alkoxy" is a Ci-C6-alkyl group, as defined above, attached via an oxygen atom. The term "Ci-Cio-alkoxy" is a Ci-Cio-alkyl group, as defined above, attached via an oxygen atom. Ci-C2-Alkoxy is methoxy or ethoxy. Ci-C3-Alkoxy is additionally, for example, n-propoxy and 1 -methylethoxy (iso- propoxy). Ci-C ₄ -Alkoxy is additionally, for example, butoxy, 1 -methylpropoxy (sec- butoxy), 2-methylpropoxy (isobutoxy) or 1 ,1 -dimethylethoxy (tert-butoxy). Ci-C6-Alkoxy is additionally, for example, pentoxy, 1 -methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1 ,1 -dimethylpropoxy, 1 ,2-dimethylpropoxy, 2,2-dimethylpropoxy, 1 -ethyl propoxy, hexoxy, 1 -methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1 ,1 - dimethylbutoxy, 1 ,2-dimethylbutoxy, 1 ,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3- dimethylbutoxy, 3,3-dimethylbutoxy, 1 -ethylbutoxy, 2-ethyl butoxy, 1 ,1 ,2- trimethylpropoxy, 1 ,2,2-trimethylpropoxy, 1 -ethyl-1-methylpropoxy or 1 -ethyl-2- methylpropoxy. Ci-Cs-Alkoxy is additionally, for example, heptyloxy, octyloxy, 2- ethylhexyloxy and positional isomers thereof. Ci-Cio-Alkoxy is additionally, for example, nonyloxy, decyloxy and positional isomers thereof.

The term "Ci-C2-haloalkoxy" is a Ci-C2-haloalkyl group, as defined above, attached via an oxygen atom. The term "Ci-C3-haloalkoxy" is a Ci-C3-haloalkyl group, as defined above, attached via an oxygen atom. The term "Ci-C ₄ -haloalkoxy" is a Ci-C ₄ -haloalkyl group, as defined above, attached via an oxygen atom. The term "Ci-C6-haloalkoxy" is a Ci-C6-haloalkyl group, as defined above, attached via an oxygen atom. The term "Ci- Cio-haloalkoxy" is a Ci-Cio-haloalkyl group, as defined above, attached via an oxygen atom. Ci-C ₂ -Haloalkoxy is, for example, OCH ₂ F, OCHF ₂ , OCF ₃ , OCH ₂ CI, OCHC , OCC , chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 2- fluoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2- trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2- fluoroethoxy, 2,2,2-trichloroethoxy or OC2F5. Ci-C3-Haloalkoxy is additionally, for ex- ample, 2-fluoropropoxy, 3-fluoropropoxy, 2,2-difluoropropoxy, 2,3-difluoropropoxy,

2- chloropropoxy, 3-chloropropoxy, 2,3-dichloropropoxy, 2-bromopropoxy,

3- bromopropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, OCH2-C2F5, OCF2- C2F5, 1 -(CH ₂ F)-2-fluoroethoxy, 1 -(CH ₂ CI)-2-chloroethoxy or 1 -(CH ₂ Br)-2-bromoethoxy. Ci-C4-Haloalkoxy is additionally, for example, 4-fluorobutoxy, 4-chlorobutoxy, 4- bromobutoxy or nonafluorobutoxy. Ci-C6-Haloalkoxy is additionally, for example, 5- fluoropentoxy, 5-chloropentoxy, 5-brompentoxy, 5-iodopentoxy, undecafluoropentoxy, 6-fluorohexoxy, 6-chlorohexoxy, 6-bromohexoxy, 6-iodohexoxy or dodecafluorohexoxy.

The term "Ci-C3-alkoxy-Ci-C3-alkyl" as used herein, refers to a straight-chain or branched alkyl group having 1 to 3 carbon atoms, as defined above, where one hydrogen atom is replaced by a Ci-C3-alkoxy group, as defined above. The term "C1-C4- alkoxy-Ci-C4-alkyl" as used herein, refers to a straight-chain or branched alkyl group having 1 to 4 carbon atoms, as defined above, where one hydrogen atom is replaced by a Ci-C4-alkoxy group, as defined above. The term "Ci-C6-alkoxy-Ci-C6-alkyl" as used herein, refers to a straight-chain or branched alkyl group having 1 to 6 carbon atoms, as defined above, where one hydrogen atom is replaced by a Ci-C6-alkoxy group, as defined above. Examples are methoxymethyl, ethoxymethyl, propoxymethyl, isopropoxymethyl, n-butoxymethyl, sec-butoxymethyl, isobutoxymethyl, tert- butoxymethyl, 1 -methoxyethyl, 1 -ethoxyethyl, 1 -propoxyethyl, 1 -isopropoxyethyl, 1 -n- butoxyethyl, 1 -sec-butoxyethyl, 1 -isobutoxyethyl, 1 -tert-butoxyethyl, 2-methoxyethyl, 2- ethoxyethyl, 2-propoxyethyl, 2-isopropoxyethyl, 2-n-butoxyethyl, 2-sec-butoxyethyl, 2- isobutoxyethyl, 2-tert-butoxyethyl, 1 -methoxypropyl, 1 -ethoxypropyl, 1 -propoxypropyl, 1 -isopropoxypropyl, 1 -n-butoxypropyl, 1 -sec-butoxypropyl, 1 -isobutoxypropyl, 1 -tert- butoxypropyl, 2-methoxypropyl, 2-ethoxypropyl, 2-propoxypropyl, 2-isopropoxypropyl,

2- n-butoxypropyl, 2-sec-butoxypropyl, 2-isobutoxypropyl, 2-tert-butoxypropyl, 3- methoxypropyl, 3-ethoxypropyl, 3-propoxypropyl, 3-isopropoxypropyl, 3-n-butoxypropyl,

3- sec-butoxypropyl, 3-isobutoxypropyl, 3-tert-butoxypropyl and the like.

The term "Ci-C4-alkoxy-methyl" as used herein, refers to methyl in which one hydrogen atom is replaced by a Ci-C4-alkoxy group, as defined above. The term "Ci-C6-alkoxy- methyl" as used herein, refers to methyl in which one hydrogen atom is replaced by a Ci-C6-alkoxy group, as defined above. Examples are methoxymethyl, ethoxymethyl, propoxymethyl, isopropoxymethyl, n-butoxymethyl, sec-butoxymethyl, isobutoxymethyl, tert-butoxymethyl, pentyloxymethyl, hexyloxymethyl and the like.

Ci-C6-Haloalkoxy-Ci-C6-alkyl is a straight-chain or branched alkyl group having from 1 to 6, especially 1 to 4 carbon atoms (=Ci-C6-haloalkoxy-Ci-C4-alkyl), wherein one of the hydrogen atoms is replaced by a Ci-C6-alkoxy group and wherein at least one, e.g. 1 , 2, 3, 4 or all of the remaining hydrogen atoms (either in the alkoxy moiety or in the alkyl moiety or in both) are replaced by halogen atoms. Ci-C4-Haloalkoxy-Ci-C4-alkyl is a straight-chain or branched alkyl group having from 1 to 4 carbon atoms, wherein one of the hydrogen atoms is replaced by a Ci-C4-alkoxy group and wherein at least one, e.g. 1 , 2, 3, 4 or all of the remaining hydrogen atoms (either in the alkoxy moiety or in the alkyl moiety or in both) are replaced by halogen atoms. Examples are difluoro- methoxymethyl (CH F2OCH2), trifluoromethoxymethyl, 1 -difluoromethoxyethyl , 1 - trifluoromethoxyethyl, 2-difluoromethoxyethyl, 2-trifluoromethoxyethyl, difluoro- methoxy-methyl (CH3OCF2), 1 ,1 -difluoro-2-methoxyethyl, 2,2-difluoro-2-methoxyethyl and the like.

The term "Ci-C2-alkylthio" is a Ci-C2-alkyl group, as defined above, attached via a sul- fur atom. The term "Ci-C3-alkylthio" is a Ci-C3-alkyl group, as defined above, attached via a sulfur atom. The term "Ci-C4-alkylthio" is a Ci-C4-alkyl group, as defined above, attached via a sulfur atom. The term "Ci-C6-alkylthio" is a Ci-C6-alkyl group, as defined above, attached via a sulfur atom. The term "Ci-Cio-alkylthio" is a Ci-Cio-alkyl group, as defined above, attached via a sulfur atom. Ci-C2-Alkylthio is methylthio or ethylthio. Ci-C3-Alkylthio is additionally, for example, n-propylthio or 1 -methylethylthio (iso- propylthio). Ci-C4-Alkylthio is additionally, for example, butylthio, 1 -methylpropylthio (sec-butylthio), 2-methylpropylthio (isobutylthio) or 1 ,1 -dimethylethylthio (tert-butylthio). Ci-C6-Alkylthio is additionally, for example, pentylthio, 1 -methylbutylthio,

2-methylbutylthio, 3-methylbutylthio, 1 ,1 -dimethylpropylthio, 1 ,2-dimethylpropylthio, 2,2-dimethylpropylthio, 1 -ethylpropylthio, hexylthio, 1 -methylpentylthio, 2- methylpentylthio, 3-methylpentylthio, 4-methylpentylthio, 1 ,1 -dimethylbutylthio, 1 ,2- dimethylbutylthio, 1 ,3-dimethylbutylthio, 2,2-dimethylbutylthio, 2,3-dimethylbutylthio, 3,3-dimethylbutylthio, 1 -ethylbutylthio, 2-ethylbutylthio, 1 ,1 ,2-trimethylpropylthio, 1 ,2,2- trimethylpropylthio, 1 -ethyl-1 -methylpropylthio or 1-ethyl-2-methylpropylthio. Ci-Cs- Alkylthio is additionally, for example, heptylthio, octylthio, 2-ethylhexylthio and positional isomers thereof. Ci-Cio-Alkylthio is additionally, for example, nonylthio, decylthio and positional isomers thereof.

The term "Ci-C2-haloalkylthio" is a Ci-C2-haloalkyl group, as defined above, attached via a sulfur atom. The term "Ci-C3-haloalkylthio" is a Ci-C3-haloalkyl group, as defined above, attached via a sulfur atom. The term "Ci-C4-haloalkylthio" is a Ci-C4-haloalkyl group, as defined above, attached via a sulfur atom. The term "Ci-C6-haloalkylthio" is a Ci-C6-haloalkyl group, as defined above, attached via a sulfur atom. The term "C1-C10- haloalkylthio" is a Ci-Cio-haloalkyl group, as defined above, attached via a sulfur atom. Ci-C ₂ -Haloalkylthio is, for example, SCH ₂ F, SCHF ₂ , SCF ₃ , SCH ₂ CI, SCHC , SCCI ₃ , chlorofluoromethylthio, dichlorofluoromethylthio, chlorodifluoromethylthio, 2- fluoroethylthio, 2-chloroethylthio, 2-bromoethylthio, 2-iodoethylthio, 2,2- difluoroethylthio, 2,2,2-trifluoroethylthio, 2-chloro-2-fluoroethylthio, 2-chloro-2,2- difluoroethylthio, 2,2-dichloro-2-fluoroethylthio, 2,2,2-trichloroethylthio or SC ₂ F ₅ . C1-C3- Haloalkylthio is additionally, for example, 2-fluoropropylthio, 3-fluoropropylthio, 2,2- difluoropropylthio, 2,3-difluoropropylthio, 2-chloropropylthio, 3-chloropropylthio, 2,3- dichloropropylthio, 2-bromopropylthio, 3-bromopropylthio, 3,3,3-trifluoropropylthio, 3,3,3-trichloropropylthio, SCH2-C2F5, SCF2-C2F5, 1-(CH ₂ F)-2-fluoroethylthio, 1 -(CH ₂ CI)-

2- chloroethylthio or 1 -(CH2Br)-2-bromoethylthio. Ci-C4-Haloalkylthio is additionally, for example, 4-fluorobutylthio, 4-chlorobutylthio, 4-bromobutylthio or nonafluorobutylthio. Ci-C6-Haloalkylthio is additionally, for example, 5-fluoropentylthio, 5-chloropentylthio, 5-brompentylthio, 5-iodopentylthio, undecafluoropentylthio, 6-fluorohexylthio, 6- chlorohexylthio, 6-bromohexylthio, 6-iodohexylthio or dodecafluorohexylthio.

The term "C 1 -C2-a I ky Is u If i nyl" is a Ci-C2-alkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term "Ci -C3-a I kylsu If i nyl" is a Ci-C3-alkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term "Ci-C4-alkylsulfinyl" is a C1-C4- alkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term "C1-C6- alkylsulfinyl" is a Ci-C6-alkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term "Ci-Cio-alkylsulfinyl" is a Ci-Cio-alkyl group, as defined above, attached via a sulfinyl [S(O)] group. Ci-C2-Alkylsulfinyl is methylsulfinyl or ethylsulfinyl. Ci-C3-Alkylsulfinyl is additionally, for example, n-propylsulfinyl and 1 -methylethylsulfinyl (isopropylsulfinyl). C1-C4-AI kylsu If i nyl is additionally, for example, butylsulfinyl,

1 -methylpropylsulfinyl (sec-butylsulfinyl), 2-methylpropylsulfinyl (isobutylsulfinyl) or 1 ,1 - dimethylethylsulfinyl (tert-butylsulfinyl). Ci-C6-Alkylsulfinyl is additionally, for example, pentylsulfinyl, 1 -methylbutylsulfinyl, 2-methylbutylsulfinyl, 3-methylbutylsulfinyl, 1 ,1 - dimethylpropylsulfinyl, 1 ,2-dimethylpropylsulfinyl, 2,2-dimethylpropylsulfinyl, 1 - ethylpropylsulfinyl, hexylsulfinyl, 1 -methylpentylsulfinyl, 2-methylpentylsulfinyl,

3- methylpentylsulfinyl, 4-methylpentylsulfinyl, 1 ,1 -dimethylbutylsulfinyl, 1 ,2- dimethylbutylsulfinyl, 1 ,3-dimethylbutylsulfinyl, 2,2-dimethylbutylsulfinyl, 2,3- dimethylbutylsulfinyl, 3,3-dimethylbutylsulfinyl, 1 -ethylbutylsulf inyl , 2-ethylbutylsulfinyl,

1 ,1 ,2-trimethylpropylsulfinyl, 1 ,2,2-trimethylpropylsulfinyl, 1 -ethyl-1 -methylpropylsulfinyl or 1 -ethyl-2-methylpropylsulfinyl. d-Cs-Alkylsulfinyl is additionally, for example, hep- tylsulfinyl, octylsulfinyl, 2-ethylhexylsulfinyl and positional isomers thereof. C1-C10- Alkylsulfinyl is additionally, for example, nonylsulfinyl, decylsulfinyl and positional isomers thereof. The term "Ci-C2-haloalkylsulfinyl" is a Ci-C2-haloalkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term "Ci-C3-haloalkylsulfinyl" is a Ci-C3-haloalkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term "C1-C4- haloalkylsulfinyl" is a Ci-C4-haloalkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term "Ci-C6-haloalkylsulfinyl" is a Ci-C6-haloalkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term "Ci-Cio-haloalkylsulfinyl" is a Ci- Cio-haloalkyl group, as defined above, attached via a sulfinyl [S(O)] group. C1-C2- Haloalkylsulfinyl is, for example, S(0)CH ₂ F, S(0)CHF ₂ , S(0)CF ₃ , S(0)CH ₂ CI,

S(0)CHCl2, S(0)CCl3, chlorofluoromethylsulfinyl, dichlorofluoromethylsulfinyl, chlorodi- fluoromethylsulfinyl, 2-fluoroethylsulfinyl, 2-chloroethylsulfinyl, 2-bromoethylsulfinyl, 2- iodoethylsulfinyl, 2,2-difluoroethylsulfinyl, 2,2,2-trifluoroethylsulfinyl, 2-chloro-2- fluoroethylsulfinyl, 2-chloro-2,2-difluoroethylsulfinyl, 2,2-dichloro-2-fluoroethylsulfinyl, 2,2,2-trichloroethylsulfinyl or S(0)C2F ₅ . Ci-C3-Haloalkylsulfinyl is additionally, for exam- pie, 2-fluoropropylsulfinyl, 3-fluoropropylsulfinyl, 2,2-difluoropropylsulfinyl, 2,3- difluoropropylsulfinyl, 2-chloropropylsulfinyl, 3-chloropropylsulfinyl, 2,3- dichloropropylsulfinyl, 2-bromopropylsulfinyl, 3-bromopropylsulfinyl, 3,3,3- trifluoropropylsulfinyl, 3,3,3-trichloropropylsulfinyl, S(0)CH ₂ -C ₂ F ₅ , S(0)CF ₂ -C ₂ F ₅ , 1 - (CH ₂ F)-2-fluoroethylsulfinyl, 1 -(CH ₂ CI)-2-chloroethylsulfinyl and 1 -(CH ₂ Br)-2- bromoethylsulfinyl. Ci-C4-Haloalkylsulfinyl is additionally, for example,

4-fluorobutylsulfinyl, 4-chlorobutylsulfinyl, 4-bromobutylsulfinyl or nonafluorobutylsulfi- nyl. Ci-C6-Haloalkylsulfinyl is additionally, for example, 5-fluoropentylsulfinyl, 5- chloropentylsulfinyl, 5-brompentylsulfinyl, 5-iodopentylsulfinyl, undecafluoropentylsulfi- nyl, 6-fluorohexylsulfinyl, 6-chlorohexylsulfinyl, 6-bromohexylsulfinyl, 6-iodohexylsulfinyl or dodecafluorohexylsulfinyl.

The term "Ci-C ₂ -alkylsulfonyl" is a Ci-C ₂ -alkyl group, as defined above, attached via a sulfonyl [S(0) ₂ ] group. The term "Ci-C3-alkylsulfonyl" is a Ci-C3-alkyl group, as defined above, attached via a sulfonyl [S(0) ₂ ] group. The term "Ci-C4-alkylsulfonyl" is a C1-C4- alkyl group, as defined above, attached via a sulfonyl [S(0) ₂ ] group. The term "C1-C6- alkylsulfonyl" is a Ci-C6-alkyl group, as defined above, attached via a sulfonyl [S(0) ₂ ] group. The term "Ci-Cio-alkylsulfonyl" is a Ci-Cio-alkyl group, as defined above, attached via a sulfonyl [S(0) ₂ ] group. Ci-C ₂ -Alkylsulfonyl is methylsulfonyl or ethyl- sulfonyl. Ci-C3-Alkylsulfonyl is additionally, for example, n-propylsulfonyl or 1 - methylethylsulfonyl (isopropylsulfonyl). Ci-C4-Alkylsulfonyl is additionally, for example, butylsulfonyl, 1 -methylpropylsulfonyl (sec-butylsulfonyl), 2-methylpropylsulfonyl (isobu- tylsulfonyl) or 1 ,1 -dimethylethylsulfonyl (tert-butylsulfonyl). Ci-C6-Alkylsulfonyl is additionally, for example, pentylsulfonyl, 1 -methylbutylsulfonyl, 2-methylbutylsulfonyl, 3- methylbutylsulfonyl, 1 ,1 -dimethylpropylsulfonyl, 1 ,2-dimethylpropylsulfonyl,

2,2-dimethylpropylsulfonyl, 1 -ethylpropylsulfonyl, hexylsulfonyl, 1 -methylpentylsulfonyl, 2-methylpentylsulfonyl, 3-methylpentylsulfonyl, 4-methylpentylsulfonyl, 1 ,1 - dimethylbutylsulfonyl, 1 ,2-dimethylbutylsulfonyl, 1 ,3-dimethylbutylsulfonyl, 2,2- dimethylbutylsulfonyl, 2,3-dimethylbutylsulfonyl, 3,3-dimethylbutylsulfonyl, 1 - ethylbutylsulfonyl, 2-ethylbutylsulfonyl, 1 ,1 ,2-trimethylpropylsulfonyl, 1 ,2,2- trimethylpropylsulfonyl, 1 -ethyl-1 -methylpropylsulfonyl or 1 -ethyl-2- methylpropylsulfonyl. d-Cs-Alkylsulfonyl is additionally, for example, heptylsulfonyl, octylsulfonyl, 2-ethylhexylsulfonyl and positional isomers thereof. Ci-Cio-Alkylsulfonyl is additionally, for example, nonylsulfonyl, decylsulfonyl and positional isomers thereof.

The term "Ci-C2-haloalkylsulfonyl" is a Ci-C2-haloalkyl group, as defined above, attached via a sulfonyl [S(0)2] group. The term "Ci-C3-haloalkylsulfonyl" is a C1-C3- haloalkyl group, as defined above, attached via a sulfonyl [S(0)2] group. The term "Ci- C4-haloalkylsulfonyl" is a Ci-C4-haloalkyl group, as defined above, attached via a sulfonyl [S(0)2] group. The term "Ci-C6-haloalkylsulfonyl" is a Ci-C6-haloalkyl group, as defined above, attached via a sulfonyl [S(0)2] group. The term "C1-C10- haloalkylsulfonyl" is a Ci-Cio-haloalkyl group, as defined above, attached via a sulfonyl [S(0) ₂ ] group. Ci-C ₂ -Haloalkylsulfonyl is, for example, S(0) ₂ CH ₂ F, S(0) ₂ CHF ₂ ,

S(0) ₂ CF ₃ , S(0) ₂ CH ₂ CI, S(0) ₂ CHCI ₂ , S(0) ₂ CCI ₃ , chlorofluoromethylsulfonyl, dichloro- fluoromethylsulfonyl, chlorodifluoromethylsulfonyl, 2-fluoroethylsulfonyl, 2- chloroethylsulfonyl, 2-bromoethylsulfonyl, 2-iodoethylsulfonyl, 2,2-difluoroethylsulfonyl, 2,2,2-trifluoroethylsulfonyl, 2-chloro-2-fluoroethylsulfonyl, 2-chloro-2,2- difluoroethylsulfonyl, 2,2-dichloro-2-fluoroethylsulfonyl, 2,2,2-trichloroethylsulfonyl or S(0)2C2F ₅ . Ci-C3-Haloalkylsulfonyl is additionally, for example, 2-fluoropropylsulfonyl, 3-fluoropropylsulfonyl, 2,2-difluoropropylsulfonyl, 2,3-difluoropropylsulfonyl,

2- chloropropylsulfonyl, 3-chloropropylsulfonyl, 2,3-dichloropropylsulfonyl, 2- bromopropylsulfonyl, 3-bromopropylsulfonyl, 3,3,3-trifluoropropylsulfonyl, 3,3,3- trichloropropylsulfonyl, S(0) ₂ CH2-C2F ₅ , S(0)2CF2-C ₂ F ₅ , 1 -(CH ₂ F)-2-fluoroethylsulfonyl, 1 -(CH ₂ CI)-2-chloroethylsulfonylor 1 -(CH ₂ Br)-2-bromoethylsulfonyl. C1-C4- Haloalkylsulfonyl is additionally, for example, 4-fluorobutylsulfonyl, 4- chlorobutylsulfonyl, 4-bromobutylsulfonyl or nonafluorobutylsulfonyl. C1-C6- Haloalkylsulfonyl is additionally, for example, 5-fluoropentylsulfonyl, 5- chloropentylsulfonyl, 5-brompentylsulfonyl, 5-iodopentylsulfonyl, undecafluoropen- tylsulfonyl, 6-fluorohexylsulfonyl, 6-chlorohexylsulfonyl, 6-bromohexylsulfonyl, 6- iodohexylsulfonyl or dodecafluorohexylsulfonyl.

The substituent "oxo" replaces a CH2 group by a C(=0) group. The term "alkylcarbonyl" is a Ci-C6-alkyl ("Ci-C6-alkylcarbonyl"), preferably a C1-C4- alkyl ("Ci-C4-alkylcarbonyl") group, as defined above, attached via a carbonyl [C(=0)] group. Examples are acetyl (methylcarbonyl), propionyl (ethylcarbonyl), propylcarbonyl, isopropylcarbonyl, n-butylcarbonyl and the like. The term "haloalkylcarbonyl" is a Ci-C6-haloalkyl ("Ci-C6-haloalkylcarbonyl"), preferably a Ci-C4-haloalkyl ("Ci-C4-haloalkylcarbonyl") group, as defined above, attached via a carbonyl [C(=0)] group. Examples are trifluoromethylcarbonyl, 2,2,2- trifluoroethylcarbonyl and the like.

The term "alkoxycarbonyl" is a Ci-C6-alkoxy ("Ci-C6-alkoxycarbonyl"), preferably a Ci- C ₄ -alkoxy ("Ci-C ₄ -alkoxycarbonyl") group, as defined above, attached via a carbonyl [C(=0)] group. Examples are methoxycarbonyl), ethoxycarbonyl, propoxycarbonyl, iso- propoxycarbonyl, n-butoxycarbonyl and the like.

The term "haloalkoxycarbonyl" is a Ci-C6-haloalkoxy ("Ci-C6-haloalkoxycarbonyl"), preferably a Ci-C ₄ -haloalkoxy ("Ci-C ₄ -haloalkoxycarbonyl") group, as defined above, attached via a carbonyl [C(=0)] group. Examples are trifluoromethoxycarbonyl, 2,2,2- trifluoroethoxycarbonyl and the like.

The term "Ci-C6-alkylamino" is a group -N(H)Ci-C6-alkyl. Examples are methylamino, ethylamino, propylamino, isopropylamino, butylamino and the like. The term "di-(Ci-C6-alkyl)amino" is a group -N(Ci-C6-alkyl)2. Examples are dimethyla- mino, diethylamino, ethylmethylamino, dipropylamino, diisopropylamino, methylpropyl- amino, methylisopropylamino, ethylpropylamino, ethylisopropylamino, dibutylamino and the like. The term "aminocarbonyl" is a group -C(0)-NH2.

The term "Ci-C6-alkylaminocarbonyl" is a group -C(0)-N(H)Ci-C6-alkyl. Examples are methylaminocarbonyl, ethylaminocarbonyl, propylaminocarbonyl, isopropylaminocar- bonyl, butylaminocarbonyl and the like.

The term "di-(Ci-C6-alkyl)aminocarbonyl" is a group -C(0)-N(Ci-C6-alkyl)2. Examples are dimethylaminocarbonyl, diethylaminocarbonyl, ethylmethylaminocarbonyl, dipropyl- aminocarbonyl, diisopropylaminocarbonyl, methylpropylaminocarbonyl, methylisoprop- ylaminocarbonyl, ethylpropylaminocarbonyl, ethylisopropylaminocarbonyl, dibutyla- minocarbonyl and the like.

The term "3-, 4-, 5-, 6-, 7-, 8-, 9- or 10-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring containing 1 , 2 or 3 (or 4) heteroatoms or het- eroatom groups selected from N, O, S, NO, SO and SO2, as ring members" denotes a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or maximum unsaturated heteromonocyclic ring or a 8-, 9- or 10-membered saturated, partially unsaturated or maximally unsaturated heterobicyclic ring containing 1 , 2 or 3 (or 4) heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members.

Unsaturated rings contain at least one C-C and/or C-N and/or N-N double bond(s). Maximally unsaturated rings contain as many conjugated C-C and/or C-N and/or N-N double bonds as allowed by the ring size. Maximally unsaturated 5- or 6-membered heterocyclic rings are aromatic. The heterocyclic ring may be attached to the remainder of the molecule via a carbon ring member or via a nitrogen ring member. As a matter of course, the heterocyclic ring contains at least one carbon ring atom. If the ring contains more than one O ring atom, these are not adjacent. The term "3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or maximum unsaturated heterocyclic ring containing 1 , 2 or 3 (or 4) heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members" [wherein "maximum unsaturated" includes also "aromatic"] as used herein denotes monocyclic radicals, the monocyclic radicals being saturated, partially unsaturated or maximum unsaturated (including aromatic). The term "3-, 4-, 5-, 6-, 7- or 8-membered saturated, partially unsaturated or maximum unsaturated heterocyclic ring containing 1 , 2 or 3 (or 4) heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members" [wherein "maximum unsaturated" includes also "aromatic"] as used herein further also encompasses 8-membered heteromonocyclic radicals containing 1 , 2 or 3 (or 4) het- eroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, the monocyclic radicals being saturated, partially unsaturated or maximum unsaturated (including aromatic). Unsaturated rings contain at least one C-C and/or C-N and/or N-N double bond(s). Maximum unsaturated rings contain as many conjugated C-C and/or C-N and/or N-N double bonds as allowed by the ring size. Maximum un- saturated 5- or 6-membered heterocyclic rings are aromatic. 7- and 8-membered rings cannot be aromatic. They are homoaromatic (7-membered ring, 3 double bonds) or have 4 double bonds (8-membered ring). The heterocyclic ring may be attached to the remainder of the molecule via a carbon ring member or via a nitrogen ring member. As a matter of course, the heterocyclic ring contains at least one carbon ring atom. If the ring contains more than one O ring atom, these are not adjacent.

Examples of a 3-, 4-, 5-, 6- or 7-membered saturated heterocyclic ring include: Oxira- nyl, thiiranyl, aziridinyl, oxetanyl, thietanyl, azetidinyl, tetrahydrofuran-2-yl, tetrahydrofu- ran-3-yl, tetrahydrothien-2-yl, tetrahydrothien-3-yl, pyrrolidin-1 -yl, pyrrolidin-2-yl, pyrrol- idin-3-yl, pyrazolidin-1 -yl, pyrazolidin-3-yl, pyrazolidin-4-yl, pyrazolidin-5-yl, imidazoli- din-1 -yl, imidazolidin-2-yl, imidazolidin-4-yl, oxazolidin-2-yl, oxazolidin-3-yl, oxazolidin- 4-yl, oxazolidin-5-yl, isoxazolidin-2-yl, isoxazolidin-3-yl, isoxazolidin-4-yl, isoxazolidin-5- yl, thiazolidin-2-yl, thiazolidin-3-yl, thiazolidin-4-yl, thiazolidin-5-yl, isothiazolidin-2-yl, isothiazolidin-3-yl, isothiazolidin-4-yl, isothiazolidin-5-yl, 1 ,2,4-oxadiazolidin-3-yl, 1 ,2,4- oxadiazolidin-5-yl, 1 ,2,4-thiadiazolidin-3-yl, 1 ,2,4-thiadiazolidin-5-yl, 1 ,2,4-triazolidin-3- yl, 1 ,3,4-oxadiazolidin-2-yl, 1 ,3,4-thiadiazolidin-2-yl, 1 ,3,4-triazolidin-1 -yl, 1 ,3,4- triazolidin-2-yl, 2-tetrahydropyranyl, 4-tetrahydropyranyl, 1 ,3-dioxan-5-yl, 1 ,4-dioxan-2- yl, piperidin-1 -yl, piperidin-2-yl, piperidin-3-yl, piperidin-4-yl, hexahydropyridazin-3-yl, hexahydropyridazin-4-yl, hexahydropyrimidin-2-yl, hexahydropyrimidin-4-yl, hexahy- dropyrimidin-5-yl, piperazin-1 -yl, piperazin-2-yl, 1 ,3,5-hexahydrotriazin-l -yl,

1 ,3,5-hexahydrotriazin-2-yl and 1 ,2,4-hexahydrotriazin-3-yl, morpholin-2-yl, morpholin- 3-yl, morpholin-4-yl, thiomorpholin-2-yl, thiomorpholin-3-yl, thiomorpholin-4-yl, 1 - oxothiomorpholin-2-yl, 1 -oxothiomorpholin-3-yl, 1 -oxothiomorpholin-4-yl, 1 ,1 - dioxothiomorpholin-2-yl, 1 ,1 -dioxothiomorpholin-3-yl, 1 ,1 -dioxothiomorpholin-4-yl, aze- pan-1 -, -2-, -3- or -4-yl, oxepan-2-, -3-, -4- or -5-yl, hexahydro-1 ,3-diazepinyl, hexahy- dro-1 ,4-diazepinyl, hexahydro-1 ,3-oxazepinyl, hexahydro-1 ,4-oxazepinyl, hexahydro- 1 ,3-dioxepinyl, hexahydro-1 ,4-dioxepinyl and the like.

Examples of a 3-, 4-, 5-, 6- or 7-membered partially unsaturated heterocyclic ring include: 2,3-d ihyd rofur-2-yl , 2,3-dihydrofur-3-yl, 2 ,4-d ihyd rofur-2-yl , 2,4-dihydrofur-3-yl, 2,3-dihydrothien-2-yl, 2,3-dihydrothien-3-yl, 2,4-dihydrothien-2-yl, 2,4-dihydrothien-3-yl, 2-pyrrolin-2-yl, 2-pyrrolin-3-yl, 3-pyrrolin-2-yl, 3-pyrrolin-3-yl, 2-isoxazolin-3-yl,

3-isoxazolin-3-yl, 4-isoxazolin-3-yl, 2-isoxazolin-4-yl, 3-isoxazolin-4-yl, 4-isoxazolin-4-yl,

2- isoxazolin-5-yl, 3-isoxazolin-5-yl, 4-isoxazolin-5-yl, 2-isothiazolin-3-yl, 3-isothiazolin-

3- yl, 4-isothiazolin-3-yl, 2-isothiazolin-4-yl, 3-isothiazolin-4-yl, 4-isothiazolin-4-yl, 2-isothiazolin-5-yl, 3-isothiazolin-5-yl, 4-isothiazolin-5-yl, 2,3-dihydropyrazol-1 -yl,

2.3- dihydropyrazol-2-yl, 2,3-dihydropyrazol-3-yl, 2,3-dihydropyrazol-4-yl,

2,3-dihydropyrazol-5-yl, 3,4-dihydropyrazol-1 -yl, 3,4-dihydropyrazol-3-yl,

3.4- dihydropyrazol-4-yl, 3,4-dihydropyrazol-5-yl, 4,5-dihydropyrazol-1 -yl,

4.5- dihydropyrazol-3-yl, 4,5-dihydropyrazol-4-yl, 4,5-dihydropyrazol-5-yl,

2 , 3-d i hyd rooxazol-2-yl , 2 , 3-d i hyd rooxazol-3-yl , 2 , 3-d i hyd rooxazol-4-yl ,

2.3- dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl,

3,4-dihydrooxazol-4-yl, 3,4-dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl,

3.4- dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 2-, 3-, 4-, 5- or 6-di- or tetrahydropyridi- nyl, 3-di- or tetrahydropyridazinyl, 4-di- or tetrahydropyridazinyl, 2-di- or tetrahydropy- rimidinyl, 4-di- or tetrahydropyrimidinyl, 5-di- or tetrahydropyrimidinyl, di- or tetrahydro- pyrazinyl, 1 ,3,5-di- or tetrahydrotriazin-2-yl, 1 ,2,4-di- or tetrahydrotriazin-3-yl, 2,3,4,5- tetrahydro[1 H]azepin-1 -, -2-, -3-, -4-, -5-, -6- or -7-yl, 3,4,5,6-tetrahydro[2H]azepin-2-, -

3- , -4-, -5-, -6- or -7-yl, 2,3,4,7-tetrahydro[1 H]azepin-1 -, -2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,6,7-tetrahydro[1 H]azepin-1 -, -2-, -3-, -4-, -5-, -6- or -7-yl, tetrahydrooxepinyl, such as 2,3,4,5-tetrahydro[1 H]oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,4,7- tetrahydro[1 H]oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,6,7-tetrahydro[1 H]oxepin-2-, -3-, -

4- , -5-, -6- or -7-yl, tetrahydro-1 ,3-diazepinyl, tetrahydro-1 ,4-diazepinyl, tetrahydro-1 ,3- oxazepinyl, tetrahydro-1 ,4-oxazepinyl, tetrahydro-1 ,3-dioxepinyl and tetrahydro-1 ,4- dioxepinyl.

Examples for a 3-, 4-, 5-, 6- or 7-membered maximally unsaturated (including aromatic) heterocyclic ring are 5- or 6-membered heteroaromatic rings, such as 2-furyl, 3-furyl, 2- thienyl, 3-thienyl, 1 -pyrrolyl, 2-pyrrolyl, 3-pyrrolyl, 1-pyrazolyl, 3-pyrazolyl, 4-pyrazolyl,

5- pyrazolyl, 2-oxazolyl, 4-oxazolyl, 5-oxazolyl, 2-thiazolyl, 4-thiazolyl, 5-thiazolyl, 1 - imidazolyl, 2-imidazolyl, 4-imidazolyl, 1 ,3,4-triazol-1 -yl, 1 ,3,4-triazol-2-yl, 2-pyridinyl, 3- pyridinyl, 4-pyridinyl, 1 -oxopyridin-2-yl, 1 -oxopyridin-3-yl, 1 -oxopyridin-4-yl,3- pyridazinyl, 4-pyridazinyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl and 2-pyrazinyl, and also homoaromatic radicals, such as 1 H-azepine, 1 H-[1 ,3]-diazepine and 1 H-[1 ,4]- diazepine.

Examples for a 8-, 9- or 10-membered saturated heterobicyclic ring containing 1 , 2 or 3 (or 4) heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members are:

Examples for a 8-, 9- or 10-membered partially unsaturated heterobicyclic ring containing 1 , 2 or 3 (or 4) heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members are:

Examples for a 8-, 9- or 10-membered maximally unsaturated heterobicyclic ring containing 1 , 2 or 3 (or 4) heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members are:

In the above structures # denotes the attachment point to the remainder of the molecule. The attachment point is not restricted to the ring on which is shown, but can be on either of the fused rings, and may be on a carbon or on a nitrogen ring atom. If the rings carry one or more substituents, these may be bound to carbon and/or to nitrogen ring atoms (if the latter are not part of a double bond).

A saturated 3-, 4-, 5-, 6-, 7-, 8- or 9-membered ring, wherein the ring may contain 1 or 2 heteroatoms or heteroatom groups selected from O, S, N, NR ¹⁴ , NO, SO and SO2 and/or 1 or 2 groups selected from C=0, C=S and C=NR ¹⁴ as ring members is either carbocyclic or heterocyclic. Examples are, in addition to the saturated heteromonocy- die rings mentioned above, carbocyclic rings, such as cyclopropyl, cyclopropanonyl, cyclobutyl, cyclobutanonyl, cyclopentyl, cyclopentanonyl, cyclohexyl, cyclohexanonyl, cyclohexadienonyl, cycloheptyl, cycloheptanonyl, cyclooctyl, cyclooctanonyl, furan-2- onyl, pyrrolidine-2-onyl, pyrrolidine-2,5-dionyl, piperidine-2-only, piperidine-2,6-dionyl and the like.

The remarks made below concerning preferred embodiments of the variables of the compounds of formula I, especially with respect to their substituents A, A ¹ , A ² , A ³ , A ⁴ , B , B ² , B ³ , G, W, X, Y, R , R ² , R ^3a , R ^3b , R ^3c , R ^3d , R ^4a , R ^4b , R ⁵ , R ⁶ , R ^7a , R ^7b , R ⁸ , R ⁹ , R ^0a , R ^0b , R ¹¹ , R ² , R ³ , R ⁴ , R ^4a , R ⁴ , R ¹⁵ , R ¹⁶ , R ¹⁷ , R ^8a , R ⁸ , m and n, the features of the use and method according to the invention and of the composition of the invention are valid both on their own and, in particular, in every possible combination with each other.

In a preferred embodiment, X is selected from heterocyclic radicals of formulae 11.1 , II.2 and 11.3

wherein

# is the attachment point to the remainder of the molecule; and

G, A, R ^4a and R ^4b have one of the above general meanings, or, in particular, one of the below preferred meanings.

More preferably, X is the heterocyclic radical of formula 11.1. In a preferred embodiment, G is S.

In particular, X is the heterocyclic radical of formula 11.1 , in which G is S. In one embodiment of the invention, A is A ¹ .

In one preferred embodiment, A ¹ is CN.

In another preferred embodiment, A ¹ is selected from -C(=NR ⁶ )R ⁸ and -N(R ⁵ )R ⁶ and is more preferably -C(=NR ⁶ )R ⁸ ; wherein R ⁵ , R ⁶ and R ⁸ have one of the above general meanings, or, in particular, one of the below preferred meanings.

R ⁶ as a radical in the group -C(=NR ⁶ )R ⁸ is preferably selected from hydrogen, cyano, Ci-Cio-alkyl, Cs-Cs-cycloalkyl, C2-Cio-alkenyl, C2-Cio-alkynyl, wherein the four last- mentioned aliphatic and cycloaliphatic radicals each independently may be partially or fully halogenated and/or may be substituted with 1 , 2, 3, 4, 5 or 6, preferably 1 , 2 or 3, in particular 1 , substituents R ⁸ ; -OR ⁹ and -NR ^10a R ^10b ; wherein R ⁸ , R ⁹ , R ^10a and R ^10b have one of the above general meanings, or, in particular, one of the below preferred meanings. More preferably, R ⁶ in -C(=NR ⁶ )R ⁸ is selected from hydrogen, Ci-Cio-alkyl, Cs-Cs- cycloalkyl, wherein the two last-mentioned aliphatic and cycloaliphatic radicals each independently may be partially or fully halogenated and/or may be substituted with 1 , 2 or 3, preferably 1 or 2, in particular 1 , substituents R ⁸ ; OR ⁹ and NR ^10a R ^10b ; wherein R ⁸ , R ⁹ , R ^10a and R ^10b have one of the above general meanings, or, in particular, one of the below preferred meanings.

Even more preferably, R ⁶ in -C(=NR ⁶ )R ⁸ is selected from -OR ⁹ and -NR ^10a R ^10b ; wherein R ⁸ , R ⁹ , R ^10a and R ^10b have one of the above general meanings, or, in particular, one of the below preferred meanings.

In OR ⁹ as a preferred meaning of R ⁶ in -C(=NR ⁶ )R ⁸ , R ⁹ is preferably selected from hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, Cs-Cs-cycloalkyl, Cs-Cs-halocycloalkyl, C3-C8- cycloalkyl-Ci-C4-alkyl-, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl and C2-C6- haloalkynyl, and more preferably from hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, Cs-Cs- cycloalkyl, C3-Cs-halocycloalkyl and C3-C8-cycloalkyl-Ci-C4-alkyk

In NR ^10a R ^10b as a preferred meaning of R ⁶ in -C(=NR ⁶ )R ⁸ , R ^10a and R ^10b , independently of each other, are selected from the group consisting of hydrogen, Ci-C6-alkyl, C1-C6- haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, Cs-Cs- cycloalkyl, C3-Cs-halocycloalkyl, Ci-C6-alkylcarbonyl, Ci-C6-haloalkylcarbonyl,

-C(=0)OR ¹⁵ , -C(=0)N(R ^4a )R ⁴ , -C(=S)N(R ^4a )R ⁴ , phenyl which is optionally substituted with 1 , 2, 3 or 4 substituents R ¹⁶ , and a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring comprising 1 , 2, 3 or 4 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring is optionally substituted with one or more substituents R ¹⁶ ;

or R ^10a and R ^10b form together with the nitrogen atom they are bonded to a 3-, 4-, 5-, 6-, 7- or 8-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring, wherein the heterocyclic ring may additionally contain one or two heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring optionally carries one or more substituents selected from halogen, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio, Cs-Cs-cycloalkyl, Cs-Cs-halocycloalkyl, C2-C6-alkenyl, C2-C6- haloalkenyl, C2-C6-alkynyl and C2-C6-haloalkynyl;

wherein R ^14a , R ^14b , R ¹⁵ and R ¹⁶ have one of the above general meanings, or, in particular, one of the below preferred meanings. More preferably,

R ^10a is selected from hydrogen, Ci-C6-alkyl and Ci-C6-haloalkyl; and

R ¹⁰ is selected from Ci-C ₆ -alkyl, Ci-C ₆ -haloalkyl, d-Ce-alkylcarbonyl, Ci-C ₆ - haloalkylcarbonyl, -C(=0)OR ¹⁵ , -C(=0)N(R ^4a )R ⁴ , -C(=S)N(R ^4a )R ⁴ , phenyl which is optionally substituted with 1 , 2, 3 or 4 substituents R ¹⁶ , and a 5- or 6- membered heteroaromatic ring comprising 1 , 2 or 3 heteroatoms selected from N, O and S, as ring members, where the heteroaromatic ring is optionally substituted with one or more substituents R ¹⁶ ;

wherein R ^14a , R ^14b , R ¹⁵ and R ¹⁶ have one of the above general meanings, or, in particular, one of the below preferred meanings.

Even more preferably,

R ^10a is selected from hydrogen, Ci-C6-alkyl and Ci-C6-haloalkyl; and

R ^0b is selected from -C(=0)N(R ^4a )R ^4b and -C(=S)N(R ^4a )R ^4b ;

wherein R ^14a and R ^14b have one of the above general meanings, or, in particular, one of the below preferred meanings.

In the above radicals R ^10a and R ^10b ,

R ^14a is selected from hydrogen, Ci-C6-alkyl and Ci-C6-haloalkyl; and

R ^14b is selected from hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, C2-C6-alkenyl, C2-C6- haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C3-C6-cycloalkyl, C3-C6- halocycloalkyl, C3-C6-cycloalkyl-Ci-C4-alkyl-, Ci-C6-alkyl substituted with a CN group, Ci-C6-alkoxy, Ci-C6-haloalkoxy, phenyl which is optionally substituted with 1 , 2, 3 or 4 substituents each independently selected from the group consisting of halogen, cyano, nitro, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, C1-C4- haloalkoxy, Ci-C4-alkylthio, Ci-C4-haloalkylthio, C3-C6-cycloalkyl, C3-C6- halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl and C2-C4- haloalkynyl; and a heterocyclic ring selected from rings of formulae E-1 to E-54

E-1 E-2 E-3 E-4 E-5

E-6 E-7 E-8 E-9

E-10 E-11 E-12 E-13

E-15 E-16 E-17 E-18 E-19

E-20 E-21 E-22 E-23 E-24

E-25 E-26 E-27 E-28 E-29

E-30 E-31 E-32 E-33 E-34

E-40 E-41 E-42 E-43 E-44

(R ¹⁶ ) _k (R ¹⁶ ) _k

E-45 E-46 E-47 E-48 E-49

E-50 E-51 E-52 E-53 E-54 wherein

k is 0, 1 , 2 or 3,

n is 0, 1 or 2; and

each R ¹⁶ is independently selected from the group consisting of halogen, cyano, ni- tro, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, Ci-C4-haloalkylthio, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, C1-C4- alkylsulfonyl, Ci-C4-haloalkylsulfonyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C2- C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, Ci-C4-alkylcarbonyl, Ci-C4-haloalkylcarbonyl, aminocarbonyl, Ci-C4-alkylaminocarbonyl and di-(Ci-C4-alkyl)aminocarbonyl; or

two R ¹⁶ present on the same carbon atom of a saturated ring may form together =0 or =S.

More preferably, in the above radicals R ^10a and R ^10b ,

R ^14a is selected from hydrogen and methyl; and

R ^14b is selected from hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl, C2-C4-alkenyl, C2-C4- haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, C3-C6-cycloalkyl, C3-C6- halocycloalkyl, C3-C6-cycloalkyl-methyl-, C3-C6-cycloalkyl substituted with a CN group, Ci-C6-alkoxy, Ci-C6-haloalkoxy, phenyl which is optionally substituted with 1 , 2, 3 or 4, preferably 1 , 2 or 3, in particular 1 , substituents R ¹⁶ selected from the group consisting of halogen, cyano, nitro, Ci-C4-alkyl, Ci-C4-haloalkyl, C1-C4- alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, Ci-C4-haloalkylthio, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl and C2-C4- haloalkynyl; and a 4-membered saturated heterocyclic ring comprising one heteroatom or heteroatom group selected from S, SO and SO2 as ring member (ring E-44), where the heterocyclic ring is optionally substituted with one or more, preferably 1 or 2, in particular 1 , substituents R ¹⁶ ;

wherein each R ¹⁶ is independently selected from the group consisting of halogen, cyano, nitro, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, C1-C4- alkylthio, Ci-C4-haloalkylthio, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C2-C4- alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl and C2-C4-haloalkynyl; or

two R ¹⁶ present on the same carbon atom may form together a group =0 or =S. Even more preferably, in the above radicals R ^10a and R ^10b ,

R ^14a is selected from hydrogen and methyl; and

R ^14b is selected from hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl, C2-C4-alkenyl, C2-C4- haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, C3-C6-cycloalkyl, C3-C6- halocycloalkyi, C3-C6-cycloalkyl-methyl-, C3-C6-cycloalkyl substituted with a CN group, Ci-C6-alkyl substituted with a CN group, Ci-C6-alkoxy and C1-C6- haloalkoxy.

Preferably, in the above radicals, each R ¹⁶ is independently selected from halogen, CN, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy.

R ⁸ as a radical in the group -C(=NR ⁶ )R ⁸ is preferably selected from hydrogen, C1-C4- alkyl, Ci-C4-haloalkyl and NR ^10a R ^10b , and more preferably from hydrogen and

NR ^10a R ^10b , and is specifically hydrogen,

wherein R ^10a and R ^10b have one of the above general meanings, or, in particular, one of the below preferred meanings.

In this case (i.e. in NR ^10a R ^10b as a meaning of R ⁸ ), R ^10a and R ^10b are preferably selected, independently of each other, from hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl, C2-C4- alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, C3-C6-cycloalkyl, C3-C6- halocycloalkyl, Ci-C4-alkylcarbonyl, Ci-C4-haloalkylcarbonyl, Ci-C4-alkylaminocarbonyl, Ci-C4-haloalkylaminocarbonyl, C3-C6-cycloalkylaminocarbonyl and C3-C6- halocycloalkylaminocarbonyl,

or, together with the nitrogen atom to which they are bound, form a 5- or 6-membered saturated, partially unsaturated or aromatic heterocyclic ring, which additionally may contain 1 or 2 further heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring may carry 1 or 2, in particular 1 , substituents selected from halogen, CN , Ci-C4-alkyl, Ci-C4-haloalkyl, C2-C4- alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, C3-C6-cycloalkyl, C3-C6- halocycloalkyi, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio and Ci-C4-haloalkylthio.

More preferably, R ^10a and R ^10b are in this case selected, independently of each other, from hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, Ci- C4-alkylaminocarbonyl and Ci-C4-haloalkylaminocarbonyl.

In an alternative embodiment of the invention, A is A ² .

In A ² , W is preferably O. In A ² , Y is preferably N(R ⁵ )R ⁶ ; wherein R ⁵ and R ⁶ have one of the above general meanings, or, in particular, one of the below preferred meanings. In an alternatively preferred embodiment, in A ² Y is hydrogen.

In an alternatively preferred embodiment, in A ² Y is -OR ⁹ . R ⁹ has one of the above general meanings, or, in particular, is selected from hydrogen, Ci-C6-alkyl, C1-C6- haloalkyl and Ci-C6-alkyl substituted by one radical R ¹³ , where R ¹³ has one of the above general meanings, or, in particular, one of the below preferred meanings and is preferably selected from CN, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, C1-C6- haloalkylthio, Ci-C6-alkylsulfinyl, Ci-C6-haloalkylsulfinyl, Ci-C6-alkylsulfonyl, C1-C6- haloalkylsulfonyl and a heterocyclic ring selected from rings of formulae E-1 to E-54 as defined above.

More preferably, in A ² , W is O and Y is -N(R ⁵ )R ⁶ ; wherein R ⁵ and R ⁶ have one of the above general meanings, or, in particular, one of the below preferred meanings.

In alternatively more preferred embodiment, in A ² , W is O and Y H.

In alternatively more preferred embodiment, in A ² , W is O and Y is -OR ⁹ , where R ⁹ has one of the above general meanings, or, in particular, is selected from hydrogen, C1-C6- alkyl, Ci-C6-haloalkyl and Ci-C6-alkyl substituted by one radical R ¹³ , where R ¹³ has one of the above general meanings, or, in particular, one of the below preferred meaning- sand is preferably selected from CN, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio, Ci-C6-alkylsulfinyl, Ci-C6-haloalkylsulfinyl, Ci-C6-alkylsulfonyl, Ci- C6-haloalkylsulfonyl and a heterocyclic ring selected from rings of formulae E-1 to E-54 as defined above. In -N(R ⁵ )R ⁶ as a radical Y,

R ⁵ is preferably selected from hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, Cs-Cs-cycloalkyl and C3-C8- halocycloalkyl, where the aforementioned aliphatic and cycloaliphatic radicals may be substituted by 1 , 2 or 3, preferably 1 , radicals R ⁸ ; and

R ⁶ is preferably selected from hydrogen, Ci-Cio-alkyl, Cs-Cs-cycloalkyl, C2-C10- alkenyl, C2-Cio-alkynyl, wherein the four last-mentioned aliphatic and cycloaliphatic radicals may be partially or fully halogenated and/or may be substituted by one or more, preferably 1 , 2 or 3, in particular 1 , substituents R ⁸ , -OR ⁹ , -NR ^10a R ^10b , -S(0) _n R ⁹ , -C(=O)NR ^0a N(R ^0a R ^0b ), -C(=0)R ⁸ , -CH=NOR ⁹ , phenyl which may be substituted with 1 , 2, 3, 4, or 5, preferably 1 , 2 or 3, in particular 1 , substituents R ¹¹ , and

a 3-, 4-, 5-, 6-, 7-, 8-, 9- or 10-membered saturated, partially unsaturated or maximally unsaturated heteromonocyclic or heterobicyclic ring containing 1 , 2, 3 or 4 heteroatoms or heteroatom groups independently selected from N, O, S, NO, SO and SO2, as ring members, where the heteromonocyclic or heterobicyclic ring may be substituted with one or more, preferably 1 , 2 or 3, in particular 1 , substituents R ¹¹ ;

or

R ⁵ and R ⁶ , together with the nitrogen atom to which they are bound, form a 3-, 4-, 5-, 6-, 7- or 8-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring, where the ring may further contain 1 , 2, 3 or 4 heteroatoms or heteroatom-containing groups selected from O, S, SO, SO2, N, NH, C=0 and C=S as ring members, wherein the heterocyclic ring may be substituted with 1 , 2, 3, 4 or 5, preferably 1 , 2 or 3, in particular 1 , substituents independently selected from the group consisting of halogen, cyano, Ci-C6-alkyl, Ci-C6-haloalkyl, C1-C6- alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio, Cs-Cs-cycloalkyl, C3-C8-halocycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6- haloalkynyl, wherein the aliphatic or cycloaliphatic moieties in the twelve last- mentioned radicals may be substituted by one or more, preferably 1 , 2 or 3, in particular 1 , radicals R ⁸ , and phenyl which may be substituted with 1 , 2, 3, 4 or 5, preferably 1 , 2 or 3, in particular 1 , substituents R ¹¹

or

R ⁵ and R ⁶ together form a group =C(R ⁸ ) ₂ , =S(0) _m (R ⁹ ) ₂ , =NR ^10a or =NOR ⁹ ;

wherein R ⁸ , R ⁹ , R ^10a , R ^10b and R ¹¹ have one of the above general meanings, or, in particular, one of the below preferred meanings.

More preferably, in -N(R ⁵ )R ⁶ as a radical Y,

R ⁵ is selected from hydrogen, Ci-C6-alkyl, C2-C3-alkynyl and -CH2-CN; and

R ⁶ is selected from hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, C2-C6-alkenyl, C2-C6- haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, C3-C6-cycloalkyl, C3-C6- halocycloalkyl, where the eight last-mentioned aliphatic and cycloaliphatic radicals may carry 1 , 2 or 3 radicals R ⁸ ; d-C ₆ -alkoxy, Ci-C ₆ -haloalkoxy, -N(R ^10a )R ^10b , -CH=NOR ⁹ , phenyl which may be substituted with 1 , 2, 3, 4, or 5 substituents R ¹¹ , and a 3-, 4-, 5- or 6-membered saturated, partially unsaturated or maximally unsaturated heteromonocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups independently selected from N, O, S, NO, SO and SO2, as ring members, where the heteromonocyclic ring may be substituted with one or more substitu- ents R ¹¹ ;

wherein R ⁸ , R ⁹ , R ^10a , R ^10b and R ¹¹ have one of the above general meanings, or, in particular, one of the below preferred meanings;

or

R ⁵ and R ⁶ , together with the nitrogen atom to which they are bound, form a 3-, 4-, 5- or 6-membered saturated heterocyclic ring, where the ring may further contain 1 or 2 heteroatoms or heteroatom-containing groups selected from O, S, SO, SO2, NH and C=0 as ring members, wherein the heterocyclic ring may be substi- tuted with 1 , 2, 3, 4 or 5, preferably 1 , 2 or 3, in particular 1 , substituents independently selected from the group consisting of halogen, cyano, Ci-C6-alkyl, Ci- C6-haloalkyl, Ci-C6-alkoxy and Ci-C6-haloalkoxy;

or

R ⁵ and R ⁶ , together with the nitrogen atom to which they are bound, form a group =S(R ⁹ ) ₂ , where R ⁹ is selected from d-Ce-alkyl and Ci-C ₆ -haloalkyl.

Even more preferably, in -N(R ⁵ )R ⁶ as a radical Y,

R ⁵ is selected from hydrogen, Ci-C6-alkyl, C2-C3-alkynyl and CH2-CN; and

R ⁶ is selected from hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C4-alkyl which carries one radical R ⁸ , C2-C6-alkenyl, C2-Cio-haloalkenyl, C2-C6-alkynyl, C3-C6-cycloalkyl which may be substituted by 1 or 2 substituents selected from F, CN and pyridyl;

-N(R ^0a )R ^0b , -CH=NOR ⁹ ,

phenyl which may be substituted with 1 , 2, 3, 4, or 5, preferably 1 , 2 or 3, in particular 1 , substituents R ¹¹ , and a 3-, 4-, 5- or 6-membered saturated, partially un- saturated or maximally unsaturated heteromonocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups independently selected from N, O, S, NO, SO and SO2, as ring members, where the heteromonocyclic ring may be substituted with one or more, preferably 1 , 2 or 3, in particular 1 , substituents R ¹¹ ;

wherein R ⁸ , R ⁹ , R ^10a , R ^10b and R ¹¹ have one of the above general meanings, or, in particular, one of the below preferred meanings;

or

R ⁵ and R ⁶ , together with the nitrogen atom to which they are bound, form a 3-, 4-, 5- or 6-membered saturated heterocyclic ring, where the ring may further contain 1 or 2 heteroatoms or heteroatom-containing groups selected from O, S, SO, SO2, NH and C=0 as ring members, wherein the heterocyclic ring may be substituted with 1 , 2 or 3, in particular 1 , substituents independently selected from the group consisting of halogen, cyano, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy and Ci-C6-haloalkoxy; or

R ⁵ and R ⁶ , together with the nitrogen atom to which they are bound, form a group where R ⁹ is selected from Ci-C6-alkyl and Ci-C6-haloalkyl. Particularly preferably, in -N(R ⁵ )R ⁶ as a radical Y,

R ⁵ selected from hydrogen, Ci-C6-alkyl, C2-C3-alkynyl and Chb-CN; and

R ⁶ is selected from hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C4-alkyl which carries one radical R ⁸ , C2-C6-alkenyl, C2-Cio-haloalkenyl, C2-C6-alkynyl, C3-C6-cycloalkyl which may be substituted by 1 or 2 substituents selected from F, CN and pyridyl; -N(R ^0a )R ^0b ,

wherein

R ^10a is selected from hydrogen and Ci-C6-alkyl; and

R ^10b is selected from hydrogen, -C(=0)N(R ^14a )R ^14b , phenyl, optionally substituted with 1 , 2, 3, 4 or 5 substituents R ¹⁶ , and a heterocyclic ring selected from rings of formulae E-1 to E-54 as defined above;

-CH=NOR ⁹ , wherein R ⁹ is selected from hydrogen, Ci-C6-alkyl and C1-C6- haloalkyl;

phenyl which may be substituted with 1 , 2, 3, 4, or 5, preferably 1 , 2 or 3, in particular 1 , substituents R ¹¹ , and

a 3-, 4-, 5- or 6-membered saturated, partially unsaturated or maximally unsaturated heteromonocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups independently selected from N, O, S, NO, SO and SO2, as ring members, where the heteromonocyclic ring may be substituted with one or more, preferably 1 , 2 or 3, in particular 1 , substituents R ¹¹ ;

wherein

each R ¹¹ is independently selected from the group consisting of halogen, cy- ano, nitro, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci- C4-alkylthio, Ci-C4-haloalkylthio, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C2- C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl and C2-C4-haloalkynyl; or two R ¹¹ present on the same carbon atom of a saturated heterocyclic ring may form together =0 or =S;

each R ⁸ is independently selected from OH, CN, Cs-Cs-cycloalkyl which

optionally carries a CN substituent, Cs-Cs-halocycloalkyl, Ci-C6-alkoxy, Ci- C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio, Ci-C6-alkylsulfonyl, Ci- Ce-haloalkylsulfonyl, -C(=O)N(R ^10a )R ^10b , phenyl, optionally substituted with

1 , 2, 3, 4 or 5, preferably 1 , 2 or 3, in particular 1 , substituents R ¹⁶ , and a 3- , 4-, 5- or 6-membered saturated, partially unsaturated or maximally unsaturated heteromonocyclic ring containing 1 , 2 or 3 heteroatoms or het- eroatom groups independently selected from N, O, S, NO, SO and SO2, as ring members, where the heteromonocyclic ring may be substituted with one or more, preferably 1 , 2 or 3, in particular 1 , substituents R ¹⁶ ;

wherein

R ^10a is selected from the group consisting of hydrogen, Ci-C6-alkyl, C2-C3- alkynyl and CH ₂ -CN;

R ^10b is selected from the group consisting of hydrogen, Ci-C6-alkyl, C2-C4- alkenyl, C ₂ -C ₄ -alkynyl, CH ₂ -CN, Ci-C ₆ -haloalkyl, C ₃ -C ₆ -cycloalkyl, C ₃ - C6-halocycloalkyl, C3-C6-cycloalkylmethyl, Ci-C6-alkoxy, C1-C6- haloalkoxy, phenyl which is optionally substituted with 1 , 2, 3, 4 or 5, preferably 1 , 2 or 3, in particular 1 , substituents selected from the group consisting of halogen, cyano, nitro, Ci-C ₄ -alkyl, Ci-C ₄ -haloalkyl, C2-C ₄ -alkenyl, C2-C ₄ -haloalkenyl, C2-C ₄ -alkynyl, C2-C ₄ -haloalkynyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, Ci-C ₄ -alkoxy, C1-C4- haloalkoxy, Ci-C ₄ -alkylthio and Ci-C ₄ -haloalkylthio; and a heterocyclic ring selected from rings of formulae E-1 to E-54 as defined above; and

each R ¹⁶ as a substituent on phenyl or the heterocyclic rings is independently selected from the group consisting of halogen, cyano, nitro, Ci-C ₄ -alkyl, Ci-C ₄ -haloalkyl, Ci-C ₄ -alkoxy, Ci-C ₄ -haloalkoxy, C1-C4- alkylthio, Ci-C ₄ -haloalkylthio, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C2-C ₄ -alkenyl, C2-C ₄ -haloalkenyl, C2-C ₄ -alkynyl and C2-C4- haloalkynyl; or

two R ¹⁶ present on the same carbon atom of a saturated heterocyclic ring may form together =0 or =S; or

R ⁵ and R ⁶ , together with the nitrogen atom to which they are bound, form a 5- or 6-membered saturated heterocyclic ring, where the ring may further contain 1 or 2 heteroatoms or heteroatom-containing groups selected from O, S, SO, SO2, NH and C=0 as ring members, wherein the heterocyclic ring may be substituted with 1 , 2 or 3, in particular 1 , substituents independently selected from the group consisting of halogen, cyano, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy and C1-C6- haloalkoxy; or

R ⁵ and R ⁶ together form a group where R ⁹ is selected from Ci-C6-alkyl and Ci-C6-haloalkyl. In particular, in N(R ⁵ )R ⁶ as a radical Y,

R ⁵ is hydrogen or Ci-C3-alkyl;

R ⁶ is selected from hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C4-alkyl which carries one radical R ⁸ , wherein R ⁸ is as defined below; C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C3-C6-cycloalkyl which may be substituted by 1 or 2 substituents selected from F, CN and pyridyl;

-N(R ^10a )R ^10b , wherein R ^10a is selected from hydrogen and d-Ce-alkyl and R ^10b is selected from hydrogen, -C(=0)N(R ^14a )R ^14b , wherein R ^14a is selected from the group consisting of hydrogen and Ci-C6-alkyl and R ^14b is selected from the group consisting of hydrogen, Ci-C6-alkyl, C2-C4-alkynyl, Chb-CN, Ci-C6-haloalkyl, C3- C6-cycloalkyl, C3-C6-halocycloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy; phenyl, optionally substituted with 1 , 2, 3, 4 or 5, preferably 1 , 2 or 3, in particular 1 , substituents R ¹¹ , wherein R ¹¹ is as defined below; and a heteroaromatic ring selected from rings of formulae F-1 to F-54;

-CH=NOR ⁹ , wherein R ⁹ is selected from hydrogen, Ci-C6-alkyl and C1-C6- haloalkyl;

phenyl which may be substituted with 1 , 2, 3, 4, or 5, preferably 1 , 2 or 3, in particular 1 , substituents R ¹¹ , wherein R ¹¹ is as defined below; and a heteromonocy- clic ring selected from rings of formulae F-1 to F-54

F-1 F-2 F-3 F-5

F-6 F-8 F-9

F-10 F-11 F-12 F-13 F-14

F-15 F-16 F-17 F-18 F-19

F-51 F-52 F-53 F-54 wherein

k is 0, 1 , 2 or 3,

n is 0, 1 or 2, and

each R ¹¹ is independently selected from the group consisting of halogen, cy- ano, nitro, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci- C4-alkylthio, Ci-C4-haloalkylthio, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C4-haloalkylsulfonyl, C3-C6-cycloalkyl, C3-C6- halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4- haloalkynyl, Ci-C4-alkylcarbonyl, Ci-C4-haloalkylcarbonyl, aminocarbonyl, Ci-C4-alkylaminocarbonyl and di-(Ci-C4-alkyl)-aminocarbonyl; or two R ¹¹ present on the same carbon atom of a saturated heterocyclic ring may form together =0 or =S;

R ⁸ is selected from OH, CN, Cs-Cs-cycloalkyl which optionally carries a CN substituent, Cs-Cs-halocycloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, C1-C6- alkylthio, Ci-C6-haloalkylthio, Ci-C6-alkylsulfinyl, Ci-C6-haloalkylsulfinyl, Ci- Ce-alkylsulfonyl, Ci-C ₆ -haloalkylsulfonyl, -C(=O)N(R ^10a )R ^10b , phenyl, optionally substituted with 1 , 2, 3, 4 or 5, preferably 1 , 2 or 3, in particular 1 , sub- stituents R ¹⁶ , and a heterocyclic ring selected from rings of formulae E-1 to E-54 as defined above;

wherein

R ^10a is selected from the group consisting of hydrogen and Ci-C6-alkyl; R ^10b is selected from the group consisting of hydrogen, Ci-C6-alkyl, C1-C6- haloalkyl, C2-C4-alkynyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, Chb-

CN, Ci-C6-alkoxy and Ci-C6-haloalkoxy; and

each R ¹⁶ as a substituent on phenyl or heterocyclic rings of formulae E-1 to E- 54 is independently selected from the group consisting of halogen, cyano, nitro, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, C1-C4- alkylthio, Ci-C4-haloalkylthio, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci- C4-alkylsulfonyl, Ci-C4-haloalkylsulfonyl, C3-C6-cycloalkyl, C3-C6- halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4- haloalkynyl, Ci-C4-alkylcarbonyl, Ci-C4-haloalkylcarbonyl, aminocarbonyl, Ci-C4-alkylaminocarbonyl and di-(Ci-C4-alkyl)-aminocarbonyl; or two R ¹⁶ present on the same carbon atom of a saturated heterocyclic ring may form together =0 or =S.

Even more particularly, in -N(R ⁵ )R ⁶ as a radical Y,

R ⁵ is hydrogen;

R ⁶ is selected from hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C4-alkyl which carries one radical R ⁸ , C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C3-C6-cycloalkyl which may be substituted by 1 or 2 substituents selected from F and CN;

-N(R ^10a )R ^10b , wherein R ^10a is hydrogen and R ^10b is -C(=0)N(R ^14a )R ^14b , wherein R ^14a is selected from the group consisting of hydrogen and Ci-C6-alkyl; and R ^14b is selected from the group consisting of hydrogen, Ci-C6-alkyl, C1-C6- haloalkyl, C2-C4-alkynyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, CH2-CN,

Ci-C4-alkoxy and Ci-C4-haloalkoxy;

-CH=NOR ⁹ , wherein R ⁹ is selected from hydrogen, Ci-C6-alkyl and C1-C6- haloalkyl; phenyl which may be substituted with 1 , 2, 3, 4, or 5 substituents R ^{1 1} , and a heteromonocyclic ring selected from rings of formulae F-1 to F-54 as defined above;

wherein

R ⁸ is selected from CN , Cs-Cs-cycloalkyl which optionally carries a CN substit- uent, C3-C8-halocycloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio, Ci-C6-alkylsulfinyl, Ci-C6-haloalkylsulfinyl, C1-C6- alkylsulfonyl, Ci-C ₆ -haloalkylsulfonyl, -C(=O)N(R ^10a )R ^10b , phenyl, optionally substituted with 1 , 2, 3, 4 or 5 substituents R ¹⁶ , and a heterocyclic ring selected from rings of formulae E-1 to E-54 as defined above; wherein R ^10a is selected from the group consisting of hydrogen and Ci-C6-alkyl; R ^10b is selected from the group consisting of hydrogen, Ci-C6-alkyl, C2-C4- alkynyl, CH ₂ -CN, Ci-C ₆ -haloalkyl, C ₃ -C ₆ -cycloalkyl, C ₃ -C ₆ - halocycloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy, and R ^{1 1} and R ¹⁶ ; independently of each occurrence and independently of each other, are selected from the group consisting of halogen, cyano, nitro, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, C1-C4- alkylthio, Ci-C4-haloalkylthio, Ci-C4-alkylsulfinyl, C1-C4- haloalkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C4-haloalkylsulfonyl, C3-C6- cycloalkyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2- C4-alkynyl, C2-C4-haloalkynyl, Ci-C4-alkylcarbonyl, C1-C4- haloalkylcarbonyl, aminocarbonyl, Ci-C4-alkylaminocarbonyl and di- (Ci-C4-alkyl)-aminocarbonyl; or

two R ¹⁶ present on the same carbon atom of a saturated heterocyclic ring may form together =0 or =S.

Specifically, in -N(R ⁵ )R ⁶ as a radical Y,

R ⁵ is hydrogen;

R ⁶ is selected from Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C4-alkyl which carries one radical R ⁸ , and a heteromonocyclic ring selected from rings of formulae F-1 to F-54, preferably F-43 to F-49, especially F-44, as defined above;

wherein

R ⁸ is selected from CN , Cs-Cs-cycloalkyl which optionally carries a CN substit- uent, C3-Cs-halocycloalkyl, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio, Ci-C6-alkylsulfinyl, Ci-C6-haloalkylsulfinyl, C1-C6- alkylsulfonyl, Ci-C6-haloalkylsulfonyl,

-C(=O)N(R ^10a )R ^10b , phenyl, optionally substituted with 1 , 2, 3, 4 or 5 substituents R ¹⁶ , and a heterocyclic ring selected from rings of formulae E-1 to E- 54, preferably E-1 to E-34, especially E-1 to E-3, E-7 and E-26 to E-31 , as defined above; wherein

R ^10a is selected from the group consisting of hydrogen and Ci-C6-alkyl; R ^10b is selected from the group consisting of hydrogen, Ci-C6-alkyl, and Ci-C6-haloalkyl, and

R ¹¹ and R ¹⁶ ; independently of each occurrence and independently of each other, are selected from the group consisting of halogen, cyano, nitro, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, C1-C4- alkylthio, Ci-C4-haloalkylthio, Ci-C4-alkylsulfinyl, C1-C4- haloalkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C4-haloalkylsulfonyl, C3-C6- cycloalkyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2- C4-alkynyl, C2-C4-haloalkynyl, Ci-C4-alkylcarbonyl, C1-C4- haloalkylcarbonyl, aminocarbonyl, Ci-C4-alkylaminocarbonyl and di- (Ci-C4-alkyl)-aminocarbonyl; or

two R ¹⁶ present on the same carbon atom of a saturated heterocyclic ring may form together =0 or =S.

In an alternative embodiment of the invention, A is A ³ . Preferably, R ^7a and R ^7b in the group A ³ are independently of each other selected from hydrogen, cyano, Ci-C4-alkyl and Ci-C4-haloalkyl, more preferably from hydrogen, Ci- C4-alkyl and Ci-C4-haloalkyl. Even more preferably, one of R ^7a and R ^7b is hydrogen and the other is hydrogen or methyl. Specifically, both are hydrogen. In the group A ³ ,

R ⁵ is preferably selected from hydrogen, cyano, Ci-C6-alkyl, C3-C6-cycloalkyl, C2-C6- alkenyl, C2-C6-alkynyl, wherein the four last-mentioned aliphatic and cycloaliphat- ic radicals may be partially or fully halogenated and/or may be substituted with one or more, preferably 1 , 2 or 3, in particular 1 , substituents R ⁸ ; and

R ⁶ is preferably selected from hydrogen, Ci-C6-alkyl, C3-C6-cycloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, wherein the four last-mentioned aliphatic and cycloaliphatic radicals may be partially or fully halogenated and/or may be substituted by one or more, preferably 1 , 2 or 3, in particular 1 , substituents R ⁸ ,

-OR ⁹ , -NR ^10a R ^10b , -S(0) _n R ⁹ , -C(=O)NR ^0a N(R ^0a )R ⁰ , -C(=0)R ⁸ ,

and a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or maximally unsaturated heteromonocyclic or heterobicyclic ring containing 1 , 2, 3 or 4 het- eroatoms or heteroatom groups independently selected from N, O, S, NO, SO and SO2, as ring members, where the heteromonocyclic or heterobicyclic ring may be substituted with one or more, preferably 1 , 2 or 3, in particular 1 , substit- uents R ¹¹ ;

or

R ⁵ and R ⁶ , together with the nitrogen atom to which they are bound, form a 3-, 4-, 5- or 6-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring, where the ring may further contain 1 , 2, 3 or 4 heteroatoms or het- eroatom-containing groups selected from O, S, N, SO, SO2, C=0 and C=S as ring members, wherein the heterocyclic ring may be substituted with 1 , 2, 3, 4 or 5, preferably 1 , 2 or 3, in particular 1 , substituents independently selected from the group consisting of halogen, cyano, Ci-C6-alkyl, Ci-C6-haloalkyl, C1-C6- alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio, Cs-Cs-cycloalkyl, C3-C8-halocycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2-C6-alkynyl, C2-C6- haloalkynyl, wherein the aliphatic or cycloaliphatic moieties in the twelve last- mentioned radicals may be substituted by one or more, preferably 1 , 2 or 3, in particular 1 , radicals R ⁸ , and phenyl which may be substituted with 1 , 2, 3, 4 or 5, preferably 1 , 2 or 3, in particular 1 , substituents R ¹¹ ;

or

R ⁵ and R ⁶ together form a group =C(R ⁸ ) ₂ , =S(0) _m (R ⁹ ) ₂ , =NR ^10a or =NOR ⁹ ;

wherein m, n, R ⁸ , R ⁹ , R ^10a , R ^10b and R ¹¹ have one of the above general meanings, or, in particular, one of the below preferred meanings.

More preferably, in the group A ³ ,

R ⁵ is selected from hydrogen, Ci-C4-alkyl, C2-C3-alkynyl, -CH2-CN and Ci-C6-alkoxy- methyl- and preferably from hydrogen and Ci-C4-alkyl; and

R ⁶ is -C(=0)R ⁸ ;

wherein R ⁸ has one of the above general meanings, or, in particular, one of the below preferred meanings.

R ⁸ in -C(=0)R ⁸ as a meaning of the radicals R ⁵ and R ⁶ of the group A ³ is preferably selected from the group consisting of hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, C2-C4- alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, Cs-Cs-cycloalkyl, C3-C8- halocycloalkyl, where the aliphatic and cycloaliphatic moieties in the eight last- mentioned radicals may be substituted by one or more, preferably 1 , 2 or 3, in particular 1 , radicals R ¹³ ;

-OR ⁹ , -S(0) _n R ⁹ , -N(R ^0a )R ^0b , -C(=O)N(R ^0a )R ^0b , -CH=NOR ⁹ ,

phenyl, optionally substituted with 1 , 2, 3, 4 or 5, preferably 1 , 2 or 3, in particular 1 , substituents R ¹⁶ , and a 3-, 4-, 5- or 6-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring comprising 1 , 2 or 3 heteroatoms or heteroa- torn groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring is optionally substituted with one or more, preferably 1 , 2 or 3, in particular 1 , substituents R ¹⁶ ,

wherein n, R ⁹ , R ^10a , R ^10b , R ¹³ and R ¹⁶ have one of the above general meanings, or, in particular, one of the below preferred meanings.

More preferably, R ⁸ in -C(=0)R ⁸ as a meaning of the radicals R ⁵ and R ⁶ of the group A ³ is selected from the group consisting of hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, C1-C6- alkyl substituted with one radical R ¹³ , C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, C3-C ₀ -cycloalkyl which optionally carries a CN substituent, C3 halocycloalkyl,

-N(R ^0a )R ^0b , -C(=O)N(R ^0a )R ^0b , -CH=NOR ⁹ ,

phenyl, optionally substituted with 1 , 2, 3, 4 or 5, preferably 1 , 2 or 3, in particular 1 , substituents R ¹⁶ , and a 3-, 4-, 5- or 6-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring comprising 1 , 2 or 3 heteroatoms or heteroa- tom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring is optionally substituted with one or more, preferably 1 , 2 or 3, in particular 1 , substituents R ¹⁶ ,

wherein R ⁹ , R ^10a , R ^10b , R ¹³ and R ¹⁶ have one of the above general meanings, or, in par- ticular, one of the below preferred meanings.

R ⁹ in -CH=NOR ⁹ as a meaning of R ⁸ in the group -C(=0)R ⁸ as a meaning of the radicals R ⁵ and R ⁶ of the group A ³ is preferably selected from hydrogen, Ci-C6-alkyl and Ci-Ce-haloalkyl.

R ^10a and R ¹⁰ in -C(=O)N(R ^10a )R ¹⁰ and -N(R ^10a )R ¹⁰ as a meaning of R ⁸ in the group -C(=0)R ⁸ as a meaning of the radicals R ⁵ and R ⁶ of the group A ³ are, independently of each other, preferably selected from hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, C2-C3- alkenyl, C2-C3-haloalkenyl, C2-C3-alkynyl, C2-C3-haloalkynyl, C3-C6-cycloalkyl which optionally carries a CN substituent, C3-C ₀ -halocycloalkyl, where the aliphatic and cycloaliphatic moieties in the 9 last-mentioned radicals may be substituted by one or more radicals R ¹³ ; -C(=0)NR( ^14a )R ^14b , phenyl, optionally substituted with 1 , 2, 3, 4 or 5 substituents R ¹⁶ ; and a heteromonocyclic ring selected from rings of formulae E-1 to E- 54 as defined above.

R ¹³ in R ⁸ in the radicals R ⁵ and R ⁶ of the group A ³ is preferably selected from CN, Ci- C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, Ci-C6-haloalkylthio, Ci-C6-alkylsulfinyl, Ci- Ce-haloalkylsulfinyl, Ci-C ₆ -alkylsulfonyl, Ci-C ₆ -haloalkylsulfonyl, -C(=0)N(R ^14a )R ¹⁴ , phenyl, optionally substituted with 1 , 2, 3, 4 or 5 substituents R ¹⁶ ; and a heterocyclic ring selected from rings of formulae E-1 to E-54 as defined above.

R ^14a and R ^14b in -C(=0)NR( ^14a )R ^14b as a meaning for R ^10a and R ^10b as well as a meaning for R ¹³ , independently of each other and independently of each occurrence, are preferably selected from hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, C2-C6-alkenyl, C2-C6- haloalkenyl, C2-C6-alkynyl, C2-C6-haloalkynyl, wherein the six last-mentioned aliphatic radicals may carry 1 substituent selected from cyano, Ci-C4-alkoxy, Ci-C4-haloalkoxy, C3-C4-cycloalkyl which may be substituted by 1 cyano group; and C3-C4-halocycloalkyl; C3-C8-cycloalkyl which may carry 1 cyano group; and Cs-Cs-halocycloalkyl;

and more preferably from hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, CH2-CN, C2-C4- alkenyl, C2-C4-alkynyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C3-C6-cycloalkylmethyl-, Ci-C4-alkoxy and Ci-C4-haloalkoxy. Preferably, each R ¹⁶ as a substituent on phenyl or heterocyclic rings of formulae E-1 to E-54 is independently selected from the group consisting of halogen, cyano, nitro, Ci- C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, C1-C4- haloalkylthio, Ci-C6-alkylsulfinyl, Ci-C6-haloalkylsulfinyl, Ci-C6-alkylsulfonyl, C1-C6- haloalkylsulfonyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4- haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, Ci-C4-alkylcarbonyl, C1-C4- haloalkylcarbonyl, aminocarbonyl, Ci-C4-alkylaminocarbonyl and di-(Ci-C4-alkyl)- aminocarbonyl; or

two R ¹⁶ present on the same carbon atom of a saturated heterocyclic ring may form together =0 or =S.

In particular, R ⁸ in -C(=0)R ⁸ as a meaning of the radicals R ⁵ and R ⁶ of the group A ³ is selected from the group consisting of hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, C1-C4- alkyl substituted by one radical R ¹³ , C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2- C4-haloalkynyl,C3-C8-cycloalkyl which optionally carries a CN substituent, C3-C8- halocycloalkyl, -N(R ^10a )R ^10b , -C(=O)N(R ^10a )R ¹⁰ , -CH=NOR ⁹ , phenyl which is optionally substituted with 1 , 2, 3, 4 or 5 substituents R ¹⁶ ; and a heterocyclic ring selected from rings of formulae E-1 to E-54 as defined above,

wherein

R ⁹ is selected from hydrogen, Ci-C6-alkyl and Ci-C6-haloalkyl;

R ^10a is selected from hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl and C3-C6-cycloalkyl, and preferably from hydrogen and Ci-C4-alkyl;

R ^10b is selected from hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, C3-C6-cycloalkyl which optionally carries a CN substituent; -C(=0)N(R ^14a )R ^14b ; phenyl, optionally substi- tuted with 1 , 2, 3, 4 or 5 substituents R ¹⁶ ; and a heteromonocyclic ring selected from rings of formulae E-1 to E-54 as defined above;

R ¹³ is selected from CN, Ci-C6-alkoxy, Ci-C6-haloalkoxy, Ci-C6-alkylthio, C1-C6- haloalkylthio, Ci-C6-alkylsulfinyl, Ci-C6-haloalkylsulfinyl, Ci-C6-alkylsulfonyl, Ci- Ce-haloalkylsulfonyl, -C(=0)N(R ^14a )R ^14b , phenyl, optionally substituted with 1 , 2, 3,

4 or 5 substituents R ¹⁶ ; and a heterocyclic ring selected from rings of formulae E-

1 to E-54 as defined above;

R ^14a is selected from hydrogen and Ci-C6-alkyl;

R ^14b is selected from hydrogen, Ci-C ₆ -alkyl, Ci-C ₆ -haloalkyl, CH ₂ -CN, C ₂ -C ₄ -alkenyl, C2-C ₄ -alkynyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C3-C6-cycloalkylmethyl-, Ci-

C ₄ -alkoxy and Ci-C ₄ -haloalkoxy; and

each R ¹⁶ as a substituent on phenyl or heterocyclic rings of formulae E-1 to E-54 is independently selected from the group consisting of halogen, cyano, nitro, Ci-C ₄ - alkyl, Ci-C ₄ -haloalkyl, Ci-C ₄ -alkoxy, Ci-C ₄ -haloalkoxy, Ci-C ₄ -alkylthio, Ci-C ₄ - haloalkylthio, Ci-C6-alkylsulfinyl, Ci-C6-haloalkylsulfinyl, Ci-C6-alkylsulfonyl, Ci-

C6-haloalkylsulfonyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C2-C ₄ -alkenyl, C2-C ₄ - haloalkenyl, C2-C ₄ -alkynyl, C2-C ₄ -haloalkynyl, Ci-C ₄ -alkylcarbonyl, Ci-C ₄ - haloalkylcarbonyl, aminocarbonyl, Ci-C ₄ -alkylaminocarbonyl and di-(Ci-C ₄ -alkyl)- aminocarbonyl; or

two R ¹⁶ present on the same carbon atom of a saturated heterocyclic ring may form together =0 or =S.

In an alternative embodiment of the invention, A is A ⁴ . A ⁴ is preferably selected from a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or maximally unsaturated heteromonocyclic ring containing 1 , 2, 3 or 4 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heteromonocyclic ring is optionally substituted with one or more, preferably 1 , 2 or 3, in particular 1 , substituents R ¹¹ , where R ¹¹ has one of the above general meanings, or, in particular, one of the below preferred meanings.

More preferably, A ⁴ is selected from a 3-, 4-, 5-, 6- or 7-membered saturated heteromonocyclic ring containing 1 or 2 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, a 5-, 6- or 7-membered partially unsaturated heteromonocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, and a 5- or 6-membered aromatic heteromonocyclic ring containing 1 , 2, 3 or 4 heteroatoms selected from N, O and S as ring members, where the heteromonocyclic ring is optionally substituted with one or more, preferably 1 , 2 or 3, in particular 1 , substituents R ¹¹ , where R ¹¹ has one of the above general meanings, or, in particular, one of the below preferred meanings.

A ⁴ is even more preferably selected from rings of formulae D-1 to D-173

D-1 D-2 D-3 D-4 D-5

D-6 D-7 D-8 D-9 D-10

D-1 1 D-12 D-13 D-14

D-15 D-16 D-17 D-18 D-19

D-20 -21 D-22 D-23 D-24

D-25 D-26 D-27 D-28 D-29

D-30 D-31 D-32 D-33 D-34

D-35 D-36 D-37 D-38 D-39

D-40 D-41 D-42 D-43 D-44

D-45 D-46 D-47 D-48 D-49

D-50 D-51 D-52 D-53 D-54

D-55 D-56 D-57 D-58 D-59

D-60 D-61 D-62 D-63 D-64

D-65 D-66 D- D-68 D-69

D-70 D-71 D-72 D-73 D-74

D-75 D-76 D-77 D-78 D-79

D-80 D-81 D-82 D-83 D-84

(

D-85 D-87 D-88 D-89

D-90 D-91 D-92 D-93 D-94

D-95 D-96 D-97 D-98 D-99 (

D-100 D-101 D-102 D-103 D-104

D-105 D-106 D-107 D-108 -109

D-120 D-121 D-122 D-123 D-124

D-125 D-126 D-127 D-128 D-129

D-130 -131 D-132 D-133 D-134

D-135 D-136 D-137 D-138 D-139

D-140 D-141 D-142 D-143 D-144

D-145 D-146 D-147 D-148 D-149

D-150 D-151 D-152 D-153 D-154

D-155 D-156 D-157 D-158 D-159

D-160 D-161 D-162 D-163 D-164

(R") _K (R ¹¹ ) ^(R " ⁾ _K (R") _K (R ¹¹ )

D-165 D-166 D-167 D-168 D-169

D-170 D-171 D-172 D-173 wherein k is 0, 1 , 2 or 3, n is 0, 1 or 2 and R ^{1 1} has one of the above general meanings, or, in particular, one of the below preferred meanings;

and is in particular selected from D-59, D-65 and D-66 and is specifically D-59.

Preferably, in the above rings D-1 to D-173,

each R ^{1 1} is independently selected from the group consisting of halogen, cyano, ni- tro, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C ₄ -alkylthio, Ci-C ₄ -haloalkylthio, Ci-C ₆ -alkylsulfinyl, Ci-C ₆ -haloalkylsulfinyl, Ci-C ₆ - alkylsulfonyl, Ci-C6-haloalkylsulfonyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C2- C ₄ -alkenyl, C2-C ₄ -haloalkenyl, C2-C ₄ -alkynyl, C2-C ₄ -haloalkynyl, C1-C4- alkylcarbonyl, Ci-C4-haloalkylcarbonyl, aminocarbonyl, Ci-C4-alkylaminocarbonyl and di-(Ci-C4-alkyl)-aminocarbonyl; or

two R ^{1 1} present on the same carbon atom of a saturated or partially unsaturated ring may form together =0 or =S.

Among the radicals A ¹ , A ² , A ³ and A ⁴ , preference is given to A ² . Preferably, B ¹ , B ² and B ³ are CR ² .

More preferably, B ¹ is CR ² , where R ² is not hydrogen, and B ² and B ³ are CR ² , where R ² has one of the above general meanings or, in particular, one of the below preferred meanings.

Preferably, R ² is selected from hydrogen, halogen, cyano, azido, nitro, -SCN , -SF ₅ , Ci- C6-alkyl, Cs-Cs-cycloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, wherein the four last mentioned aliphatic and cycloaliphatic radicals may be partially or fully halogenated and/or may be substituted by one or more radicals R ⁸ ; -OR ⁹ , -S(0) _n R ⁹ and -N R ^10a R ^10b ,

wherein R ⁸ , R ⁹ , R ^10a and R ^10b have one of the above general meanings, or, in particular, one of the below preferred meanings.

More preferably, R ² is selected from hydrogen, halogen and Ci-C2-haloalkyl, preferably from hydrogen, F, CI, Br and CF3. Preferably, R ¹ is selected from Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy-Ci-C4-alkyl, Ci-C ₄ -haloalkoxy-Ci-C ₄ -alkyl, C ₃ -C ₆ -cycloalkyl C ₃ -C ₆ -halocycloalkyl or C(=0)OR ¹³ ; more preferably, from Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6- halocycloalkyl and C(=0)OR ¹⁵ , even more preferably from Ci-C4-alkyl, Ci-C4-haloalkyl and -C(=0)OR ¹⁵ , and particularly preferably from Ci-C ₄ -haloalkyl and -C(=0)OR ¹⁵ , wherein R ¹⁵ is preferably Ci-C4-alkyl. In particular, R ¹ is Ci-C4-haloalkyl, specifically Ci- C2-haloalkyl and more specifically halomethyl, in particular fluoromethyl, such as fluo- romethyl, difluoromethyl and trifluoromethyl, and is very specifically trifluoromethyl. Preferably, R ^3a and R ^3b are selected, independently of each other, from hydrogen, halogen, hydroxyl, Ci-C3-alkyl, Ci-C3-alkenyl, Ci-C3-alkynyl, Ci-C3-haloalkyl, Ci-C3-alkoxy, Ci-C3-alkylthio and Ci-C3-alkylsulfonyl, more preferably from hydrogen and halogen, in particular from hydrogen and fluorine and are specifically hydrogen. Preferably, R ^3a and R ^3b are selected, independently of each other, from hydrogen, halogen, cyano, Ci-C4-alkyl, Ci-C4-haloalkyl, Cs-Cs-cycloalkyl, Cs-Cs-halocycloalkyl, C2- C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, Ci-C4-alkoxy, C1-C4- haloalkoxy, Ci-C4-alkylthio and Ci-C4-haloalkylthio. More preferably, R ^4a is hydrogen and R ^4b is selected from hydrogen, methyl, trifluoromethyl, F, CI and Br.

If not specified otherwise above, R ⁸ , R ⁹ , R ^10a , R ^10b , R ¹¹ , R ¹² , R ¹³ , R ¹⁵ and R ¹⁶ have following preferred meanings:

In case R ⁸ is a substituent on an alkyl, alkenyl or alkynyl group, it is preferably selected from the group consisting of cyano, Cs-Cs-cycloalkyl, Cs-Cs-halocycloalkyl, -OR ⁹ , -SR ⁹ , -C(=O)N(R ^0a )R ⁰ , -C(=S)N(R ^0a )R ⁰ , -C(=0)OR ⁹ , phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁶ , and a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or aromatic heterocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocy- die ring may be substituted by one or more radicals R ¹⁶ ; where R ⁹ , R ^10a , R ^10b and R ¹⁶ have one of the meanings given above or in particular one of the preferred meanings given below.

In case R ⁸ is a substituent on an alkyl, alkenyl or alkynyl group, it is even more prefera- bly selected from the group consisting of cyano, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, Ci-C ₄ -alkoxy, Ci-C ₄ -haloalkoxy, Ci-C ₄ -alkylthio, Ci-C ₄ -haloalkylthio, -C(=O)N(R ^10a )R ¹⁰ , -C(=S)N(R ^10a )R ¹⁰ , -C(=0)OR ⁹ , phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁶ , and a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or aromatic heterocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring may be substituted by one or more radicals R ¹⁶ ; where R ⁹ , R ^10a , R ^10b and R ¹⁶ have one of the meanings given above or in particular one of the preferred meanings given below. In particu- lar it is selected from the group consisting of cyano, C3-C6-cycloalkyl, C3-C6- halocycloalkyl, -C(=O)N(R ^0a )R ^0b , -C(=S)N(R ^0a )R ^0b , -C(=0)OR ⁹ , phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁶ , and a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or aromatic heterocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring may be substituted by one or more radicals R ¹⁶ ; where R ⁹ , R ^10a , R ^10b and R ¹⁶ have one of the meanings given above or in particular one of the preferred meanings given below.

In case R ⁸ is a substituent on a cycloalkyl group, it is preferably selected from the group consisting of cyano, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy-Ci-C6-alkyl, -OR ⁹ , -OSO2R ⁹ , -SR ⁹ , -N(R ^0a )R ⁰ , -C(=O)N(R ^0a )R ⁰ , -C(=S)N(R ^0a )R ⁰ , -C(=0)OR ⁹ , phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁶ , and a 3-, 4-, 5-, 6- or 7- membered saturated, partially unsaturated or aromatic heterocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring may be substituted by one or more radicals R ¹⁶ ; where R ⁹ , R ^10a , R ^10b and R ¹⁶ have one of the meanings given above or in particular one of the preferred meanings given below.

In case R ⁸ is a substituent on a cycloalkyl group, it is even more preferably selected from the group consisting of cyano, Ci-C4-alkyl, Ci-C3-haloalkyl, Ci-C4-alkoxy and Ci- C3-haloalkoxy. In particular, R ⁸ as a substituent on a cycloalkyl group is selected from cyano, Ci-C4-alkyl and Ci-C3-haloalkyl.

In case of R ⁸ in a group -C(=0)R ⁸ , =C(R ⁸ ) ₂ or -C(=NR ⁶ )R ⁸ , R ⁸ is preferably selected from the group consisting of hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, Ci-C6-alkoxy-Ci- C6-alkyl, Cs-Cs-cycloalkyl, Cs-Cs-halocycloalkyl, C2-C6-alkenyl, C2-C6-haloalkenyl, C2- Ce-alkynyl, C ₂ -C ₆ -haloalkynyl, -OR ⁹ , -SR ⁹ , -N(R ^10a )R ^10b , phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁶ , and a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or aromatic heterocyclic ring containing 1 , 2 or 3 heteroatoms or heteroa- torn groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring may be substituted by one or more radicals R ¹⁶ ; where R ⁹ , R ^10a , R ^10b and R ¹⁶ have one of the meanings given above or in particular one of the preferred meanings given below. In case of R ⁸ in a group -C(=0)R ⁸ , or -C(=NR ⁶ )R ⁸ , R ⁸ is more preferably selected from the group consisting of Ci-C6-alkyl, Ci-C6-haloalkyl, Cs-Cs-cycloalkyl, C3- Cs-halocycloalkyl, Ci-C ₆ -alkoxy, Ci-C ₆ -haloalkoxy, -N(R ^10a )R ^10b , phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁶ , and a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or aromatic heterocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring may be substituted by one or more radicals R ¹⁶ ; where R ^10a , R ^10b and R ¹⁶ have has one of the meanings given above or in particular one of the preferred meanings given below.

Preferably, each R ⁹ is independently selected from the group consisting of hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, Cs-Cs-cycloalkyl, Cs-Cs-halocycloalkyl, Cs-Cs-cycloalkyl- Ci-C4-alkyl, phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁶ ; and a 3-, 4- , 5-, 6- or 7-membered saturated, partially unsaturated or aromatic heterocyclic ring containing 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring may be substituted by one or more, e.g. 1 , 2, 3 or 4, preferably 1 or 2, more preferably 1 , radicals R ¹⁶ , where R ¹⁶ has one of the meanings given above or in particular one of the preferred meanings given below.

More preferably, each R ⁹ is independently selected from the group consisting of hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, phenyl which may be substituted by 1 , 2, 3, 4 or 5 radicals R ¹⁶ ; and a 5- or 6-membered heteroaromatic ring containing 1 , 2 or 3 heteroa- toms selected from N , O and S, as ring members, where the heteroaromatic ring may be substituted by one or more radicals R ¹⁶ ; where R ¹⁶ has one of the meanings given above or in particular one of the preferred meanings given below.

R ^10a and R ^10b are, independently of each other, preferably selected from hydrogen, Ci- C ₄ -alkyl, Ci-C ₄ -haloalkyl, C ₂ -C ₄ -alkenyl, C ₂ -C ₄ -haloalkenyl, C ₂ -C ₄ -alkynyl, C2-C4- haloalkynyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, Ci-C ₄ -alkylcarbonyl, C1-C4- haloalkylcarbonyl, Ci-C ₄ -alkylaminocarbonyl, Ci-C ₄ -haloalkylaminocarbonyl, C3-C6- cycloalkylaminocarbonyl, C3-C6-halocycloalkylaminocarbonyl, and a 3-, 4-, 5-, 6- or 7- membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring comprising 1 , 2 or 3 heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring is optionally substituted with one or more, preferably 1 , 2 or 3, in particular 1 , substituents selected from halogen, CN, Ci-C ₄ -alkyl, Ci-C ₄ -haloalkyl, C ₂ -C ₄ -alkenyl, C ₂ -C ₄ -haloalkenyl, C ₂ -C ₄ -alkynyl, C ₂ - C4-haloalkynyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio and Ci-C4-haloalkylthio;

or, R ^10a and R ^10b , together with the nitrogen atom to which they are bound, form a 5- or 6-membered saturated, partially unsaturated or aromatic heterocyclic ring, which addi- tionally may contain 1 or 2 further heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring may carry 1 or 2, in particular 1 , substituents selected from halogen, CN, Ci-C4-alkyl, Ci-C4-haloalkyl, C2- C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4-haloalkynyl, C3-C6-cycloalkyl, C3- C6-halocycloalkyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio and C1-C4- haloalkylthio.

More preferably, R ^10a and R ^10b are, independently of each other, selected from hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, and a 3- or 4-membered saturated heterocyclic ring comprising 1 heteroatom or heteroatom group selected from N, O, S, NO, SO and SO2, as ring member, where the heterocyclic ring is optionally substituted with one or more, preferably 1 , 2 or 3, in particular 1 , substituents selected from halogen, CN , Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci- C4-haloalkoxy; and are specifically, independently of each other, selected from hydrogen, Ci-C4-alkyl and Ci-C4-haloalkyl.

Each R ¹¹ and each R ¹⁶ are independently of each occurrence and independently of each other preferably selected from halogen, CN , Ci-C4-alkyl, Ci-C4-haloalkyl, C1-C4- alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, Ci-C4-haloalkylthio, Ci-C4-alkylsulfinyl, C1-C4- haloalkylsulfinyl, Ci-C4-alkylsulfonyl and Ci-C4-haloalkylsulfonyl, and more preferably from halogen, CN, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy.

Each R ¹² is preferably selected from Ci-C4-alkyl and is in particular methyl.

In case R ¹³ is a substituent on an alkyl, alkenyl or alkynyl group, it is preferably select- ed from the group consisting of cyano, Cs-Cs-cycloalkyl, Cs-Cs-halocycloalkyl, -OH, - SH, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, Ci-C4-haloalkylthio, C1-C4- alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C4-haloalkylsulfonyl and phenyl which may be substituted by 1 , 2 or 3 radicals selected from halogen, C1-C4- alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy.

In case R ¹³ is a substituent on a cycloalkyl group, it is preferably selected from the group consisting of cyano, Ci-C6-alkyl, Ci-C6-haloalkyl, Cs-Cs-cycloalkyl, Cs-Cs- halocycloalkyl, -OH, -SH, Ci-C4-alkoxy, Ci-C4-haloalkoxy, Ci-C4-alkylthio, C1-C4- haloalkylthio, Ci-C4-alkylsulfinyl, Ci-C4-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, C1-C4- haloalkylsulfonyl and phenyl which may be substituted by 1 , 2 or 3 radicals selected from halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy. In case R ¹³ is a substituent on a cycloalkyl group, it is even more preferably selected from the group consisting of halogen, Ci-C4-alkyl, Ci-C3-haloalkyl, Ci-C4-alkoxy and Ci-C3-haloalkoxy. In particular, R ¹³ as a substituent on a cycloalkyl group is selected from halogen, Ci-C4-alkyl and Ci-C3-haloalkyl. In case of R ¹³ in a group -C(=0)R ¹³ , -C(=S)R ¹³ , =C(R ¹³ ) ₂ or -C(=NR ⁴ )R ¹³ , R ⁸ is preferably selected from the group consisting of hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, C3- Cs-cycloalkyl, Cs-Cs-halocycloalkyl, -OH, -SH, Ci-C6-alkoxy, Ci-C6-haloalkoxy and phenyl which may be substituted by 1 , 2 or 3 radicals selected from halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy.

R ¹⁴ , R ^14a and R ^14b are, independently of each other, preferably selected from hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, C2-C4- haloalkynyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl and benzyl, where the phenyl ring in benzyl is optionally substituted 1 , 2 or 3, in particular 1 , substituents selected from hal- ogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy;

or, R ^14a and R ^14b , together with the nitrogen atom to which they are bound, form a 5- or 6-membered saturated, partially unsaturated or aromatic heterocyclic ring, which additionally may contain 1 or 2 further heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring may carry 1 or 2, in particular 1 , substituents selected from halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, C1-C4- alkoxy and Ci-C4-haloalkoxy.

More preferably, R ¹⁴ , R ^14a and R ^14b are, independently of each other, selected from hydrogen, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl and ben- zyl, where the phenyl ring in benzyl is optionally substituted 1 , 2 or 3, in particular 1 , substituents selected from halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci- C4-haloalkoxy;

or, R ^14a and R ^14b , together with the nitrogen atom to which they are bound, form a 5- or 6-membered saturated, partially unsaturated or aromatic heterocyclic ring, which addi- tionally may contain 1 or 2 further heteroatoms or heteroatom groups selected from N, O, S, NO, SO and SO2, as ring members, where the heterocyclic ring may carry 1 or 2, in particular 1 , substituents selected from halogen, Ci-C4-alkyl, Ci-C4-haloalkyl, C1-C4- alkoxy and Ci-C4-haloalkoxy. Each R ¹⁵ is preferably selected from hydrogen, Ci-C6-alkyl, Ci-C6-haloalkyl, phenyl, benzyl, pyridyl and phenoxy, wherein the four last-mentioned radicals may be unsubsti- tuted and/or carry 1 , 2 or 3 substituents selected from Ci-C6-alkyl, Ci-C6-haloalkyl, Ci- C6-alkoxy and Ci-C6-haloalkoxy.

In a articular embodiment of the invention, compound I is a compound of formula IA

where A, R ^4a and R ^4b have one of the above-given general or, in particular, one of the above-given preferred meanings, and R ^2a , R ^2b and R ^2c , independently of each other, have one of the general or, in particular, one of the preferred meanings given above for R ² , and where R ^4a is preferably hydrogen. Examples of preferred compounds are compounds of the following formulae la.1 to la.37, where R ^2a , R ^2b and R ^2c have one of the general or preferred meanings given above for R ² and the other variables have one of the general or preferred meanings given above. Examples of preferred compounds are the individual compounds compiled in the tables 1 to 4376 below, Moreover, the meanings mentioned below for the individual variables in the tables are per se, independently of the combination in which they are mentioned, a particularly preferred embodiment of the substituents in question.



Table 1

Compounds of the formula la.1 in which R ^14b is hydrogen, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2

Compounds of the formula la.1 in which R ^14b is methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 3

Compounds of the formula la.1 in which R ^14b is ethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 4

Compounds of the formula la.1 in which R ^14b is propyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 5

Compounds of the formula la.1 in which R ^14b is isopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 6

Compounds of the formula la.1 in which R ^14b is n-butyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 7

Compounds of the formula la.1 in which R ^14b is sec-butyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 8

Compounds of the formula la.1 in which R ^14b is isobutyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 9

Compounds of the formula la.1 in which R ^14b is tert-butyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 10

Compounds of the formula la.1 in which R ^14b is 2,2-difluoroethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 1 1

Compounds of the formula la.1 in which R ^14b is 2,2,2-trifluoroethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 12

Compounds of the formula la.1 in which R ^14b is 3,3,3-trifluoropropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 13

Compounds of the formula la.1 in which R ^14b is allyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 14

Compounds of the formula la.1 in which R ^14b is propargyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 15

Compounds of the formula la.1 in which R ^14b is cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 16

Compounds of the formula la.1 in which R ^14b is 1 -cyanocyclopropyl, and the combina- tion of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 17

Compounds of the formula la.1 in which R ^14b is cyclobutyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 18

Compounds of the formula la.1 in which R ^14b is 1 -cyanocyclobutyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 19

Compounds of the formula la.1 in which R ^14b is cyclopentyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 20

Compounds of the formula la.1 in which R ^14b is 1 -cyanocyclopentyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 21

Compounds of the formula la.1 in which R ^14b is Chb-CN, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 22

Compounds of the formula la.1 in which R ^14b is Chb-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 23

Compounds of the formula la.1 in which R ^14b is CH2-(1 -cyanocyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 24

Compounds of the formula la.1 in which R ^14b is Chb-cyclobutyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 25

Compounds of the formula la.1 in which R ^14b is CH2-(1 -cyanocyclobutyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 26

Compounds of the formula la.1 in which R ^14b is Chb-cyclopentyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 27

Compounds of the formula la.1 in which R ^14b is CH2-(1 -cyanocyclopentyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 28

Compounds of the formula la.1 in which R ^14b is methoxy, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 29

Compounds of the formula la.1 in which R ^14b is ethoxy, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 30

Compounds of the formula la.1 in which R ^14b is isopropoxy, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Tables 31 to 60

Compounds of the formula la.2 in which R ^14b is as defined in any of tables 1 to 30 and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 61 to 90 Compounds of the formula la.3 in which R ^14b is as defined in any of tables 1 to 30 and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 91 to 120

Compounds of the formula la.4 in which R ^14b is as defined in any of tables 1 to 30 and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 121 to 150

Compounds of the formula la.5 in which R ^14b is as defined in any of tables 1 to 30 and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 151 to 180

Compounds of the formula la.6 in which R ^14b is as defined in any of tables 1 to 30 and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 181 to 210

Compounds of the formula la.7 in which R ^14b is as defined in any of tables 1 to 30 and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 21 1 to 240

Compounds of the formula la.8 in which R ^14b is as defined in any of tables 1 to 30 and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 241

Compounds of the formula la.9 in which R ^10b is phenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 242

Compounds of the formula la.9 in which R ^10b is 2-fluorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 243

Compounds of the formula la.9 in which R ^10b is 3-fluorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 244

Compounds of the formula la.9 in which R ^10b is 4-fluorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 245

Compounds of the formula la.9 in which R ^10b is 2-chlorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 246

Compounds of the formula la.9 in which R ^10b is 3-chlorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 247

Compounds of the formula la.9 in which R ^10b is 4-chlorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 248

Compounds of the formula la.9 in which R ^10b is 2,3-difluorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 249

Compounds of the formula la.9 in which R ^10b is 2,4-difluorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 250

Compounds of the formula la.9 in which R ^10b is 2,5-difluorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 251

Compounds of the formula la.9 in which R ^10b is 2,6-difluorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 252

Compounds of the formula la.9 in which R ^10b is 3,4-difluorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 253

Compounds of the formula la.9 in which R ^10b is 3,5-difluorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 254

Compounds of the formula la.9 in which R ^10b is 2-methylphenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 255

Compounds of the formula la.9 in which R ^10b is 3-methylphenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 256 Compounds of the formula la.9 in which R ^10b is 4-methylphenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 257

Compounds of the formula la.9 in which R ^10b is 2-methoxyphenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 258

Compounds of the formula la.9 in which R ^10b is 3-methoxyphenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 259

Compounds of the formula la.9 in which R ^10b is 4-methoxyphenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 260

Compounds of the formula la.9 in which R ^10b is pyridin-2-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 261

Compounds of the formula la.9 in which R ^10b is pyridin-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 262

Compounds of the formula la.9 in which R ^10b is pyridin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 263

Compounds of the formula la.9 in which R ^10b is pyrrol-2-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 264

Compounds of the formula la.9 in which R ^10b is pyrrol-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 265

Compounds of the formula la.9 in which R ^10b is hydrogen, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 266

Compounds of the formula la.9 in which R ^10b is methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 267

Compounds of the formula la.9 in which R ^10b is ethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 268

Compounds of the formula la.9 in which R ^10b is propyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 269

Compounds of the formula la.9 in which R ^10b is isopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 270

Compounds of the formula la.9 in which R ^10b is methylcarbonyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 271

Compounds of the formula la.9 in which R ^10b is ethylcarbonyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 272

Compounds of the formula la.9 in which R ^10b is isopropylcarbonyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 273

Compounds of the formula la.9 in which R ^10b is methoxycarbonyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 274

Compounds of the formula la.9 in which R ^10b is ethoxycarbonyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 275

Compounds of the formula la.9 in which R ^10b is isopropoxycarbonyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 276 to 310

Compounds of the formula la.10 in which R ^10b is as defined in tables 241 to 275, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 31 1 to 345

Compounds of the formula la.1 1 in which R ^10b is as defined in tables 241 to 275, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 346 to 380 Compounds of the formula la.12 in which R ^10b is as defined in tables 241 to 275, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 381

Compounds of the formula la.13 in which the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 382

Compounds of the formula la.14 in which the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 383

Compounds of the formula la.15 in which R ⁶ is hydrogen, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 384

Compounds of the formula la.15 in which R ⁶ is methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 385

Compounds of the formula la.15 in which R ⁶ is ethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 386

Compounds of the formula la.15 in which R ⁶ is propyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 387

Compounds of the formula la.15 in which R ⁶ is isopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 388

Compounds of the formula la.15 in which R ⁶ is n-butyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 389

Compounds of the formula la.15 in which R ⁶ is sec-butyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 390

Compounds of the formula la.15 in which R ⁶ is isobutyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 391

Compounds of the formula la.15 in which R ⁶ is tert-butyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 392 Compounds of the formula la.15 in which R ⁶ is CH2-C(CH3)3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 393

Compounds of the formula la.15 in which R ⁶ is -CH2CN, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 394

Compounds of the formula la.15 in which R ⁶ is -CH2-CH=CH2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 395

Compounds of the formula la.15 in which R ⁶ is -CH2-CH2-CH=CH2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 396

Compounds of the formula la.15 in which R ⁶ is -CH2C≡CH, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 397

Compounds of the formula la.15 in which R ⁶ is -CH2CH2C≡CH, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 398

Compounds of the formula la.15 in which R ⁶ is -CH2CH2OH, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 399

Compounds of the formula la.15 in which R ⁶ is -CH2CH2OCH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 400

Compounds of the formula la.15 in which R ⁶ is -CH2CH2OCH2CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 401

Compounds of the formula la.15 in which R ⁶ is -ChbChbOCI-bCI-^CI-b, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 402

Compounds of the formula la.15 in which R ⁶ is -CH2CH20CH2C≡CH, and the combina- tion of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 403 Compounds of the formula la.15 in which R ⁶ is -ChbChbOCI-b-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 404

Compounds of the formula la.15 in which R ⁶ is -CH2CH2OCF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 405

Compounds of the formula la.15 in which R ⁶ is -CH2CH2OCH2CF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 406

Compounds of the formula la.15 in which R ⁶ is -CH(CH3)CH20CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 407

Compounds of the formula la.15 in which R ⁶ is -CH(CH ₃ )CH20CH2CI-l3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 408

Compounds of the formula la.15 in which R ⁶ is -CH2CH2SCH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 409

Compounds of the formula la.15 in which R ⁶ is -CH2CH2S(0)CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 410

Compounds of the formula la.15 in which R ⁶ is -CH2CH2S(0)2CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 41 1

Compounds of the formula la.15 in which R ⁶ is -CH2CH2SCH2CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 412

Compounds of the formula la.15 in which R ⁶ is -CH2CH2S(0)CH ₂ CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 413 Compounds of the formula la.15 in which R ⁶ is -CH2CH2S(0)2CH2CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 414

Compounds of the formula la.15 in which R ⁶ is -CH2CH2S(0)2CH ₂ CH=CH2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 415

Compounds of the formula la.15 in which R ⁶ is -CH2CH2S(0)2CH ₂ C≡CH, and the com- bination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 416

Compounds of the formula la.15 in which R ⁶ is -CH2CH2S(0)2CH2-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 417

Compounds of the formula la.15 in which R ⁶ is -CH(CH3)CH2SCH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 418

Compounds of the formula la.15 in which R ⁶ is -CH(CH ₃ )CH2S(0)CH ₃ , and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 419

Compounds of the formula la.15 in which R ⁶ is -CH(CH3)CH ₂ S(0)2CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 420

Compounds of the formula la.15 in which R ⁶ is -C(CH3)2CH2SCH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 421

Compounds of the formula la.15 in which R ⁶ is -C(CH3)2CH2S(0)CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 422 Compounds of the formula la.15 in which R ⁶ is -C(CH3)2CH2S(0)2CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 423

Compounds of the formula la.15 in which R ⁶ is -CH2CH2SCF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 424

Compounds of the formula la.15 in which R ⁶ is NH2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 425

Compounds of the formula la.15 in which R ⁶ is CH2CHF2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 426

Compounds of the formula la.15 in which R ⁶ is CH2CF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 427

Compounds of the formula la.15 in which R ⁶ is CH2CH2CF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 428

Compounds of the formula la.15 in which R ⁶ is CH(CH3)CF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 429

Compounds of the formula la.15 in which R ⁶ is CH(CF3)2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 430

Compounds of the formula la.15 in which R ⁶ is CH2CH2CH2CF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 431

Compounds of the formula la.15 in which R ⁶ is CH2CH=CF2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 432

Compounds of the formula la.15 in which R ⁶ is CH2CF=CF2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 433

Compounds of the formula la.15 in which R ⁶ is CH2CH2CH=CF2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 434 Compounds of the formula la.15 in which R ⁶ is CH2CH2CF=CF2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 435

Compounds of the formula la.15 in which R ⁶ is cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 436

Compounds of the formula la.15 in which R ⁶ is 1 -cyano-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 437

Compounds of the formula la.15 in which R ⁶ is 1 -(pyridin-2-yl)-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 438

Compounds of the formula la.15 in which R ⁶ is cyclobutyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 439

Compounds of the formula la.15 in which R ⁶ is 1 -cyano-cyclobutyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 440

Compounds of the formula la.15 in which R ⁶ is 3,3-difluorocyclobutyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 441

Compounds of the formula la.15 in which R ⁶ is cyclopentyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 442

Compounds of the formula la.15 in which R ⁶ is 1 -cyano-cyclopentyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 443

Compounds of the formula la.15 in which R ⁶ is cyclohexyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 444 Compounds of the formula la.15 in which R ⁶ is 1 -cyano-cyclohexyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 445

Compounds of the formula la.15 in which R ⁶ is -Chb-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 446

Compounds of the formula la.15 in which R ⁶ is -CH2-(1 -cyano-cyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 447

Compounds of the formula la.15 in which R ⁶ is -CH2-(1 -fluoro-cyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 448

Compounds of the formula la.15 in which R ⁶ is -CH2-(1 -chloro-cyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 449

Compounds of the formula la.15 in which R ⁶ is -CH2-(1 -bromo-cyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 450

Compounds of the formula la.15 in which R ⁶ is -CH2-(2,2-difluorocyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 451

Compounds of the formula la.15 in which R ⁶ is -CH2-(2,2-dichlorocyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 452

Compounds of the formula la.15 in which R ⁶ is -CH2-(2,2-dibromocyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 453

Compounds of the formula la.15 in which R ⁶ is -Chb-cyclobutyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 454

Compounds of the formula la.15 in which R ⁶ is -CH2-(1 -cyano-cyclobutyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 455

Compounds of the formula la.15 in which R ⁶ is -CH2-(1 -fluoro-cyclobutyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 456

Compounds of the formula la.15 in which R ⁶ is -CH2-(1 -chloro-cyclobutyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 457

Compounds of the formula la.15 in which R ⁶ is -CH2-(2,2-difluorocyclobutyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 458

Compounds of the formula la.15 in which R ⁶ is -CH2-(3,3-difluorocyclobutyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 459

Compounds of the formula la.15 in which R ⁶ is -CH2-(2,2,3,3-tetrafluorocyclobutyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 460

Compounds of the formula la.15 in which R ⁶ is -CH2-(2,2,3,3,4,4-hexafluorocyclobutyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 461

Compounds of the formula la.15 in which R ⁶ is -Chb-cyclopentyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 462

Compounds of the formula la.15 in which R ⁶ is -CH2-(1 -fluoro-cyclopentyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 463 Compounds of the formula la.15 in which R ⁶ is -CH2-(1 -chloro-cyclopentyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 464

Compounds of the formula la.15 in which R ⁶ is -CH2-(1 -cyano-cyclopentyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 465

Compounds of the formula la.15 in which R ⁶ is -CH2-(2,2-difluorocyclopentyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 466

Compounds of the formula la.15 in which R ⁶ is R ⁶ is -CH2-(3,3-difluorocyclopentyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 467

Compounds of the formula la.15 in which R ⁶ is -CH2-(1 -fluorocyclohexyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 468

Compounds of the formula la.15 in which R ⁶ is -CH2-(1 -chlorocyclohexyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 469

Compounds of the formula la.15 in which R ⁶ is -CH2-(1 -cyanocyclohexyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 470

Compounds of the formula la.15 in which R ⁶ is thietan-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 471

Compounds of the formula la.15 in which R ⁶ is 1 -oxo-thietan-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 472

Compounds of the formula la.15 in which R ⁶ is 1 ,1-dioxo-thietan-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 473

Compounds of the formula la.15 in which R ⁶ is 3-methyl-thietan-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 474

Compounds of the formula la.15 in which R ⁶ is 3-methyl-1 -oxo-thietan-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 475

Compounds of the formula la.15 in which R ⁶ is 3-methyl-1 ,1 -dioxo-thietan-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 476

Compounds of the formula la.15 in which R ⁶ is -CH2-(thietan-3-yl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 477

Compounds of the formula la.15 in which R ⁶ is -CH2-(1 -oxo-thietan-3-yl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 478

Compounds of the formula la.15 in which R ⁶ is -CH2-(1 ,1 -dioxo-thietan-3-yl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 479

Compounds of the formula la.15 in which R ⁶ is tetrahydrothiophen-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 480

Compounds of the formula la.15 in which R ⁶ is 1 -oxo-tetrahydrothiophen-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 481

Compounds of the formula la.15 in which R ⁶ is 1 ,1-dioxo-tetrahydrothiophen-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 482 Compounds of the formula la.15 in which R ⁶ is phenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 483

Compounds of the formula la.15 in which R ⁶ is CH2-CONH2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 484

Compounds of the formula la.15 in which R ⁶ is pyridin-2-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 485

Compounds of the formula la.15 in which R ⁶ is pyridin-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 486

Compounds of the formula la.15 in which R ⁶ is pyridin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 487

Compounds of the formula la.15 in which R ⁶ is pyrimidin-2-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 488

Compounds of the formula la.15 in which R ⁶ is pyrimidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 489

Compounds of the formula la.15 in which R ⁶ is pyrimidin-5-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 490

Compounds of the formula la.15 in which R ⁶ is thiazol-2-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 491

Compounds of the formula la.15 in which R ⁶ is 4-trifluoromethylthiazol-2-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 492

Compounds of the formula la.15 in which R ⁶ is oxetan-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 493

Compounds of the formula la.15 in which R ⁶ is tetrahydrofuran-2-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 494 Compounds of the formula la.15 in which R ⁶ is tetrahydrofuran-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 495

Compounds of the formula la.15 in which R ⁶ is 2-oxotetrahydrofuran-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 496

Compounds of the formula la.15 in which R ⁶ is 2-oxopyrrolidin-3-yl, and the combina- tion of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 497

Compounds of the formula la.15 in which R ⁶ is 1 -methyl-2-oxopyrrolidin-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 498

Compounds of the formula la.15 in which R ⁶ is 2-oxo-1 -(2,2,2-trifluoroethyl)-pyrrolidin- 3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 499

Compounds of the formula la.15 in which R ⁶ is azetidin-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 500

Compounds of the formula la.15 in which R ⁶ is 1 -acetyl-azetidin-3-yl, and the combina- tion of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 501

Compounds of the formula la.15 in which R ⁶ is -NH-phenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 502

Compounds of the formula la.15 in which R ⁶ is -NH-pyridin-2-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 503

Compounds of the formula la.15 in which R ⁶ is -NH-pyridin-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 504

Compounds of the formula la.15 in which R ⁶ is -NH-pyridin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 505

Compounds of the formula la.15 in which R ⁶ is -N(CH3)-pyridin-2-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 506

Compounds of the formula la.15 in which R ⁶ is -N(CH3)-pyrimidin-2-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 507

Compounds of the formula la.15 in which R ⁶ is -NH-pyrimidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 508

Compounds of the formula la.15 in which R ⁶ is -NH-pyrimidin-5-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 509

Compounds of the formula la.15 in which R ⁶ is -CH2-C(=0)OCH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 510

Compounds of the formula la.15 in which R ⁶ is -CH2-C(=0)0-CH2CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 51 1

Compounds of the formula la.15 in which R ⁶ is -CH2-CONH-CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 512

Compounds of the formula la.15 in which R ⁶ is -CH2-CONH-CH2CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 513

Compounds of the formula la.15 in which R ⁶ is -CH2-CONH-CH2CHF2, and the combi- nation of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 514 Compounds of the formula la.15 in which R ⁶ is -CH2-CONH-CH2CF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 515

Compounds of the formula la.15 in which R ⁶ is -Chb-CONH-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 516

Compounds of the formula la.15 in which R ⁶ is -Chb-CONH-isopropyl, and the combi- nation of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 517

Compounds of the formula la.15 in which R ⁶ is -CH2-CONH-CH(CF ₃ )CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 518

Compounds of the formula la.15 in which R ⁶ is -CH2-CONH-CH(CF3)2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 519

Compounds of the formula la.15 in which R ⁶ is -CH2-CONH-CH2CH2CF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 520

Compounds of the formula la.15 in which R ⁶ is -CH2-CONH-CH2CN, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 521

Compounds of the formula la.15 in which R ⁶ is -CH2-CONH-CH ₂ CH=CH2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 522

Compounds of the formula la.15 in which R ⁶ is -CH2-CONH-CH2C≡CH, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 523 Compounds of the formula la.15 in which R ⁶ is -CH2-CON(CH ₃ )-CH2CF ₃ , and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 524

Compounds of the formula la.15 in which R ⁶ is -CH(CH ₃ )-CONH-CH ₂ CF ₃ , and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 525

Compounds of the formula la.15 in which R ⁶ is -CH2-CONH-CH ₂ -cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 526

Compounds of the formula la.15 in which R ⁶ is -CH2-CONH-CH ₂ -(1 -cyano-cyclopropyl), and the combination of R ^2a , R ^b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 527

Compounds of the formula la.15 in which R ⁶ is -CH ₂ -CONH-(thietan-3-yl), and the combination of R ^2a , R , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 528

Compounds of the formula la.15 in which R ⁶ is -CH ₂ -CONH-(1 -oxo-thietan-3-yl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 529

Compounds of the formula la.15 in which R ⁶ is -CH ₂ -CONH-(1 ,1 -dioxo-thietan-3-yl), and the combination of R ^a , R ² , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 530

Compounds of the formula la.15 in which R ⁶ is benzyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 531

Compounds of the formula la.15 in which R ⁶ is 2-fluorobenzyl, and the combination of R ^2a , R ^2b , R ^2c and R ⁴ for a compound corresponds in each case to one row of Table A Table 532

Compounds of the formula la.15 in which R ⁶ is 3-fluorobenzyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 533 Compounds of the formula la.15 in which R ⁶ is 4-fluorobenzyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 534

Compounds of the formula la.15 in which R ⁶ is 2-chlorobenzyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 535

Compounds of the formula la.15 in which R ⁶ is 3-chlorobenzyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 536

Compounds of the formula la.15 in which R ⁶ is 4-chlorobenzyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 537

Compounds of the formula la.15 in which R ⁶ is pyridazin-4-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 538

Compounds of the formula la.15 in which R ⁶ is tetrahydrofuran-2-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 539

Compounds of the formula la.15 in which R ⁶ is ([1 ,2,3]-thiadiazol-5-yl)-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 540

Compounds of the formula la.15 in which R ⁶ is 2-methylsulfanylbenzyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 541

Compounds of the formula la.15 in which R ⁶ is 3-methylsulfanylbenzyl, and the combi- nation of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 542

Compounds of the formula la.15 in which R ⁶ is 4-methylsulfanylbenzyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 543 Compounds of the formula la.15 in which R ⁶ is 2-methylsulfonylbenzyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 544

Compounds of the formula la.15 in which R ⁶ is 3-methylsulfonylbenzyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 545

Compounds of the formula la.15 in which R ⁶ is 4-methylsulfonylbenzyl, and the combi- nation of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 546

Compounds of the formula la.15 in which R ⁶ is pyridin-2-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 547

Compounds of the formula la.15 in which R ⁶ is pyridin-3-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 548

Compounds of the formula la.15 in which R ⁶ is (6-chloro-pyridin-3-yl)-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 549

Compounds of the formula la.15 in which R ⁶ is pyridin-4-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 550

Compounds of the formula la.15 in which R ⁶ is (5-chloro-pyridin-2-yl)-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 551

Compounds of the formula la.15 in which R ⁶ is [6-(trifluoromethyl)-pyridin-2-yl]-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 552 Compounds of the formula la.15 in which R ⁶ is [6-(trifluoromethyl)-pyridin-3-yl]-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 553

Compounds of the formula la.15 in which R ⁶ is pyrimidin-2-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 554

Compounds of the formula la.15 in which R ⁶ is pyrimidin-4-yl-methyl, and the combina- tion of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 555

Compounds of the formula la.15 in which R ⁶ is pyrimidin-5-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 556

Compounds of the formula la.15 in which R ⁶ is pyridazin-3-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 557

Compounds of the formula la.15 in which R ⁶ is pyrazin-2-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 558

Compounds of the formula la.15 in which R ⁶ is thien-2-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 559

Compounds of the formula la.15 in which R ⁶ is thien-3-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 560

Compounds of the formula la.15 in which R ⁶ is thiazol-2-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 561 Compounds of the formula la.15 in which R ⁶ is thiazol-4-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 562

Compounds of the formula la.15 in which R ⁶ is thiazol-5-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 563

Compounds of the formula la.15 in which R ⁶ is (2-chloro-thiazol-5-yl)-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 564

Compounds of the formula la.15 in which R ⁶ is isothiazol-3-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 565

Compounds of the formula la.15 in which R ⁶ is isothiazol-4-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 566

Compounds of the formula la.15 in which R ⁶ is isothiazol-5-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 567

Compounds of the formula la.15 in which R ⁶ is oxazol-2-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 568

Compounds of the formula la.15 in which R ⁶ is oxazol-4-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 569

Compounds of the formula la.15 in which R ⁶ is oxazol-5-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 570 Compounds of the formula la.15 in which R ⁶ is isoxazol-3-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 571

Compounds of the formula la.15 in which R ⁶ is isoxazol-4-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 572

Compounds of the formula la.15 in which R ⁶ is isoxazol-5-yl-methyl, and the combina- tion of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 573

Compounds of the formula la.15 in which R ⁶ is ([1 ,2,3]-thiadiazol-4-yl)-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 574

Compounds of the formula la.15 in which R ⁶ is ([1 ,3,4]-thiadiazol-2-yl)-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 575

Compounds of the formula la.15 in which R ⁶ is (1 -methyl-imidazol-2-yl)-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 576

Compounds of the formula la.15 in which R ⁶ is (1 -methyl-imidazol-4-yl)-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 577

Compounds of the formula la.15 in which R ⁶ is (1 -methyl-imidazol-5-yl)-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 578

Compounds of the formula la.15 in which R ⁶ is (1 -methyl-pyrazol-3-yl)-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 579 Compounds of the formula la.15 in which R ⁶ is (2-methyl-pyrazol-3-yl)-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 580

Compounds of the formula la.15 in which R ⁶ is tetrahydrofuran-3-yl-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 581

Compounds of the formula la.15 in which R ⁶ is (1 ,3-dioxolan-2-yl)-methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 582

Compounds of the formula la.15 in which R ⁶ is 2-pyridyl-eth-1 -yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 583

Compounds of the formula la.15 in which R ⁶ is (1 R)-2-pyridyl-eth-1 -yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 584

Compounds of the formula la.15 in which R ⁶ is (1 S)-2-pyridyl-eth-1 -yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 585

Compounds of the formula la.15 in which R ⁶ is -CONH2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 586

Compounds of the formula la.15 in which R ⁶ is -CONH-CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 587

Compounds of the formula la.15 in which R ⁶ is -CONH-CH2CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 588

Compounds of the formula la.15 in which R ⁶ is -CONH-CH2CH2CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 589 Compounds of the formula la.15 in which R ⁶ is -CONH-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 590

Compounds of the formula la.15 in which R ⁶ is -CONH-Chb-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 591

Compounds of the formula la.15 in which R ⁶ is -CONH-phenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 592

Compounds of the formula la.15 in which R ⁶ is -CONH-benzyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 593

Compounds of the formula la.15 in which R ⁶ is -NHCO-NH-CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 594

Compounds of the formula la.15 in which R ⁶ is -NHCO-NH-CH2CH3, and the combina- tion of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 595

Compounds of the formula la.15 in which R ⁶ is -NHCO-NH-CH2CH2CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 596

Compounds of the formula la.15 in which R ⁶ is -NHCO-NH-CH(CHs)2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 597

Compounds of the formula la.15 in which R ⁶ is -NHCO-NH-CH2CF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 598

Compounds of the formula la.15 in which R ⁶ is -NHCO-NH-CH2CHF2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 599 Compounds of the formula la.15 in which R ⁶ is -NHCO-NH-CH(CH ₃ )CF ₃ , and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 600

Compounds of the formula la.15 in which R ⁶ is -NHCO-NH-CH(CF3)2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 601

Compounds of the formula la.15 in which R ⁶ is -NHCO-NH-CH2CN, and the combina- tion of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 602

Compounds of the formula la.15 in which R ⁶ is -NHCO-NH-CH ₂ -CH=CH ₂ , and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 603

Compounds of the formula la.15 in which R ⁶ is -NHCO-NH-CH ₂ -CH≡CH, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 604

Compounds of the formula la.15 in which R ⁶ is -NHCO-NH-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 605

Compounds of the formula la.15 in which R ⁶ is -NHCO-NH-(l -cyanocyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 606

Compounds of the formula la.15 in which R ⁶ is -NHCO-NH-cyclobutyl, and the combi- nation of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 607

Compounds of the formula la.15 in which R ⁶ is -NHCO-NH-(l -cyanocyclobutyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 608 Compounds of the formula la.15 in which R ⁶ is -NHCO-NH-Chb-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 609

Compounds of the formula la.15 in which R ⁶ is -NHCO-NH-CH2-(1 -cyanocyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 610

Compounds of the formula la.15 in which R ⁶ is -CH=NOCH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 61 1

Compounds of the formula la.15 in which R ⁶ is -CH=NOCH2CF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 612

Compounds of the formula la.15 in which R ⁶ is 3-oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 613

Compounds of the formula la.15 in which R ⁶ is 2-methyl-3-oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 614

Compounds of the formula la.15 in which R ⁶ is 2-ethyl-3-oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 615

Compounds of the formula la.15 in which R ⁶ is 2-propyl-3-oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 616

Compounds of the formula la.15 in which R ⁶ is 2-butyl-3-oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 617

Compounds of the formula la.15 in which R ⁶ is 2-(but-2-yl)-3-oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 618

Compounds of the formula la.15 in which R ⁶ is 2-(3-bromopropyl)-3-oxo-isoxazolidin-4- yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 619

Compounds of the formula la.15 in which R ⁶ is 2-(2-fluoroethyl)-3-oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 620

Compounds of the formula la.15 in which R ⁶ is 2-(2,2-difluoroethyl)-3-oxo-isoxazolidin- 4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 621

Compounds of the formula la.15 in which R ⁶ is 2-(2,2,2-trifluoroethyl)-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 622

Compounds of the formula la.15 in which R ⁶ is 2-(3,3,3-trifluoropropyl)-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corre- sponds in each case to one row of Table A

Table 623

Compounds of the formula la.15 in which R ⁶ is 2-(2-methoxyethyl)-3-oxo-isoxazolidin- 4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 624

Compounds of the formula la.15 in which R ⁶ is 2-(1 -methoxy-prop-2-yl)-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 625

Compounds of the formula la.15 in which R ⁶ is 2-cyclobutyl-3-oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 626

Compounds of the formula la.15 in which R ⁶ is 2-(2-methylcyclohex-1 -yl)-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 627 Compounds of the formula la.15 in which R ⁶ is 2-(phenylmethyl)-3-oxo-isoxazolidin-4- yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 628

Compounds of the formula la.15 in which R ⁶ is 2-(1 -phenyl-eth-1 -yl)-3-oxo-isoxaolidin- 4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 629

Compounds of the formula la.15 in which R ⁶ is 2-(2-phenyl-eth-1 -yl)-3-oxo-isoxazolidin- 4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 630

Compounds of the formula la.15 in which R ⁶ is 2-[(3-chlorophenyl)-methyl]-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corre- sponds in each case to one row of Table A

Table 631

Compounds of the formula la.15 in which R ⁶ is 2-[(2-fluorophenyl)-methyl]-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 632

Compounds of the formula la.15 in which R ⁶ is 2-[(4-methoxyphenyl)-methyl]-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 633

Compounds of the formula la.15 in which R ⁶ is 2-[(2-trifluoromethylphenyl)-methyl]-3- oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 634

Compounds of the formula la.15 in which R ⁶ is R ⁶ is 2-[(2-trifluoromethoxyphenyl)- methyl]-3-oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 635

Compounds of the formula la.15 in which R ⁶ is 2-(pyridin-2-yl-methyl)-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corre- sponds in each case to one row of Table A

Table 636 Compounds of the formula la.15 in which R ⁶ is 2-(pyridin-3-yl-methyl)-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 637

Compounds of the formula la.15 in which R ⁶ is 2-[(2-chloropyridin-5-yl)-methyl]-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 638

Compounds of the formula la.15 in which R ⁶ is 2-[(1 -methyl-1 H-imidazol-4-yl)-methyl]- 3-oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 639

Compounds of the formula la.15 in which R ⁶ is 2-[(furan-2-yl)-methyl]-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corre- sponds in each case to one row of Table A

Table 640

Compounds of the formula la.15 in which R ⁶ is 2-[(2-thiophen-2'-yl)-eth-1 -yl]-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 641

Compounds of the formula la.15 in which R ⁶ is 2-[2-(indol-3'-yl)-eth-1 -yl]-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 642

Compounds of the formula la.15 in which R ⁶ is 2-[(1 H-benzimidazol-2-yl)-methyl]-3- oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 643

Compounds of the formula la.15 in which R ⁶ is 2-[(oxetan-2-yl)-methyl]-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 644

Compounds of the formula la.15 in which R ⁶ is 2-[(tetrahydrofuran-2-yl)-methyl]-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corre- sponds in each case to one row of Table A

Table 645 Compounds of the formula la.15 in which R ⁶ is 2-[(2-[1 ',3']dioxolan-2'-yl)-eth-1 -yl]-3- oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 646

Compounds of the formula la.15 in which R ⁶ is 2-[(2-morpholin-4'-yl)-eth-1 yl]-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 647

Compounds of the formula la.15 in which R ⁶ is 2-[(2-benzo[1 ',3']dioxol-5'-yl)-eth-1 -yl]-3- oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 648

Compounds of the formula la.15 in which R ⁶ is 2-[(2,3-dihydro-benzo[1 ,4]dioxin-6-yl)- methyl]-3-oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a com- pound corresponds in each case to one row of Table A

Table 649

Compounds of the formula la.15 in which R ⁶ is 2-(2-chlorophenyl)-3-oxo-isoxazolidin-4- yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 650

Compounds of the formula la.15 in which R ⁶ is 2-(3-fluorophenyl)-3-oxo-isoxazolidin-4- yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 651

Compounds of the formula la.15 in which R ⁶ is 2-(2-methylphenyl)-3-oxo-isoxazolidin- 4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 652

Compounds of the formula la.15 in which R ⁶ is 2-(2-chloro-6-methylphenyl)-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 653

Compounds of the formula la.15 in which R ⁶ is 2-(2-trifluoromethylphenyl)-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corre- sponds in each case to one row of Table A

Table 654 Compounds of the formula la.15 in which R ⁶ is 2-(2,4-dimethoxyphenyl)-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 655

Compounds of the formula la.15 in which R ⁶ is 2-(3-methylpyrid-2-yl)-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 656

Compounds of the formula la.15 in which R ⁶ is 2-(1 ,3-dimethyl-1 H-pyrazol-5-yl)-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 657

Compounds of the formula la.15 in which R ⁶ is 2-(4-methylthiazol-2-yl)-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corre- sponds in each case to one row of Table A

Table 658

Compounds of the formula la.15 in which R ⁶ is 2-(5-methylthiadiazol-2-yl)-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 659

Compounds of the formula la.15 in which R ⁶ is 2-(quinolin-2-yl)-3-oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 660

Compounds of the formula la.15 in which R ⁶ is 2-(quinolin-5-yl)-3-oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 661

Compounds of the formula la.15 in which R ⁶ is 2-(benzothiazol-6-yl)-3-oxo-isoxazolidin- 4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 662

Compounds of the formula la.15 in which R ⁶ is 2-(4-methylbenzothiazol-2-yl)-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corre- sponds in each case to one row of Table A

Table 663 Compounds of the formula la.15 in which R ⁶ is 2-(thietan-3-yl)-3-oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 664

Compounds of the formula la.15 in which R ⁶ is 2-(1 -oxo-thietan-3-yl)-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 665

Compounds of the formula la.15 in which R ⁶ is 2-(1 ,1 -dioxo-thietan-3-yl)-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 666

Compounds of the formula la.15 in which R ⁶ is 2-(3-methylthietan-3-yl)-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corre- sponds in each case to one row of Table A

Table 667

Compounds of the formula la.15 in which R ⁶ is 2-(oxetan-3-yl)-3-oxo-isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 668

Compounds of the formula la.15 in which R ⁶ is 2-(tetrahydropyran-4-yl)-3-oxo- isoxazolidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 669 to 954

Compounds of the formula la.16 in which R ⁶ is as defined in tables 383 to 668 and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 955 to 1240

Compounds of the formula la.17 in which R ⁶ is as defined in tables 383 to 668 and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 1241 to 1526

Compounds of the formula la.18 in which R ⁶ is as defined in tables 383 to 668 and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 1527 to 1812 Compounds of the formula la.19 in which R ⁶ is as defined in tables 383 to 668 and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 1813 to 2098

Compounds of the formula la.20 in which R ⁶ is as defined in tables 383 to 668 and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 2099 to 2384

Compounds of the formula la.21 in which R ⁶ is as defined in tables 383 to 668 and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 2385 to 2670

Compounds of the formula la.22 in which R ⁶ is as defined in tables 383 to 668 and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2671

Compounds of the formula la.23 in which R ^9a and R ^9b are methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2672

Compounds of the formula la.23 in which R ^9a and R ^9b are ethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2673

Compounds of the formula la.23 in which R ^9a and R ^9b are propyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2674

Compounds of the formula la.23 in which R ^9a and R ^9b are isopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2675 to 2678

Compounds of the formula la.24 in which R ^9a and R ^9b are as defined in tables 2671 to 2674, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2679

Compounds of the formula la.25 in which R ⁸ is hydrogen, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2680 Compounds of the formula la.25 in which R ⁸ is methyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2681

Compounds of the formula la.25 in which R ⁸ is ethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2682

Compounds of the formula la.25 in which R ⁸ is propyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2683

Compounds of the formula la.25 in which R ⁸ is isopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2684

Compounds of the formula la.25 in which R ⁸ is n-butyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2685

Compounds of the formula la.25 in which R ⁸ is sec-butyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2686

Compounds of the formula la.25 in which R ⁸ is isobutyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2687

Compounds of the formula la.25 in which R ⁸ is tert-butyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2688

Compounds of the formula la.25 in which R ⁸ is ChbF, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2689

Compounds of the formula la.25 in which R ⁸ is CHF2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2690

Compounds of the formula la.25 in which R ⁸ is CF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2691

Compounds of the formula la.25 in which R ⁸ is CH2CHF2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2692

Compounds of the formula la.25 in which R ⁸ is CH2CF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2693

Compounds of the formula la.25 in which R ⁸ is CF2CF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2694

Compounds of the formula la.25 in which R ⁸ is CH2CH2CF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2695

Compounds of the formula la.25 in which R ⁸ is CH(CH3)CF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2696

Compounds of the formula la.25 in which R ⁸ is CH(CF3)2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2697

Compounds of the formula la.25 in which R ⁸ is CF(CF3)2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2698

Compounds of the formula la.25 in which R ⁸ is CH2CN, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2699

Compounds of the formula la.25 in which R ⁸ is -CH=CH2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2700

Compounds of the formula la.25 in which R ⁸ is allyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2701

Compounds of the formula la.25 in which R ⁸ is -C≡CH, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2702

Compounds of the formula la.25 in which R ⁸ is propargyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2703

Compounds of the formula la.25 in which R ⁸ is CN, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2704

Compounds of the formula la.25 in which R ⁸ is -CH=CHF, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2705 Compounds of the formula la.25 in which R ⁸ is -CH=CF2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2706

Compounds of the formula la.25 in which R ⁸ is -CF=CF2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2707

Compounds of the formula la.25 in which R ⁸ is cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2708

Compounds of the formula la.25 in which R ⁸ is 1 -fluorocyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2709

Compounds of the formula la.25 in which R ⁸ is 1 -cyanocyclopropyl, and the combina- tion of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2710

Compounds of the formula la.25 in which R ⁸ is cyclobutyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 271 1

Compounds of the formula la.25 in which R ⁸ is 1 -fluorocyclobutyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2712

Compounds of the formula la.25 in which R ⁸ is 1 -cyanocyclobutyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2713

Compounds of the formula la.25 in which R ⁸ is cyclobut-1 -enyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2714

Compounds of the formula la.25 in which R ⁸ is -Chb-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2715

Compounds of the formula la.25 in which R ⁸ is -CH2-(1 -cyanocyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2716

Compounds of the formula la.25 in which R ⁸ is -Chb-cyclobutyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2717

Compounds of the formula la.25 in which R ⁸ is -CH2-(1 -cyanocyclobutyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2718

Compounds of the formula la.25 in which R ⁸ is oxetan-2-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2719

Compounds of the formula la.25 in which R ⁸ is oxetan-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2720

Compounds of the formula la.25 in which R ⁸ is tetrahydrofuran-2-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2721

Compounds of the formula la.25 in which R ⁸ is tetrahydrofuran-3-yl, and the combina- tion of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2722

Compounds of the formula la.25 in which R ⁸ is thietan-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2723

Compounds of the formula la.25 in which R ⁸ is 1 -oxo-thietan-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2724

Compounds of the formula la.25 in which R ⁸ is 1 ,1-dioxo-thietan-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2725

Compounds of the formula la.25 in which R ⁸ is phenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2726

Compounds of the formula la.25 in which R ⁸ is 2-fluorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2727

Compounds of the formula la.25 in which R ⁸ is 3-fluorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2728

Compounds of the formula la.25 in which R ⁸ is 4-fluorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2729

Compounds of the formula la.25 in which R ⁸ is 2,3-difluorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2730

Compounds of the formula la.25 in which R ⁸ is 2,4-difluorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2731

Compounds of the formula la.25 in which R ⁸ is 2,5-difluorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2732

Compounds of the formula la.25 in which R ⁸ is 2,6-difluorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2733

Compounds of the formula la.25 in which R ⁸ is 3,4-difluorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2734

Compounds of the formula la.25 in which R ⁸ is 3,5-difluorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2735

Compounds of the formula la.25 in which R ⁸ is 2-chlorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2736

Compounds of the formula la.25 in which R ⁸ is 3-chlorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2737 Compounds of the formula la.25 in which R ⁸ is 4-chlorophenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2738

Compounds of the formula la.25 in which R ⁸ is 2-methoxyphenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2739

Compounds of the formula la.25 in which R ⁸ is 3-methoxyphenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2740

Compounds of the formula la.25 in which R ⁸ is 4-methoxyphenyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2741

Compounds of the formula la.25 in which R ⁸ is pyridin-2-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2742

Compounds of the formula la.25 in which R ⁸ is pyridin-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2743

Compounds of the formula la.25 in which R ⁸ is pyridin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2744

Compounds of the formula la.25 in which R ⁸ is 4-chloropyridin-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2745

Compounds of the formula la.25 in which R ⁸ is pyrimidin-2-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2746

Compounds of the formula la.25 in which R ⁸ is methoxymethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2747

Compounds of the formula la.25 in which R ⁸ is ethoxymethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2748 Compounds of the formula la.25 in which R ⁸ is trifluoromethoxymethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2749

Compounds of the formula la.25 in which R ⁸ is methylthiomethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2750

Compounds of the formula la.25 in which R ⁸ is ethylthiomethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2751

Compounds of the formula la.25 in which R ⁸ is trifluoromethylthiomethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2752

Compounds of the formula la.25 in which R ⁸ is methylsulfinylmethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2753

Compounds of the formula la.25 in which R ⁸ is ethylsulfinylmethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2754

Compounds of the formula la.25 in which R ⁸ is trifluoromethylsulfinylmethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2755

Compounds of the formula la.25 in which R ⁸ is methylsulfonylmethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2756

Compounds of the formula la.25 in which R ⁸ is ethylsulfonylmethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2757

Compounds of the formula la.25 in which R ⁸ is trifluoromethylsulfonylmethyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2758

Compounds of the formula la.25 in which R ⁸ is -CH(CH3)-S02-CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2759

Compounds of the formula la.25 in which R ⁸ is -C(CH3)2-S02-CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2760

Compounds of the formula la.25 in which R ⁸ is -CH2-N(CH3)2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2761

Compounds of the formula la.25 in which R ⁸ is -CH2-CH2-N(CH3)2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2762

Compounds of the formula la.25 in which R ⁸ is -N(H)CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2763

Compounds of the formula la.25 in which R ⁸ is -N(H)CH2CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2764

Compounds of the formula la.25 in which R ⁸ is -N(H)CH2CHF2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2765

Compounds of the formula la.25 in which R ⁸ is -N(H)CH2CF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2766

Compounds of the formula la.25 in which R ⁸ is -N(H)CH2CH=CH2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2767

Compounds of the formula la.25 in which R ⁸ is -N(H)CH2C≡CH, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2768

Compounds of the formula la.25 in which R ⁸ is -N(H)CH2CN, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2769 Compounds of the formula la.25 in which R ⁸ is -N(H)-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2770

Compounds of the formula la.25 in which R ⁸ is -N(H)-(1 -cyanocyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2771

Compounds of the formula la.25 in which R ⁸ is Nhb, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2772

Compounds of the formula la.25 in which R ⁸ is -N(H)-CH2-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2773

Compounds of the formula la.25 in which R ⁸ is -N(H)-CH2-(1 -cyanocyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2774

Compounds of the formula la.25 in which R ⁸ is -C(0)-N(H)CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2775

Compounds of the formula la.25 in which R ⁸ is -C(0)-N(H)CH2CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2776

Compounds of the formula la.25 in which R ⁸ is -C(0)-N(H)CH2CHF2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2777

Compounds of the formula la.25 in which R ⁸ is -C(0)-N(H)CH2CF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2778

Compounds of the formula la.25 in which R ⁸ is -C(0)-N(H)CH ₂ CH=CH ₂ , and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2779 Compounds of the formula la.25 in which R ⁸ is -C(0)-N(H)CH2C≡CH, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2780

Compounds of the formula la.25 in which R ⁸ is -C(0)-N(H)CH2CN, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2781

Compounds of the formula la.25 in which R ⁸ is -C(0)-N(H)-cyclopropyl, and the combi- nation of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2782

Compounds of the formula la.25 in which R ⁸ is -C(0)-N(H)-(1 -cyanocyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2783

Compounds of the formula la.25 in which R ⁸ is -C(0)-N(H)-CH2-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2784

Compounds of the formula la.25 in which R ⁸ is -C(0)-N(H)-CH2-(1 -cyanocyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2785

Compounds of the formula la.25 in which R ⁸ is -CH2-C(0)-N(H)CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2786

Compounds of the formula la.25 in which R ⁸ is -CH2-C(0)-N(H)CH ₂ CH3, and the com- bination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2787

Compounds of the formula la.25 in which R ⁸ is -CH2-C(0)-N(H)CH ₂ CHF2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2788 Compounds of the formula la.25 in which R ⁸ is -CH ₂ -C(0)-N(H)CH2CF ₃ , and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2789

Compounds of the formula la.25 in which R ⁸ is -CH2-C(0)-N(H)CH ₂ CH=CH2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2790

Compounds of the formula la.25 in which R ⁸ is -CH2-C(0)-N(H)CH ₂ C≡CH, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2791

Compounds of the formula la.25 in which R ⁸ is -CH ₂ -C(0)-N(H)CH ₂ CN, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2792

Compounds of the formula la.25 in which R ⁸ is -CH ₂ -C(0)-N(H)-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2793

Compounds of the formula la.25 in which R ⁸ is -CH ₂ -C(0)-N(H)-(1 -cyanocyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2794

Compounds of the formula la.25 in which R ⁸ is -CH ₂ -C(0)-N(H)-CH ₂ -cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2795

Compounds of the formula la.25 in which R ⁸ is -CH ₂ -C(0)-N(H)-CH ₂ -(1 - cyanocyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2796

Compounds of the formula la.25 in which R ⁸ is -NH-C(0)-N(H)CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2797 Compounds of the formula la.25 in which R ⁸ is -NH-C(0)-N(H)CH ₂ CH ₃ , and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2798

Compounds of the formula la.25 in which R ⁸ is -NH-C(0)-N(H)CH ₂ CHF ₂ , and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2799

Compounds of the formula la.25 in which R ⁸ is -NH-C(0)-N(H)CH ₂ CF ₃ , and the combi- nation of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2800

Compounds of the formula la.25 in which R ⁸ is -NH-C(0)-N(H)CH ₂ CH=CH ₂ , and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2801

Compounds of the formula la.25 in which R ⁸ is -NH-C(0)-N(H)CH ₂ C≡CH, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2802

Compounds of the formula la.25 in which R ⁸ is -NH-C(0)-N(H)CH ₂ CN, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2803

Compounds of the formula la.25 in which R ⁸ is -NH-C(0)-N(H)-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2804

Compounds of the formula la.25 in which R ⁸ is -NH-C(0)-N(H)-(1 -cyanocyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2805

Compounds of the formula la.25 in which R ⁸ is -NH-C(0)-N(H)-CH ₂ -cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2806 Compounds of the formula la.25 in which R ⁸ is -NH-C(0)-N(H)-CH ₂ -(1 - cyanocyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2807

Compounds of the formula la.25 in which R ⁸ is -CH=N-OCH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2808

Compounds of the formula la.25 in which R ⁸ is -CH=N-OCH2CH3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2809

Compounds of the formula la.25 in which R ⁸ is -CH=N-OCH2CHF2, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2810

Compounds of the formula la.25 in which R ⁸ is -CH=N-OCH2CF3, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 281 1

Compounds of the formula la.25 in which R ⁸ is -CH=N-OCH ₂ CH=CH ₂ , and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2812

Compounds of the formula la.25 in which R ⁸ is -CH=N-OCH2C≡CH, and the combina- tion of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2813

Compounds of the formula la.25 in which R ⁸ is -CH=N-OCH2CN, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2814

Compounds of the formula la.25 in which R ⁸ is -CH=N-0-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2815

Compounds of the formula la.25 in which R ⁸ is -CH=N-0-(1 -cyanocyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 2816

Compounds of the formula la.25 in which R ⁸ is -CH=N-0-CH2-cyclopropyl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 2817

Compounds of the formula la.25 in which R ⁸ is -CH=N-0-CH2-(1 -cyanocyclopropyl), and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 2818 to 2956

Compounds of the formula la.26 in which R ⁸ is as defined in tables 2679 to 2817, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 2957 to 3095

Compounds of the formula la.27 in which R ⁸ is as defined in tables 2679 to 2817, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 3096 to 3234

Compounds of the formula la.28 in which R ⁸ is as defined in tables 2679 to 2817, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 3235 to 3373

Compounds of the formula la.29 in which R ⁸ is as defined in tables 2679 to 2817, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 3374 to 3512

Compounds of the formula la.30 in which R ⁸ is as defined in tables 2679 to 2817, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 3513 to 3651

Compounds of the formula la.31 in which R ⁸ is as defined in tables 2679 to 2817, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 3652 to 3790

Compounds of the formula la.32 in which R ⁸ is as defined in tables 2679 to 2817, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 3791 to 3929 Compounds of the formula la.33 in which R ⁸ is as defined in tables 2679 to 2817, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 3930 to 4068

Compounds of the formula la.34 in which R ⁸ is as defined in tables 2679 to 2817, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 4069 to 4207

Compounds of the formula la.35 in which R ⁸ is as defined in tables 2679 to 2817, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Tables 4208 to 4346

Compounds of the formula la.36 in which R ⁸ is as defined in tables 2679 to 2817, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 4347

Compounds of the formula la.37 in which A ⁴ is 1 H-pyrrol-1 -yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 4348

Compounds of the formula la.37 in which A ⁴ is 1 H-3-chloro-pyrrol-1 -yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 4349

Compounds of the formula la.37 in which A ⁴ is 1 H-3-cyano-pyrrol-1 -yl, and the combi- nation of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 4350

Compounds of the formula la.37 in which A ⁴ is 1 H-pyrazol-1 -yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 4351

Compounds of the formula la.37 in which A ⁴ is 1 H-4-cloro-pyrazol-1 -yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 4352

Compounds of the formula la.37 in which A ⁴ is 1 H-4-cyano-pyrazol-1 -yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 4353 Compounds of the formula la.37 in which A ⁴ is 1 H-imidazol-1 -yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 4354

Compounds of the formula la.37 in which A ⁴ is 1 H-4-chloro-imidazol-1 -yl, and the com- bination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 4355

Compounds of the formula la.37 in which A ⁴ is 1 H-4-cyano-imidazol-1 -yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 4356

Compounds of the formula la.37 in which A ⁴ is 1 H-[1 ,2,4]-triazol-1 -yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 4357

Compounds of the formula la.37 in which A ⁴ is 1 H-[1 ,2,4]-3-chloro-triazol-1 -yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 4358

Compounds of the formula la.37 in which A ⁴ is 1 H-[1 ,2,4]-3-cyano-triazol-1 -yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 4359

Compounds of the formula la.37 in which A ⁴ is 1 H-1 -methyl-pyrrol-2-yl, and the combi- nation of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 4360

Compounds of the formula la.37 in which A ⁴ is 1 H-1 -methyl-pyrrol-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 4361

Compounds of the formula la.37 in which A ⁴ is 1 H-1 -methyl-pyrazol-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 4362

Compounds of the formula la.37 in which A ⁴ is 1 H-1 -methyl-pyrazol-5-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 4363

Compounds of the formula la.37 in which A ⁴ is 1 H-1 ,3-dimethyl-pyrazol-5-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 4364

Compounds of the formula la.37 in which A ⁴ is 1 H-1 -methyl-3-trifluoromethyl-pyrazol-5- yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 4365

Compounds of the formula la.37 in which A ⁴ is 1 H-1 -[1 ,2,3]-triazol-5-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A

Table 4366

Compounds of the formula la.37 in which A ⁴ is pyridin-2-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 4367

Compounds of the formula la.37 in which A ⁴ is pyridin-3-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 4368

Compounds of the formula la.37 in which A ⁴ is pyridin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 4369

Compounds of the formula la.37 in which A ⁴ is pyrimidin-2-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 4370

Compounds of the formula la.37 in which A ⁴ is pyrimidin-4-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 4371

Compounds of the formula la.37 in which A ⁴ is pyrimidin-5-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table 4372

Compounds of the formula la.37 in which A ⁴ is pyrazin-2-yl, and the combination of R ^2a , R ^2b , R ^2c and R ^4b for a compound corresponds in each case to one row of Table A Table A

No. _R 2a _R 2b _R 2c _R 4b

A-1 F H F H _R 2a _R 2b _R 2c _R 4b

A-2 F F F H

A-3 F CI F H

A-4 F Br F H

A-5 F H CI H

A-6 F H Br H

A-7 CI H CI H

A-8 CI CI CI H

A-9 CI F CI H

A-10 CI Br CI H

A-1 1 CI H Br H

A-12 Br H Br H

A-13 Br F Br H

A-14 Br CI Br H

A-15 CFs H F H

A-16 CFs H CI H

A-17 CFs H Br H

A-18 CFs H CFs H

A-19 CFs F F H

A-20 CFs CI CI H

A-21 CFs Br Br H

A-22 SF ₅ H F H

A-23 SF ₅ H CI H

A-24 SF ₅ H Br H

A-25 SF ₅ H CFs H

A-26 SF ₅ H H H

A-27 CFs H H H

A-28 Br H H H

A-29 CI H H H

A-30 F H H H

A-31 F H F CHs

A-32 F F F CHs

A-33 F CI F CHs

A-34 F Br F CHs

A-35 F H CI CHs

A-36 F H Br CHs

A-37 CI H CI CHs _R 2a _R 2b _R 2c _R 4b

A-1 10 CFs CI CI CH(CHs) ₂

A-1 1 1 CFs Br Br CH(CHs) ₂

A-1 12 SF ₅ H F CH(CHs) ₂

A-1 13 SF ₅ H CI CH(CHs) ₂

A-1 14 SF ₅ H Br CH(CHs) ₂

A-1 15 SF ₅ H CFs CH(CHs) ₂

A-1 16 SF ₅ H H CH(CHs) ₂

A-1 17 CFs H H CH(CHs) ₂

A-1 18 Br H H CH(CHs) ₂

A-1 19 CI H H CH(CHs) ₂

A-120 F H H CH(CHs) ₂

A-121 F H F CHF ₂

A-122 F F F CHF ₂

A-123 F CI F CHF ₂

A-124 F Br F CHF ₂

A-125 F H CI CHF ₂

A-126 F H Br CHF ₂

A-127 CI H CI CHF ₂

A-128 CI CI CI CHF ₂

A-129 CI F CI CHF ₂

A-130 CI Br CI CHF ₂

A-131 CI H Br CHF ₂

A-132 Br H Br CHF ₂

A-133 Br F Br CHF ₂

A-134 Br CI Br CHF ₂

A-135 CFs H F CHF ₂

A-136 CFs H CI CHF ₂

A-137 CFs H Br CHF ₂

A-138 CFs H CFs CHF ₂

A-139 CFs F F CHF ₂

A-140 CFs CI CI CHF ₂

A-141 CFs Br Br CHF ₂

A-142 SF ₅ H F CHF ₂

A-143 SF ₅ H CI CHF ₂

A-144 SF ₅ H Br CHF ₂

A-145 SF ₅ H CFs CHF _{2 R} 2a _R 2b _R 2c _R 4b

A-146 SF ₅ H H CHF ₂

A-147 CFs H H CHF ₂

A-148 Br H H CHF ₂

A-149 CI H H CHF ₂

A-150 F H H CHF ₂

A-151 F H F CFs

A-152 F F F CFs

A-153 F CI F CFs

A-154 F Br F CFs

A-155 F H CI CFs

A-156 F H Br CFs

A-157 CI H CI CFs

A-158 CI CI CI CFs

A-159 CI F CI CFs

A-160 CI Br CI CFs

A-161 CI H Br CFs

A-162 Br H Br CFs

A-163 Br F Br CFs

A-164 Br CI Br CFs

A-165 CFs H F CFs

A-166 CFs H CI CFs

A-167 CFs H Br CFs

A-168 CFs H CFs CFs

A-169 CFs F F CFs

A-170 CFs CI CI CFs

A-171 CFs Br Br CFs

A-172 SF ₅ H F CFs

A-173 SF ₅ H CI CFs

A-174 SF ₅ H Br CFs

A-175 SF ₅ H CFs CFs

A-176 SF ₅ H H CFs

A-177 CFs H H CFs

A-178 Br H H CFs

A-179 CI H H CFs

A-180 F H H CFs

A-181 F H F CH ₂ -CH=CH ₂

£0l£90/H0Zd3/I3d 60690Z/H0Z OAV

£0l£90/H0Zd3/I3d 60690Z/H0Z OAV _R 2a _R 2b _R 2c _R 4b

A-254 Br CI Br C≡CH

A-255 CFs H F C≡CH

A-256 CFs H CI C≡CH

A-257 CFs H Br C≡CH

A-258 CFs H CFs C≡CH

A-259 CFs F F C≡CH

A-260 CFs CI CI C≡CH

A-261 CFs Br Br C≡CH

A-262 SF ₅ H F C≡CH

A-263 SF ₅ H CI C≡CH

A-264 SF ₅ H Br C≡CH

A-265 SF ₅ H CFs C≡CH

A-266 SF ₅ H H C≡CH

A-267 CFs H H C≡CH

A-268 Br H H C≡CH

A-269 CI H H C≡CH

A-270 F H H C≡CH

A-271 F H F ^c CsH ₅ ^*

A-272 F F F ^c CsH ₅ ^*

A-273 F CI F ^c CsH ₅ ^*

A-274 F Br F ^c CsH ₅ ^*

A-275 F H CI ^c CsH ₅ ^*

A-276 F H Br ^c CsH ₅ ^*

A-277 CI H CI ^c CsH ₅ ^*

A-278 CI CI CI ^c CsH ₅ ^*

A-279 CI F CI ^c CsH ₅ ^*

A-280 CI Br CI ^c CsH ₅ ^*

A-281 CI H Br ^c CsH ₅ ^*

A-282 Br H Br ^c CsH ₅ ^*

A-283 Br F Br ^c CsH ₅ ^*

A-284 Br CI Br ^c CsH ₅ ^*

A-285 CFs H F ^c CsH ₅ ^*

A-286 CFs H CI ^c CsH ₅ ^*

A-287 CFs H Br ^c CsH ₅ ^*

A-288 CFs H CFs ^c CsH ₅ ^*

A-289 CFs F F ^c CsH ₅ ^* _R 2a _R 2b _R 2c _R 4b

A-290 CFs CI CI ^c CsH ₅ ^*

A-291 CFs Br Br ^c CsH ₅ ^*

A-292 SF ₅ H F ^c CsH ₅ ^*

A-293 SF ₅ H CI ^c CsH ₅ ^*

A-294 SF ₅ H Br ^c CsH ₅ ^*

A-295 SF ₅ H CFs ^c CsH ₅ ^*

A-296 SF ₅ H H ^c CsH ₅ ^*

A-297 CFs H H ^c CsH ₅ ^*

A-298 Br H H ^c CsH ₅ ^*

A-299 CI H H ^c CsH ₅ ^*

A-300 F H H ^c CsH ₅ ^*

A-301 F H F F

A-302 F F F F

A-303 F CI F F

A-304 F Br F F

A-305 F H CI F

A-306 F H Br F

A-307 CI H CI F

A-308 CI CI CI F

A-309 CI F CI F

A-310 CI Br CI F

A-31 1 CI H Br F

A-312 Br H Br F

A-313 Br F Br F

A-314 Br CI Br F

A-315 CFs H F F

A-316 CFs H CI F

A-317 CFs H Br F

A-318 CFs H CFs F

A-319 CFs F F F

A-320 CFs CI CI F

A-321 CFs Br Br F

A-322 SF ₅ H F F

A-323 SF ₅ H CI F

A-324 SF ₅ H Br F

A-325 SF ₅ H CFs F _R 2a _R 2b _R 2c _R 4b

A-326 SF ₅ H H F

A-327 CFs H H F

A-328 Br H H F

A-329 CI H H F

A-330 F H H F

A-331 F H F CI

A-332 F F F CI

A-333 F CI F CI

A-334 F Br F CI

A-335 F H CI CI

A-336 F H Br CI

A-337 CI H CI CI

A-338 CI CI CI CI

A-339 CI F CI CI

A-340 CI Br CI CI

A-341 CI H Br CI

A-342 Br H Br CI

A-343 Br F Br CI

A-344 Br CI Br CI

A-345 CFs H F CI

A-346 CFs H CI CI

A-347 CFs H Br CI

A-348 CFs H CFs CI

A-349 CFs F F CI

A-350 CFs CI CI CI

A-351 CFs Br Br CI

A-352 SF ₅ H F CI

A-353 SF ₅ H CI CI

A-354 SF ₅ H Br CI

A-355 SF ₅ H CFs CI

A-356 SF ₅ H H CI

A-357 CFs H H CI

A-358 Br H H CI

A-359 CI H H CI

A-360 F H H CI

A-361 F H F Br _R 2a _R 2b _R 2c _R 4b

A-362 F F F Br

A-363 F CI F Br

A-364 F Br F Br

A-365 F H CI Br

A-366 F H Br Br

A-367 CI H CI Br

A-368 CI CI CI Br

A-369 CI F CI Br

A-370 CI Br CI Br

A-371 CI H Br Br

A-372 Br H Br Br

A-373 Br F Br Br

A-374 Br CI Br Br

A-375 CFs H F Br

A-376 CFs H CI Br

A-377 CFs H Br Br

A-378 CFs H CFs Br

A-379 CFs F F Br

A-380 CFs CI CI Br

A-381 CFs Br Br Br

A-382 SF ₅ H F Br

A-383 SF ₅ H CI Br

A-384 SF ₅ H Br Br

A-385 SF ₅ H CFs Br

A-386 SF ₅ H H Br

A-387 CFs H H Br

A-388 Br H H Br

A-389 CI H H Br

A-390 F H H Br

A-391 F H F CN

A-392 F F F CN

A-393 F CI F CN

A-394 F Br F CN

A-395 F H CI CN

A-396 F H Br CN

A-397 CI H CI CN _R 2a _R 2b _R 2c _R 4b

A-398 CI CI CI CN

A-399 CI F CI CN

A-400 CI Br CI CN

A-401 CI H Br CN

A-402 Br H Br CN

A-403 Br F Br CN

A-404 Br CI Br CN

A-405 CFs H F CN

A-406 CFs H CI CN

A-407 CFs H Br CN

A-408 CFs H CFs CN

A-409 CFs F F CN

A-410 CFs CI CI CN

A-41 1 CFs Br Br CN

A-412 SF ₅ H F CN

A-413 SF ₅ H CI CN

A-414 SF ₅ H Br CN

A-415 SF ₅ H CFs CN

A-416 SF ₅ H H CN

A-417 CFs H H CN

A-418 Br H H CN

A-419 CI H H CN

A-420 F H H CN

A-421 F H F OCHs

A-422 F F F OCHs

A-423 F CI F OCHs

A-424 F Br F OCHs

A-425 F H CI OCHs

A-426 F H Br OCHs

A-427 CI H CI OCHs

A-428 CI CI CI OCHs

A-429 CI F CI OCHs

A-430 CI Br CI OCHs

A-431 CI H Br OCHs

A-432 Br H Br OCHs

A-433 Br F Br OCHs _R 2a _R 2b _R 2c _R 4b

A-506 SF ₅ H H OCH(CHs) ₂

A-507 CFs H H OCH(CHs) ₂

A-508 Br H H OCH(CHs) ₂

A-509 CI H H OCH(CHs) ₂

A-510 F H H OCH(CHs) ₂

A-51 1 F H F OCH ₂ CH=CH ₂

A-512 F F F OCH ₂ CH=CH ₂

A-513 F CI F OCH ₂ CH=CH ₂

A-514 F Br F OCH ₂ CH=CH ₂

A-515 F H CI OCH ₂ CH=CH ₂

A-516 F H Br OCH ₂ CH=CH ₂

A-517 CI H CI OCH ₂ CH=CH ₂

A-518 CI CI CI OCH ₂ CH=CH ₂

A-519 CI F CI OCH ₂ CH=CH ₂

A-520 CI Br CI OCH ₂ CH=CH ₂

A-521 CI H Br OCH ₂ CH=CH ₂

A-522 Br H Br OCH ₂ CH=CH ₂

A-523 Br F Br OCH ₂ CH=CH ₂

A-524 Br CI Br OCH ₂ CH=CH ₂

A-525 CFs H F OCH ₂ CH=CH ₂

A-526 CFs H CI OCH ₂ CH=CH ₂

A-527 CFs H Br OCH ₂ CH=CH ₂

A-528 CFs H CFs OCH ₂ CH=CH ₂

A-529 CFs F F OCH ₂ CH=CH ₂

A-530 CFs CI CI OCH ₂ CH=CH ₂

A-531 CFs Br Br OCH ₂ CH=CH ₂

A-532 SF ₅ H F OCH ₂ CH=CH ₂

A-533 SF ₅ H CI OCH ₂ CH=CH ₂

A-534 SF ₅ H Br OCH ₂ CH=CH ₂

A-535 SF ₅ H CFs OCH ₂ CH=CH ₂

A-536 SF ₅ H H OCH ₂ CH=CH ₂

A-537 CFs H H OCH ₂ CH=CH ₂

A-538 Br H H OCH ₂ CH=CH ₂

A-539 CI H H OCH ₂ CH=CH ₂

A-540 F H H OCH ₂ CH=CH ₂

A-541 F H F 0- ^c CsH ₅ ^* _R 2a _R 2b _R 2c _R 4b

A-722 F F F SCH(CHs) ₂

A-723 F CI F SCH(CHs) ₂

A-724 F Br F SCH(CHs) ₂

A-725 F H CI SCH(CHs) ₂

A-726 F H Br SCH(CHs) ₂

A-727 CI H CI SCH(CHs) ₂

A-728 CI CI CI SCH(CHs) ₂

A-729 CI F CI SCH(CHs) ₂

A-730 CI Br CI SCH(CHs) ₂

A-731 CI H Br SCH(CHs) ₂

A-732 Br H Br SCH(CHs) ₂

A-733 Br F Br SCH(CHs) ₂

A-734 Br CI Br SCH(CHs) ₂

A-735 CFs H F SCH(CHs) ₂

A-736 CFs H CI SCH(CHs) ₂

A-737 CFs H Br SCH(CHs) ₂

A-738 CFs H CFs SCH(CHs) ₂

A-739 CFs F F SCH(CHs) ₂

A-740 CFs CI CI SCH(CHs) ₂

A-741 CFs Br Br SCH(CHs) ₂

A-742 SF ₅ H F SCH(CHs) ₂

A-743 SF ₅ H CI SCH(CHs) ₂

A-744 SF ₅ H Br SCH(CHs) ₂

A-745 SF ₅ H CFs SCH(CHs) ₂

A-746 SF ₅ H H SCH(CHs) ₂

A-747 CFs H H SCH(CHs) ₂

A-748 Br H H SCH(CHs) ₂

A-749 CI H H SCH(CHs) ₂

A-750 F H H SCH(CHs) ₂

A-751 F H F SCH ₂ CH=CH ₂

A-752 F F F SCH ₂ CH=CH ₂

A-753 F CI F SCH ₂ CH=CH ₂

A-754 F Br F SCH ₂ CH=CH ₂

A-755 F H CI SCH ₂ CH=CH ₂

A-756 F H Br SCH ₂ CH=CH ₂

A-757 CI H CI SCH ₂ CH=CH _{2 R} 2a _R 2b _R 2c _R 4b

A-758 CI CI CI SCH ₂ CH=CH ₂

A-759 CI F CI SCH ₂ CH=CH ₂

A-760 CI Br CI SCH ₂ CH=CH ₂

A-761 CI H Br SCH ₂ CH=CH ₂

A-762 Br H Br SCH ₂ CH=CH ₂

A-763 Br F Br SCH ₂ CH=CH ₂

A-764 Br CI Br SCH ₂ CH=CH ₂

A-765 CFs H F SCH ₂ CH=CH ₂

A-766 CFs H CI SCH ₂ CH=CH ₂

A-767 CFs H Br SCH ₂ CH=CH ₂

A-768 CFs H CFs SCH ₂ CH=CH ₂

A-769 CFs F F SCH ₂ CH=CH ₂

A-770 CFs CI CI SCH ₂ CH=CH ₂

A-771 CFs Br Br SCH ₂ CH=CH ₂

A-772 SF ₅ H F SCH ₂ CH=CH ₂

A-773 SF ₅ H CI SCH ₂ CH=CH ₂

A-774 SF ₅ H Br SCH ₂ CH=CH ₂

A-775 SF ₅ H CFs SCH ₂ CH=CH ₂

A-776 SF ₅ H H SCH ₂ CH=CH ₂

A-777 CFs H H SCH ₂ CH=CH ₂

A-778 Br H H SCH ₂ CH=CH ₂

A-779 CI H H SCH ₂ CH=CH ₂

A-780 F H H SCH ₂ CH=CH ₂

A-781 F H F S- ^c CsH ₅ ^*

A-782 F F F S- ^c CsH ₅ ^*

A-783 F CI F S- ^c CsH ₅ ^*

A-784 F Br F S- ^c CsH ₅ ^*

A-785 F H CI S- ^c CsH ₅ ^*

A-786 F H Br S- ^c CsH ₅ ^*

A-787 CI H CI S- ^c CsH ₅ ^*

A-788 CI CI CI S- ^c CsH ₅ ^*

A-789 CI F CI S- ^c CsH ₅ ^*

A-790 CI Br CI S- ^c CsH ₅ ^*

A-791 CI H Br S- ^c CsH ₅ ^*

A-792 Br H Br S- ^c CsH ₅ ^*

A-793 Br F Br S- ^c CsH ₅ ^* _R 2a _R 2b _R 2c _R 4b

A-794 Br CI Br S- ^c CsH ₅ ^*

A-795 CFs H F S- ^c CsH ₅ ^*

A-796 CFs H CI S- ^c CsH ₅ ^*

A-797 CFs H Br S- ^c CsH ₅ ^*

A-798 CFs H CFs S- ^c CsH ₅ ^*

A-799 CFs F F S- ^c CsH ₅ ^*

A-800 CFs CI CI S- ^c CsH ₅ ^*

A-801 CFs Br Br S- ^c CsH ₅ ^*

A-802 SF ₅ H F S- ^c CsH ₅ ^*

A-803 SF ₅ H CI S- ^c CsH ₅ ^*

A-804 SF ₅ H Br S- ^c CsH ₅ ^*

A-805 SF ₅ H CFs S- ^c CsH ₅ ^*

A-806 SF ₅ H H S- ^c CsH ₅ ^*

A-807 CFs H H S- ^c CsH ₅ ^*

A-808 Br H H S- ^c CsH ₅ ^*

A-809 CI H H S- ^c CsH ₅ ^*

A-810 F H H S- ^c CsH ₅ ^*

A-81 1 F H F SCFs

A-812 F F F SCFs

A-813 F CI F SCFs

A-814 F Br F SCFs

A-815 F H CI SCFs

A-816 F H Br SCFs

A-817 CI H CI SCFs

A-818 CI CI CI SCFs

A-819 CI F CI SCFs

A-820 CI Br CI SCFs

A-821 CI H Br SCFs

A-822 Br H Br SCFs

A-823 Br F Br SCFs

A-824 Br CI Br SCFs

A-825 CFs H F SCFs

A-826 CFs H CI SCFs

A-827 CFs H Br SCFs

A-828 CFs H CFs SCFs

A-829 CFs F F SCFs

* ^C C3H ₅ = cyclopropyl

Among the above compounds, preference is given to compounds of formula la.1 , la.13, la.15, la.25, la.26, and la.27, and especially to la.15.

The compounds of the formula (I) can be prepared by the methods as described in the below schemes or and in the synthesis descriptions of the working examples, or by standard methods of organic chemistry. The substituents, variables and indices are as defined above for formula (I), if not otherwise specified.

Compounds of formula I can be prepared by dehydrating a compound of formula 1 as shown in scheme 1 below. X' corresponds to a heterocyclic radical X, which however either carries a group A or a group A, where A' is a precursor of A. Typical precursors of A are a halogen atom, CN, carboxy, tert-butoxycarbonyl, an acetale group, a pro- tected aldehyde group or -OS02-R ^z1 , where R ^z1 is Ci-C4-alkyl, Ci-C4-haloalkyl or phenyl which may be substituted by 1 , 2 or 3 radicals selected from Ci-C4-alkyl, C1-C4- haloalkyl Ci-C4-alkoxy or Ci-C4-haloalkoxy. Compounds Γ correspond to compounds I when A' is A (or X' is X). Dehydration either occurs spontaneously or with the help of dehydrating agents, such as molecular sieves, acid-washed molecular sieves, magne- sium sulfate, sodium sulfate, silica gel, SOC , POCI3, Burgess reagent, trifluoroacetic anhydride, p-toluene sulfonic acid, anhydrous HCI or sulfuric acid. Preferably, p-toluene sulfonic acid or acid-washed molecular sieves are used. The water formed may alternatively be removed, e.g. by azeotropic distillation, e.g. with benzene/toluene as en- trainer, e.g. using a Dean Stark trap. If necessary (i.e. if A is a precursor of A), A' is then converted into a group A.

Scheme 1

1 Γ

Compounds 1 wherein R ^3b is hydrogen can be prepared by reacting a compound 3 with an amination agent to give a compound of formula 2, which reacts spontaneously to the compound 1 , as shown in scheme 2. Depending on the amination agents used, amination can the carried out in a one step reaction, wherein compound 3 reacts directly to compound 2, or as a two step reaction, wherein the SH group of compound 3 is first oxidized to a S-CI group, which then further reacts to a S-NH2 group, thus giving compound 2.

Suitable amination agents for the one step reaction are for example HOSA (hydroxyla- mine-O-sulfonic acid), which is generally used in the presence of a base (suitable bases being for example sodium hydrogen phosphate, potassium hydrogen phosphate, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, so- dium methanolate, triethylamine and the like), 0-(diphenylphosphoryl)hydroxyl amine, which is generally also used in the presence of a base (suitable bases being for example sodium hydrogen phosphate, potassium hydrogen phosphate, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium methanolate, triethylamine and the like), 2,4-dinitrophenylhydroxyl amine, O- mesitylensulfonylhydroxylamine and 2-oxa-1 -azaspiro[2.5]octane, among which HOSA and 0-(diphenylphosphoryl)hydroxyl amine are preferred. The amination is generally carried out in a solvent, suitable solvents being for example chlorinated alkanes, such as methylene chloride or chloroform, aromatic solvents, such as benzene, toluene, the xylenes, chlorobenzene or dichlorobenzene, and ethers, such as diethylether, dipro- pylether, methyl tert-butylether, methyl isobutylether, ethylenegylcol dimethylether, tet- rahydrofuran (THF) or dioxane and the like. The reaction is suitably carried out low temperature, e.g. at from -100 to 0°C or -78 to 0°C. Generally, the compound 3 is dispersed in a solvent and cooled to the desired temperature and the base is added followed by the amination agent, or the amination agent is added followed by the base, or base and amination agent are added simultaneously. HOSA is suitably used in combination with an amine base, such as triethylamine. In this case, it is preferred to cool compound 3 to -30 to 0°C, preferably -20 to -10°C, to add the amine base at this temperature and then HOSA and keep the reaction at approximately -10 to 0°C. Alternatively, 0-(diphenylphosphoryl)hydroxyl amine can be used in combination with a base, e.g. with an inorganic base, such as sodium hydrogen phosphate, potassium hydrogen phosphate, sodium hydroxide, potassium hydroxide, sodium carbonate or potassium carbonate and specifically sodium hydrogen phosphate. In this case, it is suitable to cool compound 3 to -80 to -30°C, especially -80 to -70°C, to add the base at this temperature and then 0-(diphenylphosphoryl)hydroxyl amine and keep the reaction at approximately 0°C to room temperature. In the two step reaction, the compound 3 is first reacted with a chlorination agent which converts the SH group into an S-CI group. Suitable chlorination agents are for example sulfurylchloride, N-chloro succinimide (NCS), sodium hypochlorite, monochloroamine (NH2CI) or chlorine, which is preferably used in the presence of FeC . The chlorination can be carried out in analogy to the method described in Synthesis 1987, 1987, 683- 688, Tetrahedron 66(36), 2010, 7279-7287, J. Org. Chem. 59(4), 1994, 914-921 , J.

Org. Chem. 63, 1998, 4878-4888 or J. Chem Soc. 1938, 21 14-21 17. The chlorination is generally carried out in a solvent. Suitable solvents are for example ethers, such as diethylether, dipropylether, methyl tert-butylether, methyl isobutylether, ethylenegylcol dimethylether, tetrahydrofuran or dioxane. The reaction temperature can vary over wide ranges and is generally from 0°C to the boiling point of the reaction mixture (if a solvent is used). The chlorinated compound is then reacted without isolation with ammonia or ammonium hydroxide. If anhydrous ammonia is used, the reaction is generally carried out at from -78 to -33°C. If aqueous ammonia or ammonium hydroxide is used, the reaction can also be carried out at higher temperatures, such as 0 to 25°C. The reaction is generally carried out in a solvent. Suitable solvents are for example the above-listed ethers, among which the water-miscible ethers, such as THF and dioxane, are preferred. In general, the chlorinated compound is dissolved in a solvent to which ammonia or ammonium hydroxide is added. The reaction can be carried out as described, for example, in Synthesis, 1987, 8, 683-688. The chlorination/amination can also be carried as a one pot reaction. For example, the thiol 3 is reacted simultaneously with a chlorinating agent (such as NCS or aqueous sodium hypochlorite) and anhydrous or aqueous ammonia in ethereal solvents (such as THF or Et ₂ 0) or water. Preferred is the reaction with NCS in a mixture of THF and anhydrous liquid ammonia at - 33°C. For instance, a solution of the thiol 3 in THF is added to a solution of NCS (N- chlorosuccinimide) in THF/liquid ammonia at -78°C. The solution is warmed to -30°C and stirred until the ammonia has evaporated. Alternatively, at 0°C, a solution of the sodium thiolate (NaSR) in water is added to a mixture of aqueous ammonia (25%) and aqueous sodium hypochlorite (1 N). The one pot chlorination/amination reaction can be carried out as described, for example, in Tetrahedron 2010, 66, 7279-7287 or in J. Org. Chem. 1994, 59, 914-921.

Compound 2 can virtually not be isolated as it generally reacts spontaneously in a ring- closing reaction to compound 1.

Scheme 2

The compound of formula 3 can be prepared by reacting a compound of formula 4

with a sulfur source. Suitable sulfur sources are for example H ₂ S, metal hydrogen sul- fides, such as NaSH or KSH, metal sulfides, such as Na ₂ S, K ₂ S Li ₂ S, Cu ₂ S, MgS, CaS, CuS, FeS and the like, ammonium sulfide [(NH ₄ ) ₂ S], tetraalkylammonium sulfides (R ₄ NSH), such as tetramethylammonium sulfide, tetraethylammonium sulfide, tetrapropylammonium sulfide and the like, or bistrimethylsilyl sulfide. H ₂ S as a sulfur source is generally used in the presence of a base, such as Na ₂ C03, K ₂ C03, Cs ₂ C03, sodium acetate, potassium acetate, cesium acetate, amines, such as diethylamine, dipropylamine, triethylamine, diisopropylethylamine and the like, or basic nitrogen- containing heterocycles, such as pyrrolidine, piperidine, piperazine, pyridine, lutidine and the like. Alternatively, H ₂ S as a sulfur source can be used in the presence of a Lewis acid, such as AlC or FeC . The reaction of compound 4 with a sulfur source is generally carried out in a solvent, suitable solvents being for example chlorinated al- kanes, such as methylene chloride or chloroform, and aromatic solvents, such as benzene, toluene, the xylenes, chlorobenzene or dichlorobenzene. The reaction tempera- ture can vary over a wide range, such as -78°C to room temperature. In general, compound 4 is dissolved in a solvent, optionally cooled, then the base (if used) and subsequently the sulfur source is added. The compound 4 can alternatively be reacted with a sulfur source which provides a compound 3 which is protected at the thiol group SH by a protective group (S-PG). This is advantageous if compound 3 is for example subjected to harsher purification conditions or is derivatized, e.g. for converting the precursor group A' into a group A or for modifying group A at this stage. Moreover, purification of the protected product is easier. Suitable sulfuration reagents which give such protected thiols are for example thiourea (NH2-C(=S)-NH2), optionally substituted benzyl thiols, such as benzylthiol, o- or p-methoxy-benzylthiol, o- or p-hydroxybenzylthiol, o- or p- acetoxybenzylthiol, o- or p-nitrobenzylthiol or 2,4,6-trimethylbenzylthiol, pyridin-4-yl- methylthiol, quinolin-2-yl-methylthiol, benzyl metal sulfides, such as sodium benzyl- sulfide, phenylthiol, 2,4-dinitrophenylthiol, tritylthiol, tert-butylthiol, compounds of formula R-C(=0)-NH-CH ₃ -SH, wherein R is methyl, tert-butyl, allyl, phenyl or benzyl, 2- trimethylsilanyl-ethanethiol, 2-(2,4-dinitrophenyl)-ethanethiol, 2-phenylsulfonyl- ethanethiol, acylated thiols, such as methylcarbonylthiol or phenylcarbonylthiol, and thiocarbamates R-NH-C(=0)-SH, wherein R is e.g. methyl or ethyl. The benzyl and alkyl thiols are generally used in the presence of a base, such as sodium hydroxide, potassium hydroxide, sodium phosphate, potassium phosphate, sodium hy- drogenphosphate, potassium hydrogenphosphate, sodium carbonate, potassium carbonate, caesium carbonate, sodium hydride, potassium hydride, lithium diisopropyl amide (LDA), sodium methanolate, sodium ethanolate, potassium tert-butoxide, aqueous sodium tetraborate, n-butyllithium, tert-butylithium, tetrabutylammoniumfluoride (TBAF), NaHMDS and the like, or in the presence of a Lewis or Bronsted acid, such as FeC , Zn(CI0 ₄ )2, Cu(BF ₄ )2, HBF ₄ or HCI0 ₄ . The reaction is generally carried out in a solvent, suitable solvents being for example chlorinated alkanes, such as methylene chloride or chloroform, and ethers, such as diethylether, dipropylether, methyl tert- butylether, methyl isobutylether, ethylenegylcol dimethylether, tetrahydrofuran (THF) or dioxane and the like. The reaction temperature can vary over a wide range, such as from -25°C to the boiling point of the reaction mixture. The acylated thiols can be reacted neat or in a solvent, suitable solvents being for example chlorinated alkanes, such as methylene chloride or chloroform, and ethers, such as diethylether, dipropylether, methyl tert-butylether, methyl isobutylether, ethylenegylcol dimethylether, tetrahydrofuran (THF) or dioxane and the like. They can be used with or without a base. The S- protected compound 3 can then be deprotected to the free thiol 3 under conditions generally known for the respective protective group, such as described, for example, in Peter G. M. Wuts, Theodora Greene, Protective Groups in Organic Synthesis, 4 ^th edition, John Wiley & Sons, Inc., 2007, Chapter 6. Compound 4 can be prepared in analogy to the method described in EP-A-2172462.

Compounds 1 (in which R ^3b is not necessarily hydrogen) can be prepared alternatively by reacting a compound of formula 6 with an amination agent to a compound of formula 5, which reacts spontaneously to the compound 1 , as shown in scheme 3. The reaction can be carried out in analogy to that of compounds 3 and 2.

Scheme 3

The compound of formula 6 can be obtained by reacting a compound of formula 7 with a compound of formula 8.

The reaction is preferably carried out as a Mukaiyama aldol reaction. To this purpose, the trialklysilyl-enolate derivative of 8 is reacted with 7 in the presence of a Lewis acid, such as TiCU or BF3[0(C2H ₅ )2]. Alternatively, the reaction can be carried out in the presence of a strong base, such as lithium diisopropylamide (LDA), sodium bistrime- thylsilylamide (sodium hexamethyldisilazide; NaHMDS) and amines, such as triethyla- mine, tripropylamine or diisopropylethylamine. The reaction is generally carried out in a solvent. If a lithium or sodium base is used, the solvent is suitably an ether, such as diethylether, dipropylether, methyl tert-butylether, methyl isobutylether, ethylenegylcol dimethylether, tetrahydrofuran (THF) or dioxane and the like. Suitable reaction temperatures range from -78 to 25°C. If an amine base is used, the solvent is suitably an ether, such as diethylether, dipropylether, methyl tert-butylether, methyl isobutylether, ethylenegylcol dimethylether, tetrahydrofuran (THF) or dioxane, or an alkane, such as pentane, hexane or heptane. Suitable reaction temperatures range from 25 to 100°C. The compound of formula 7 can be obtained by reacting a compound of formula 9 with a sulfuration agent, such as Lawesson's reagent or P2S5.

The reaction is generally carried out in a solvent, suitable solvents being for example aromatic solvents, such as benzene, toluene, the xylenes, chlorobenzene or dichloro- benzene, ethers, such as diethylether, dipropylether, methyl tert-butylether, methyl iso- butylether, ethylenegylcol dimethylether, tetrahydrofuran (THF) or dioxane, and hexa- methyl phosphoric acid triamide (HMPA). The reaction is generally carried out at a temperature of from 25°C to the boiling point of the reaction mixture.

Compounds of formula I wherein R ¹ is CF3 can moreover be prepared by reacting a compound of formula 10 with a fluorinating agent and, if necessary (i.e. if A' is a precursor of A), converting the group A' into a group A.

Suitable fluorinating agents are, for example, SF ₄ , preferably in combination with HF or BF3[0(C2H ₅ )2], phenylsulfur trifluoride (Ph-SFs), preferably in combination with HF and pyridine, 4-tert-butyl-2,6-dimethylphenylsulfur trifluoride ("Fluoled"), and bis(2- methoxyethyl)aminosulfur trifluoride [(Ch OCI-bCI-b^NSFs]. Among these, preference is given to SF ₄ in combination with HF. If SF ₄ in combination with HF is used, the reaction is carried out neat, i.e. without any further solvent. The reaction is generally carried out under elevated pressure stemming from the reactants, e.g. at a pressure of from 2 to 10 bar, preferably from 5 to 8 bar. The reaction temperature can vary over wide ranges, such as from 25 to 120°C, preferably from 60 to 100°C.

Alternatively, fluorination can be carried out by a two step method, in which the carbox- yl group on the isothiazoline ring is first converted into a CC group, and this is subsequently fluorinated to the CF3 group. The conversion of the COOH group to the CCb group is preferably carried out by reacting the compound VI with PCI5 and phenyl- phosphoroxy dichloride (Ph-P(=0)Cl2). The reaction can be carried out neat, i.e. with- out any further solvent. Suitably, the reaction is carried out at elevated temperatures, for example at from 50°C to reflux and preferably at reflux. Fluorination agents for con- verting the CCI3 group into a CF3 group are those mentioned above, and further HF and HF in combination with SbCIs and HF in combination with CI2 and SbF3. The reaction can be carried out neat, i.e. without any further solvent. The reaction temperature can vary over wide ranges, for examples from 25 to 300°C, preferably from 50 to 200°C and in particular from 80 to 120°C. If the fluorination agent is HF or HF in combination with a further agent, the reaction generally takes place at the pressure stemming from HF and ranging generally from 2 to 10 bar, preferably from 5 to 8 bar.

The compound of formula 10 is preferably obtained by hydrolyzing a compound of for- mula

Hydrolysis can be carried out by any suitable means known for hydrolyzing ester groups, such as acidic conditions, e.g. using hydrochloric acid, hydrobromic acid, sulfu- ric acid, trifluoroacetic acid, etc., or by basic conditions, e.g. using an alkali metal hydroxide, such as LiOH, NaOH or KOH, or an alkali metal carbonate, such as sodium or potassium carbonate.

The compound of formula 11 can in turn be obtained by reacting a compound 12 with a compound 13

The reaction is carried out at elevated temperature, e.g. at from 90 to 200°C, preferably from 100 to 180°C and in particular from 120 to 160°C, e.g. at about 140°C.

The compound of formula 12 can in turn be obtained by reacting a compound 15 with a compound 16

15 16

The reaction is generally carried out in a solvent, suitable solvents being for example aromatic solvents, such as benzene, toluene, the xylenes, chlorobenzene and dichlo- robenzene. The reaction temperature is preferably from 80 to 140°C, more preferably from 100 to 120°C.

Compounds of formula I wherein however R ¹ is CF3 can moreover be prepared by reacting a compound of formula 12 as defined above with a compound of formula 14 and, if necessary, converting the group A' into a group A.

The reaction is carried out at elevated temperature, e.g. at from 90 to 200°C, preferably from 100 to 180°C and in particular from 120 to 160°C, e.g. at about 140°C.

Compounds Γ, in which A' is a precursor of A can be converted as shown below into the different groups A ¹ to A ³ .

Compounds Γ, in which A is CI, Br, I or -OS02-R ^z1 , where R ^z1 is as defined above, can be converted to compounds I wherein A is a group A ¹ , wherein A ¹ is an imino group -C(=NR ⁶ )R ⁸ , by reaction with carbon monoxide and a hydride source, such as tri- ethylsilane, in the presence of a transition metal complex catalyst, preferably a palladium catalyst, to a carbonyl compound 17. This reaction converts the starting group A

17 The aldehyde 17 can also be obtained by reducing the ester 20 (see below; R = C1-C4- alkyl) with diisobutylaluminium hydride (DIBAL-H) either directly to the aldehyde 17 or via the corresponding alcohol, which is then oxidized to the aldehyde. For obtaining compounds in which R ⁸ in the imino group is H, such carbonyl compounds 17 are then reacted with an amine (derivative) NH2R ⁶ . Alternatively, the compound Γ, in which A' is CI, Br, I or -OS02-R ^z1 , where R ^z1 is as defined above, can be reacted in a one pot reaction with carbon monoxide and hydrogen in the presence of a transition metal complex catalyst and the amine NH2R ⁶ .

For obtaining compounds in which R ⁸ in the imino group is not H, the carbonyl compounds are reacted with a Grignard reagent R ⁸ -MgHal, where Hal is CI, Br or I, or an organolithium compound R ⁸ -Li to obtain an alcohol of formula 18, which is then oxidized to a carbonyl compound of the formula 19, as shown in scheme 4. This is then reacted with an amine NH2R ⁶ to the respective imine compound.

Sche

These reactions can be carried out in analogy to the methods described in PCT/EP 201 1/060388 or in WO 2010/072781 and the references cited therein, especially WO 2006135763, Fattorusso et al, J. Med. Chem. 2008, 51 , 1333-1343 and WO

2008/122375. Compounds I wherein A is a group A ¹ , wherein A ¹ is -S(0) _n R ⁹ or -N(R ⁵ )R ⁶ , can for example be prepared by reacting a compound Γ wherein A' is CI, Br or I in a Ullmann-type reaction with an amine NHR ⁵ R ⁶ or a thiol SHR ⁹ in the presence of a Cu(l) catalyst. To obtain a compound wherein A ¹ is -S(0) _n R ⁹ wherein n is not 0 the thiol can then be oxidized, e.g. with hydrogen peroxide. Amine and thiol groups can further be introduced in a Buchwald-Hartwig reaction by reacting a compound Γ wherein A' is CI, Br or I with an amine NHR ⁵ R ⁶ or a thiol HSR ⁹ in the presence of a palladium catalyst, such as PdCl2(dppf) in the presence of a base, such as cesium carbonate or N,N- diisopropylethyl amine, and optionally in the presence of a phosphine ligand, such as Xantphos ("4,5-Bis(diphenylphosphino)-9,9-dimethylxanthene").

Thioethers (A ¹ = -SR ⁹ ) can further be introduced by reacting a compound Γ wherein A is F in an SNAr reaction (nucleophilic aromatic substitution reaction) with a thiol HSR ⁹ in the presence of a base, such as potassium carbonate (K2CO3), or with a thiolate (e.g. NaSR ⁹ ).

Compounds I wherein A is a group A ² , wherein W is O can be prepared by reacting a compound Γ wherein A' is CI, Br, I or triflate with carbon monoxide in the presence of a palladium catalyst and an alcohol ROH, wherein R is Ci-C4-alkyl, to a compound of formula 20. Suitable palladium catalysts are for example those described in PCT/EP 201 1/

This ester is then hydrolyzed to the respective carboxylic acid, which is the reacted under standard amidation conditions with an amine NHR ⁵ R ⁶ . Hydrolyzation can be carried out under standard conditions, e.g. under acidic conditions using for example hydrochloric acid, sulfuric acid or trifluoroacetic acid, or under basic conditions using for example an alkali metal hydroxide, such as LiOH, NaOH or KOH. Amidation is prefera- bly carried out by activation of the carboxylic acids with oxalylchloride [(COCI)2] or thio- nylchloride (SOC ) to the respective acid chlorides, followed by reaction with an amine NHR ⁵ R ⁶ . Alternatively, amidation is carried out in the presence of a coupling reagent. Suitable coupling reagent (activators) are well known and are for instance selected from carbodiimides, such as DCC (dicyclohexylcarbodiimide) and DCI (diisopropylcar- bodiimide), benzotriazol derivatives, such as HATU (0-(7-azabenzotriazol-1 -yl)- Ν,Ν,Ν',Ν'-tetramethyluronium hexafluorophosphate), HBTU ((O-benzotriazol-1 -yl)- Ν,Ν,Ν',Ν'-tetramethyluronium hexafluorophosphate) and HCTU (1 H-benzotriazolium-1 - [bis(dimethylamino)methylene]-5-chloro tetrafluoroborate) and phosphonium-derived activators, such as BOP ((benzotriazol-1 -yloxy)-tris(dimethylamino)phosphonium hex- afluorophosphate), Py-BOP ((benzotriazol-l -yloxy)-tripyrrolidinphosphonium hexafluorophosphate) and Py-BrOP (bromotripyrrolidinphosphonium hexafluorophosphate). Generally, the activator is used in excess. The benzotriazol and phosphonium coupling reagents are generally used in a basic medium.

Compounds I wherein A is a group A ² , wherein W is S, can be prepared by reacting the corresponding oxo-compound (W is O) with Lawesson's reagent (CAS 19172-47-5), see for example Jesberger et al., Synthesis, 2003, 1929-1958 and references therein. Solvents such as HMPA or THF at an elevated temperature such as 60°C to 100°C can be used. Preferred reaction conditions are THF at 65°C.

Compounds I wherein A is a group A ³ , wherein R ^7a and R ^7b are hydrogen, can be prepared by reducing a compound 20 or 17 for example with LAH (lithium aluminium hydride) hydride) to a compound 21 .

21

This is then reacted in an SN reaction with an amine NHR ⁵ R ⁶ . For this purpose, the OH group can first be converted into a better leaving group, e.g. into a sulfonate (for example mesylate, tosylate or a triflate group). If R ⁶ is a group -C(0)R ⁸ , it is alternatively possible to react compound 21 with an amine N H2R ⁵ and react then the resulting ben- zylic amine with an acid R ⁸ -COOH or a derivative thereof, such as its acid chloride R ⁸ - COCI, in an amidation reaction.

Compounds I wherein A is a group A ³ , wherein R ^7a is optionally substituted alkyl or optionally substituted cycloalkyl and R ^7b is hydrogen, can be prepared by subjecting a ketone 19, in which R ⁸ corresponds to R ^7a which is optionally substituted Ci-C6-alkyl or optionally substituted Cs-Cs-cycloalkyl, to a reductive amination to furnish compounds 22. Typical conditions for the reductive amination are: Reacting ketone 19 with an amine H2N R ⁵ to yield the corresponding imine which is reduced to amine 22 with a reducing agent reagent such as Na(CN)BH3. The reaction from ketone 19 to amine 22 may also be carried out as a one pot procedure.

For obtaining compounds in which R ^7a and R ^7b are optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted alkenyl or optionally substituted alkynyl, carbonyl compounds such as 19, in which R ⁸ corresponds to R ^7a which is optionally substituted Ci-C6-alkyl, optionally substituted Cs-Cs-cycloalkyl, optionally substituted C2-C6-alkenyl or optionally substituted C2-C6-alkynyl, is reacted with a Grignard reagent R ^7b -MgHal, where Hal is CI, Br or I, or an organolithium compound R ^7b -Li, where R ^7b is optionally substituted Ci-C6-alkyl, optionally substituted Cs-Cs-cycloalkyl, optionally substituted C2-C6-alkenyl or optionally substituted C2-C6-alkynyl, to obtain an alcohol of formu

Alcohol 23 can then be converted into amine 24 via the corresponding azide, as described, for example, in O 48.

If desired, this can be converted into compounds I wherein R ⁵ and R ⁶ are different from hydrogen, for example by standard alkylation or acylation reactions.

Compounds I wherein A is a group A ³ , wherein R ^7a is optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl or CN and R ^7b is hydrogen, can be prepared by converting an aldehyde 17 into an imine 25 by reaction with an amine derivative NH2R ⁶ , wherein R ⁶ is tert-butyl sulfinyl, or, for preparing a compound with R ^7a = CN, tosylate.

This imine is then reacted with a compound H-R ^7a in an addition reaction under condi- tions as described for example in J. Am. Chem. Soc. 2009, 3850-3851 and the references cited therein, or, for introducing CN as a group R ^7a , Chemistry - A European Journal 2009, 15, 1 1642-1 1659.

Compounds I wherein A is a group A ³ , wherein both R ^7a and R ^7b are optionally substi- tuted alkyl, alkenyl, alkynyl, cycloalkyl or CN, can be prepared analogously by converting a ketone 19, wherein R ⁸ is has the meaning desired for R ^7b and is optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl or CN, into an imine by reaction with an amine derivative NH2R ⁶ , wherein R ⁶ is tert-butyl sulfinyl, or, for preparing a compound 26 with R ^7a = CN, tosylate.

This imine is then reacted with a compound H-R ^7a in an addition reaction under conditions as described for example in J. Org. Chem 2002, 67, 7819-7832 and the references cited therein, or, for introducing CN as a group R ^7a , Chemistry - A European Journal 2009, 15, 1 1642-1 1659. If desired, R ⁶ can then be removed to yield an amino group NH ₂ .

Compounds I wherein A is A ⁴ can be prepared by standard ring coupling reactions. For example, compounds, wherein A ⁴ is an N-bound heterocyclic ring can be prepared by reacting a compound Γ wherein A is CI, Br or I with the respective ring A ⁴ -H (H being on the nitrogen ring atom to be coupled) under Ullmann coupling conditions, such as described, for example, in WO 2007/075459. Typically, copper(l) iodide or copper(l) oxide and a ligand such as 1 ,2-cyclohexyldiamine is used, see for example Kanemasa et al., European Journal of Organic Chemistry, 2004, 695-709. If A' is F, the reaction is typically run in a polar aprotic solvent such as Ν,Ν-dimethylformamide, N,N- dimethylacetamide or N-methylpyrrolidone, and in the presence of an inorganic base such as sodium, potassium or cesium carbonate.

Compounds, wherein A ⁴ is a C-bound heterocyclic ring can be prepared by reacting a compound Γ wherein A is Br or I with the boronic acid of the respective ring A ⁴ -B(OH)2 or the boronate ester of the respective ring A ⁴ -B(OR2) under Suzuki reaction conditions via Pd-catalyzed cross coupling, such as described, for example, in WO 2007/075459. A typical catalyst is tetrakis(triphenylphosphine)palladium(0). Solvents such as tetrahy- drofuran, acetonitrile, diethyl ether and dioxane are suitable. The boronic acids A ⁴ - B(OH)2 are either commercially available or can be prepared by known methods. Other methods for introduction of the heterocyclic groups A ⁴ are the Heck, Stille, Kumada and Buchwald-Hartwig coupling procedures; see for example Tetrahedron, 2004, 60, 8991 - 9016.

As a rule, the compounds of formula (I) including their stereoisomers, salts, and N- oxides, and their precursors in the synthesis process, can be prepared by the methods described above. If individual compounds can not be prepared via the above-described routes, they can be prepared by derivatization of other compounds (I) or the respective precursor or by customary modifications of the synthesis routes described. For example, in individual cases, certain compounds of formula (I) can advantageously be prepared from other compounds of formula (I) by derivatization, e.g. by ester hydrolysis, amidation, esterification, ether cleavage, olefination, reduction, oxidation and the like, or by customary modifications of the synthesis routes described.

The reaction mixtures are worked up in the customary manner, for example by mixing with water, separating the phases, and, if appropriate, purifying the crude products by chromatography, for example on alumina or on silica gel. Some of the intermediates and end products may be obtained in the form of colorless or pale brown viscous oils which are freed or purified from volatile components under reduced pressure and at moderately elevated temperature. If the intermediates and end products are obtained as solids, they may be purified by recrystallization or trituration.

Due to their excellent activity, the compounds of the present invention may be used for controlling invertebrate pests. Accordingly, the present invention also provides a method for controlling invertebrate pests which method comprises treating the pests, their food supply, their habitat or their breeding ground or a cultivated plant, plant propagation materials (such as seed), soil, area, material or environment in which the pests are growing or may grow, or the materials, cultivated plants, plant propagation materials (such as seed), soils, surfaces or spaces to be protected from pest attack or infestation with a pesticidally effective amount of a compound of the present invention or a composition as defined above. The invention also relates to the use of a compound of the invention, of a stereoisomer and/or of an agriculturally or veterinarily acceptable salt thereof for combating inverte- brate pests

Preferably, the method of the invention serves for protecting plant propagation material (such as seed) and the plant which grows therefrom from invertebrate pest attack or infestation and comprises treating the plant propagation material (such as seed) with a pesticidally effective amount of a compound of the present invention as defined above or with a pesticidally effective amount of an agricultural composition as defined above and below. The method of the invention is not limited to the protection of the "substrate" (plant, plant propagation materials, soil material etc.) which has been treated according to the invention, but also has a preventive effect, thus, for example, accord- ing protection to a plant which grows from a treated plant propagation materials (such as seed), the plant itself not having been treated.

Alternatively preferably, the method of the invention serves for protecting plants from attack or infestation by invertebrate pests, which method comprises treating the plants with a pesticidally effective amount of at least one compound of the invention, a stereoisomer thereof and/or at least one agriculturally acceptable salt thereof.

In the sense of the present invention, "invertebrate pests" are preferably selected from arthropods and nematodes, more preferably from harmful insects, arachnids and nem- atodes, and even more preferably from insects, acarids and nematodes. In the sense of the present invention, "invertebrate pests" are most preferably insects.

The invention further provides an agricultural composition for combating invertebrate pests, which comprises such an amount of at least one compound according to the invention and at least one inert liquid and/or solid agronomically acceptable carrier that has a pesticidal action and, if desired, at least one surfactant.

Such a composition may comprise a single active compound of the present invention or a mixture of several active compounds of the present invention. The composition ac- cording to the present invention may comprise an individual isomer or mixtures of isomers or a salt as well as individual tautomers or mixtures of tautomers.

The compounds of the present invention, including their salts, stereoisomers and tau- tomers, are in particular suitable for efficiently controlling arthropodal pests such as arachnids, myriapedes and insects as well as nematodes. They are especially suitable for efficiently combating or controlling the following pests: insects from the order of the lepidopterans (Lepidoptera), for example Acronicta major, Adoxophyes orana, Aedia leucomelas, Agrotis spp. such as Agrotis fucosa, Agrotis segetum, Agrotis ypsilon; Alabama argillacea, Anticarsia gemmatalis, Anticarsia spp., Argyresthia conjugella, Autographa gamma, Barathra brassicae, Bucculatrix thurberiel- la, Bupalus piniarius, Cacoecia murinana, Cacoecia podana, Capua reticulana, Car- pocapsa pomonella, Cheimatobia brumata, Chilo spp. such as Chilo suppressalis; Choristoneura fumiferana, Choristoneura occidentalis, Cirphis unipuncta, Clysia am- biguella, Cnaphalocerus spp., Cydia pomonella, Dendrolimus pini, Diaphania nitidalis, Diatraea grandiosella, Earias insulana, Elasmopalpus lignosellus, Ephestia cautella, Ephestia kuehniella, Eupoecilia ambiguella, Euproctis chrysorrhoea, Euxoa spp., Evetria bouliana, Feltia spp. such as Feltia subterranean; Galleria mellonella, Grapho- litha funebrana, Grapholitha molesta, Helicoverpa spp. such as Helicoverpa armigera, Helicoverpa zea; Heliothis spp. such as Heliothis armigera, Heliothis virescens, Helio- this zea; Hellula undalis, Hibernia defoliaria, Hofmannophila pseudospretella, Homona magnanima, Hyphantria cunea, Hyponomeuta padella, Hyponomeuta malinellus, Keiferia lycopersicella, Lambdina fiscellaria, Laphygma spp. such as Laphygma exigua; Leucoptera coffeella, Leucoptera scitella, Lithocolletis blancardella, Lithophane anten- nata, Lobesia botrana, Loxagrotis albicosta, Loxostege sticticalis, Lymantria spp. such as Lymantria dispar, Lymantria monacha; Lyonetia clerkella, Malacosoma neustria, Mamestra spp. such as Mamestra brassicae; Mocis repanda, Mythimna separata, Or- gyia pseudotsugata, Oria spp., Ostrinia spp. such as Ostrinia nubilalis; Oulema oryzae, Panolis flammea, Pectinophora spp. such as Pectinophora gossypiella; Peridroma saucia, Phalera bucephala, Phthorimaea spp. such as Phthorimaea operculella; Phyl- locnistis citrella, Pieris spp. such as Pieris brassicae, Pieris rapae; Plathypena scabra, Plutella maculipennis, Plutella xylostella, Prodenia spp., Pseudaletia spp., Pseudoplu- sia includens, Pyrausta nubilalis, Rhyacionia frustrana, Scrobipalpula absoluta, Sitotro- ga cerealella, Sparganothis pilleriana, Spodoptera spp. such as Spodoptera frugiperda, Spodoptera littoralis, Spodoptera litura; Thaumatopoea pityocampa, Thermesia gemmatalis, Tinea pellionella, Tineola bisselliella, Tortrix viridana, Trichoplusia spp. such as Trichoplusia ni; Tuta absoluta, and Zeiraphera canadensis, beetles (Coleoptera), for example Acanthoscehdes obtectus, Adoretus spp., Agelastica alni, Agrilus sinuatus, Agriotes spp. such as Agriotes fuscicollis, Agriotes lineatus, Agri- otes obscurus; Amphimallus solstitialis, Anisandrus dispar, Anobium punctatum, Anomala rufocuprea, Anoplophora spp. such as Anoplophora glabripennis; Anthono- mus spp. such as Anthonomus grandis, Anthonomus pomorum; Anthrenus spp., Aph- thona euphoridae, Apogonia spp., Athous haemorrhoidalis, Atomaria spp. such as Atomaria linearis; Attagenus spp., Aulacophora femoralis, Blastophagus piniperda, Blitophaga undata, Bruchidius obtectus, Bruchus spp. such as Bruchus lentis, Bruchus pisorum, Bruchus rufimanus; Byctiscus betulae, Callosobruchus chinensis, Cassida nebulosa, Cerotoma trifurcata, Cetonia aurata, Ceuthorhynchus spp. such as Ceuthor- rhynchus assimilis, Ceuthorrhynchus napi; Chaetocnema tibialis, Cleonus mendicus, Conoderus spp. such as Conoderus vespertinus; Cosmopolites spp., Costelytra zea- landica, Crioceris asparagi, Cryptorhynchus lapathi, Ctenicera ssp. such as Ctenicera destructor; Curculio spp., Dectes texanus, Dermestes spp., Diabrotica spp. such as Diabrotica 12-punctata Diabrotica speciosa, Diabrotica longicornis, Diabrotica semi- punctata, Diabrotica virgifera; Epilachna spp. such as Epilachna varivestis, Epilachna vigintioctomaculata; Epitrix spp. such as Epitrix hirtipennis; Eutinobothrus brasiliensis, Faustinus cubae, Gibbium psylloides, Heteronychus arator, Hylamorpha elegans, Hy- lobius abietis, Hylotrupes bajulus, Hypera brunneipennis, Hypera postica, Hypothene- mus spp., Ips typographus, Lachnosterna consanguinea, Lema bilineata, Lema mela- nopus, Leptinotarsa spp. such as Leptinotarsa decemlineata; Limonius californicus, Lissorhoptrus oryzophilus, Lissorhoptrus oryzophilus, Lixus spp., Lyctus spp. such as Lyctus bruneus; Melanotus communis, Meligethes spp. such as Meligethes aeneus; Melolontha hippocastani, Melolontha melolontha, Migdolus spp., Monochamus spp. such as Monochamus alternatus; Naupactus xanthographus, Niptus hololeucus, Oryctes rhinoceros, Oryzaephilus surinamensis, Otiorrhynchus sulcatus, Otiorrhynchus ovatus, Otiorrhynchus sulcatus, Oulema oryzae, Oxycetonia jucunda, Phaedon cochle- ariae, Phyllobius pyri, Phyllopertha horticola, Phyllophaga spp., Phyllotreta spp. such as Phyllotreta chrysocephala, Phyllotreta nemorum, Phyllotreta striolata; Phyllophaga spp., Phyllopertha horticola, Popillia japonica, Premnotrypes spp., Psylliodes chrysocephala, Ptinus spp., Rhizobius ventralis , Rhizopertha dominica, Sitona lineatus, Sitophilus spp. such as Sitophilus granaria, Sitophilus zeamais; Sphenophorus spp. such as Sphenophorus levis; Sternechus spp. such as Sternechus subsignatus; Sym- phyletes spp., Tenebrio molitor, Tribolium spp. such as Tribolium castaneum; Tro- goderma spp., Tychius spp., Xylotrechus spp., and Zabrus spp. such as Zabrus teneb- rioides, flies, mosquitoes (Diptera), e.g. Aedes spp. such as Aedes aegypti, Aedes albopictus, Aedes vexans; Anastrepha ludens, Anopheles spp. such as Anopheles albimanus, Anopheles crucians, Anopheles freeborni, Anopheles gambiae, Anopheles leucosphy- rus, Anopheles maculipennis, Anopheles minimus, Anopheles quadrimaculatus, Anopheles sinensis; Bibio hortulanus, Calliphora erythrocephala, Calliphora vicina, Cerafitis capitata, Ceratitis capitata, Chrysomyia spp. such as Chrysomya bezziana, Chrysomya hominivorax, Chrysomya macellaria; Chrysops atlanticus, Chrysops discal- is, Chrysops silacea, Cochliomyia spp. such as Cochliomyia hominivorax; Contarinia spp. such as Contarinia sorghicola; Cordylobia anthropophaga, Culex spp. such as Culex nigripalpus, Culex pipiens, Culex quinquefasciatus, Culex tarsalis, Culex tri- taeniorhynchus; Culicoides furens, Culiseta inornata, Culiseta melanura, Cuterebra spp., Dacus cucurbitae, Dacus oleae, Dasineura brassicae, Delia spp. such as Delia antique, Delia coarctata, Delia platura, Delia radicum; Dermatobia hominis, Drosophila spp., Fannia spp. such as Fannia canicularis; Gastraphilus spp. such as Gasterophilus intestinalis; Geomyza Tripunctata, Glossina fuscipes, Glossina morsitans, Glossina palpalis, Glossina tachinoides, Haematobia irritans, Haplodiplosis equestris, Hippelates spp., Hylemyia spp. such as Hylemyia platura; Hypoderma spp. such as Hypoderma lineata; Hyppobosca spp., Leptoconops torrens, Liriomyza spp. such as Liriomyza sati- vae, Liriomyza trifolii; Lucilia spp. such as Lucilia caprina, Lucilia cuprina, Lucilia serica- ta; Lycoria pectoralis, Mansonia titillanus, Mayetiola spp. such as Mayetiola destructor; Musca spp. such as Musca autumnalis, Musca domestica; Muscina stabulans, Oestrus spp. such as Oestrus ovis; Opomyza florum, Oscinella spp. such as Oscinella frit; Pe- gomya hysocyami, Phlebotomus argentipes, Phorbia spp. such as Phorbia antiqua, Phorbia brassicae, Phorbia coarctata; Prosimulium mixtum, Psila rosae, Psorophora columbiae, Psorophora discolor, Rhagoletis cerasi, Rhagoletis pomonella, Sarcophaga spp. such as Sarcophaga haemorrhoidalis; Simulium vittatum, Stomoxys spp. such as Stomoxys calcitrans; Tabanus spp. such as Tabanus atratus, Tabanus bovinus, Taba- nus lineola, Tabanus similis; Tannia spp., Tipula oleracea, Tipula paludosa, and Wohlfahrtia spp., thrips (Thysanoptera), e.g. Baliothrips biformis, Dichromothrips corbetti, Dichromothrips ssp., Enneothrips flavens, Frankliniella spp. such as Frankliniella fusca, Frankliniella occidentalis, Frankliniella tritici; Heliothrips spp., Hercinothrips femoralis, Kakothrips spp., Rhipiphorothrips cruentatus, Scirtothrips spp. such as Scirtothrips citri; Taeni- othrips cardamoni, Thrips spp. such as Thrips oryzae, Thrips palmi, Thrips tabaci; termites (Isoptera), e.g. Calotermes flavicollis, Coptotermes formosanus, Heterotermes aureus, Heterotermes longiceps, Heterotermes tenuis, Leucotermes flavipes, Odonto- termes spp., Reticulitermes spp. such as Reticulitermes speratus, Reticulitermes fla- vipes, Reticulitermes grassei, Reticulitermes lucifugus, Reticulitermes santonensis, Reticulitermes virginicus; Termes natalensis, cockroaches (Blattaria - Blattodea), e.g. Acheta domesticus, Blatta orientalis, Blattella asahinae, Blattella germanica, Gryllotalpa spp., Leucophaea maderae, Locusta spp., Melanoplus spp., Periplaneta americana, Periplaneta australasiae, Periplaneta brun- nea, Periplaneta fuligginosa, Periplaneta japonica, bugs, aphids, leafhoppers, whiteflies, scale insects, cicadas (Hemiptera), e.g. Acros- ternum spp. such as Acrosternum hilare; Acyrthosipon spp. such as Acyrthosiphon onobrychis, Acyrthosiphon pisum; Adelges laricis, Aeneolamia spp., Agonoscena spp., Aleurodes spp., Aleurolobus barodensis, Aleurothrixus spp., Amrasca spp., Anasa tris- tis, Antestiopsis spp., Anuraphis cardui, Aonidiella spp., Aphanostigma piri, Aphidula nasturtii, Aphis spp. such as Aphis fabae, Aphis forbesi, Aphis gossypii, Aphis grossu- lariae, Aphis pomi, Aphis sambuci, Aphis schneideri, Aphis spiraecola; Arboridia apica- lis, Arilus critatus, Aspidiella spp., Aspidiotus spp., Atanus spp., Aulacorthum solani, Bemisia spp. such as Bemisia argentifolii, Bemisia tabaci; Blissus spp. such as Blissus leucopterus; Brachycaudus cardui, Brachycaudus helichrysi, Brachycaudus persicae, Brachycaudus prunicola, Brachycolus spp., Brevicoryne brassicae, Calligypona margi- nata, Calocoris spp., Campylomma livida, Capitophorus horni, Carneocephala fulgida, Cavelerius spp., Ceraplastes spp., Ceratovacuna lanigera, Cercopidae, Cerosipha gossypii, Chaetosiphon fragaefolii, Chionaspis tegalensis, Chlorita onukii, Chromaphis juglandicola, Chrysomphalus ficus, Cicadulina mbila, Cimex spp. such as Cimex he- mipterus, Cimex lectularius; Coccomytilus halli, Coccus spp., Creontiades dilutus,

Cryptomyzus ribis, Cryptomyzus ribis, Cyrtopeltis notatus, Dalbulus spp., Dasynus pi- peris, Dialeurades spp., Diaphorina spp., Diaspis spp., Dichelops furcatus, Diconocoris hewetti, Doralis spp., Dreyfusia nordmannianae, Dreyfusia piceae, Drosicha spp., Dysaphis spp. such as Dysaphis plantaginea, Dysaphis pyri, Dysaphis radicola; Dysau- lacorthum pseudosolani, Dysdercus spp. such as Dysdercus cingulatus, Dysdercus intermedius; Dysmicoccus spp., Empoasca spp. such as Empoasca fabae, Empoasca solana; Eriosoma spp., Erythroneura spp., Eurygaster spp. such as Eurygaster integri- ceps; Euscelis bilobatus, Euschistus spp. such as Euschistuos heros, Euschistus im- pictiventris, Euschistus servus; Geococcus coffeae, Halyomorpha spp. such as Halyo- morpha halys; Heliopeltis spp., Homalodisca coagulata, Horcias nobilellus, Hyalopterus pruni, Hyperomyzus lactucae, lcerya spp., Idiocerus spp., Idioscopus spp., Laodelphax striatellus, Lecanium spp., Lepidosaphes spp., Leptocorisa spp., Leptoglossus phyl- lopus, Lipaphis erysimi, Lygus spp. such as Lygus hesperus, Lygus lineolaris, Lygus pratensis; Macropes excavatus, Macrosiphum spp. such as Macrosiphum rosae, Ma- crosiphum avenae, Macrosiphum euphorbiae; Mahanarva fimbriolata, Megacopta cri- braria, Megoura viciae, Melanaphis pyrarius, Melanaphis sacchari, Metcafiella spp., Metopolophium dirhodum, Miridae spp., Monellia costalis, Monelliopsis pecanis, Myzus spp. such as Myzus ascalonicus, Myzus cerasi, Myzus persicae, Myzus varians; Naso- novia ribis-nigri, Nephotettix spp. such as Nephotettix malayanus, Nephotettix nigropic- tus, Nephotettix parvus, Nephotettix virescens; Nezara spp. such as Nezara viridula; Nilaparvata lugens, Oebalus spp., Oncometopia spp., Orthezia praelonga, Parabemisia myricae, Paratrioza spp., Parlatoria spp., Pemphigus spp. such as Pemphigus bur- sarius; Pentomidae, Peregrinus maidis, Perkinsiella saccharicida, Phenacoccus spp., Phloeomyzus passerinii, Phorodon humuli, Phylloxera spp., Piesma quadrata, Piezodo- rus spp. such as Piezodorus guildinii, Pinnaspis aspidistrae, Planococcus spp., Proto- pulvinaria pyriformis, Psallus seriatus, Pseudacysta persea, Pseudaulacaspis pentago- na, Pseudococcus spp. such as Pseudococcus comstocki; Psylla spp. such as Psylla mali, Psylla piri; Pteromalus spp., Pyrilla spp., Quadraspidiotus spp., Quesada gigas, Rastrococcus spp., Reduvius senilis, Rhodnius spp., Rhopalomyzus ascalonicus, Rho- palosiphum spp. such as Rhopalosiphum pseudobrassicas, Rhopalosiphum insertum, Rhopalosiphum maidis, Rhopalosiphum padi; Sagatodes spp., Sahlbergella singularis, Saissetia spp., Sappaphis mala, Sappaphis mali, Scaphoides titanus, Schizaphis gra- minum, Schizoneura lanuginosa, Scotinophora spp., Selenaspidus articulatus, Sitobion avenae, Sogata spp., Sogatella furcifera, Solubea insularis , Stephanitis nashi, Sticto- cephala festina, Tenalaphara malayensis, Thyanta spp. such as Thyanta perditor; Ti- braca spp., Tinocallis caryaefoliae, Tomaspis spp., Toxoptera spp. such as Toxoptera aurantii; Trialeurodes spp. such as Trialeurodes vaporariorum; Triatoma spp., Trioza spp., Typhlocyba spp., Unaspis spp. such as Unaspis yanonensis; and Viteus vitifolii, ants, bees, wasps, sawflies (Hymenoptera), e.g. Athalia rosae, Atta capiguara, Atta cephalotes, Atta cephalotes, Atta laevigata, Atta robusta, Atta sexdens, Atta texana, Bombus spp., Camponotus floridanus, Crematogaster spp., Dasymutilla occidentalis, Diprion spp., Dolichovespula maculata, Hoplocampa spp. such as Hoplocampa minuta, Hoplocampa testudinea; Lasius spp. such as Lasius niger, Linepithema humile, Mono- morium pharaonis, Paravespula germanica, Paravespula pennsylvanica, Paravespula vulgaris, Pheidole megacephala, Pogonomyrmex barbatus, Pogonomyrmex californi- cus, Polistes rubiginosa, Solenopsis geminata, Solenopsis invicta, Solenopsis richteri, Solenopsis xyloni, Vespa spp. such as Vespa crabro, and Vespula squamosa, crickets, grasshoppers, locusts (Orthoptera), e.g. Acheta domestica, Calliptamus itali- cus, Chortoicetes terminifera, Dociostaurus maroccanus, Gryllotalpa africana, Gryllo- talpa gryllotalpa, Hieroglyphus daganensis, Kraussaria angulifera, Locusta migratoria, Locustana pardalina, Melanoplus bivittatus, Melanoplus femurrubrum, Melanoplus mexicanus, Melanoplus sanguinipes, Melanoplus spretus, Nomadacris septemfasciata, Oedaleus senegalensis, Schistocerca americana, Schistocerca gregaria, Tachycines asynamorus, and Zonozerus variegatus, arachnids (Arachnida), such as acari,e.g. of the families Argasidae, Ixodidae and Sar- coptidae, such as Amblyomma spp. (e.g. Amblyomma americanum, Amblyomma var- iegatum, Amblyomma maculatum), Argas spp. (e.g. Argas persicus), Boophilus spp. (e.g. Boophilus annulatus, Boophilus decoloratus, Boophilus microplus), Dermacentor silvarum, Dermacentor andersoni, Dermacentor variabilis, Hyalomma spp. (e.g. Hy- alomma truncatum), Ixodes spp. (e.g. Ixodes ricinus, Ixodes rubicundus, Ixodes scapu- laris, Ixodes holocyclus, Ixodes pacificus), Ornithodorus spp. (e.g. Ornithodorus mou- bata, Ornithodorus hermsi, Ornithodorus turicata), Ornithonyssus bacoti, Otobius megnini, Dermanyssus gallinae, Psoroptes spp. (e.g. Psoroptes ovis), Rhipicephalus spp. (e.g. Rhipicephalus sanguineus, Rhipicephalus appendiculatus, Rhipicephalus evertsi), Rhizoglyphus spp., Sarcoptes spp. (e.g. Sarcoptes scabiei), and Eriophyidae spp. such as Acaria sheldoni, Aculops spp. (e.g. Aculops pelekassi) Aculus spp. (e.g. Aculus schlechtendali), Epitrimerus pyri, Phyllocoptruta oleivora and Eriophyes spp. (e.g. Eriophyes sheldoni); Tarsonemidae spp. such as Hemitarsonemus spp., Phy- tonemus pallidus and Polyphagotarsonemus latus, Stenotarsonemus spp.; Tenuipalpi- dae spp. such as Brevipalpus spp. (e.g. Brevipalpus phoenicis); Tetranychidae spp. such as Eotetranychus spp., Eutetranychus spp., Oligonychus spp., Tetranychus cin- nabarinus, Tetranychus kanzawai, Tetranychus pacificus, Tetranychus telarius and Tetranychus urticae; Bryobia praetiosa, Panonychus spp. (e.g. Panonychus ulmi, Panonychus citri), Metatetranychus spp. and Oligonychus spp. (e.g. Oligonychus pratensis), Vasates lycopersici; Araneida, e.g. Latrodectus mactans, and Loxosceles reclusa. And Acarus siro, Chorioptes spp., Scorpio maurus fleas (Siphonaptera), e.g. Ceratophyllus spp., Ctenocephalides felis, Ctenocephalides canis, Xenopsylla cheopis, Pulex irritans, Tunga penetrans, and Nosopsyllus fasciatus, silverfish, firebrat (Thysanura), e.g. Lepisma saccharina and Thermobia domestica, centipedes (Chilopoda), e.g. Geophilus spp., Scutigera spp. such as Scutigera coleop- trata; millipedes (Diplopoda), e.g. Blaniulus guttulatus, Narceus spp., Earwigs (Dermaptera), e.g. forficula auricularia, lice (Phthiraptera), e.g. Damalinia spp., Pediculus spp. such as Pediculus humanus capitis, Pediculus humanus corporis; Pthirus pubis, Haematopinus spp. such as Hae- matopinus eurysternus, Haematopinus suis; Linognathus spp. such as Linognathus vituli; Bovicola bovis, Menopon gallinae, Menacanthus stramineus and Solenopotes capillatus, Trichodectes spp., springtails (Collembola ), e.g. Onychiurus ssp. such as Onychiurus armatus,

They are also suitable for controlling nematodes: plant parasitic nematodes such as root knot nematodes, Meloidogyne hapla, Meloidogyne incognita, Meloidogyne javani- ca, and other Meloidogyne species; cyst-forming nematodes, Globodera rostochiensis and other Globodera species; Heterodera avenae, Heterodera glycines, Heterodera schachtii, Heterodera trifolii, and other Heterodera species; Seed gall nematodes, An- guina species; Stem and foliar nematodes, Aphelenchoides species such as Aphelen- choides besseyi ; Sting nematodes, Belonolaimus longicaudatus and other Belono- laimus species; Pine nematodes, Bursaphelenchus lignicolus Mamiya et Kiyohara, Bursaphelenchus xylophilus and other Bursaphelenchus species; Ring nematodes, Criconema species, Criconemella species, Criconemoides species, Mesocriconema species; Stem and bulb nematodes, Ditylenchus destructor, Ditylenchus dipsaci and other Ditylenchus species; Awl nematodes, Dolichodorus species; Spiral nematodes, Heliocotylenchus multicinctus and other Helicotylenchus species; Sheath and sheathoid nematodes, Hemicycliophora species and Hemicriconemoides species;

Hirshmanniella species; Lance nematodes, Hoploaimus species; false rootknot nematodes, Nacobbus species; Needle nematodes, Longidorus elongatus and other Lon- gidorus species; Lesion nematodes, Pratylenchus brachyurus, Pratylenchus neglectus, Pratylenchus penetrans, Pratylenchus curvitatus, Pratylenchus goodeyi and other Pratylenchus species; Burrowing nematodes, Radopholus similis and other

Radopholus species; Reniform nematodes, Rotylenchus robustus, Rotylenchus reni- formis and other Rotylenchus species; Scutellonema species; Stubby root nematodes, Trichodorus primitivus and other Trichodorus species, Paratrichodorus species; Stunt nematodes, Tylenchorhynchus claytoni, Tylenchorhynchus dubius and other Tylencho- rhynchus species; Citrus nematodes, Tylenchulus species such as Tylenchulus semi- penetrans; Dagger nematodes, Xiphinema species; and other plant parasitic nematode species. Examples of further pest species which may be controlled by compounds of fomula (I) include: from the class of the Bivalva, for example, Dreissena spp.; from the class of the Gastropoda, for example, Arion spp., Biomphalaria spp., Bulinus spp., Deroceras spp., Galba spp., Lymnaea spp., Oncomelania spp., Succinea spp.; from the class of the helminths, for example, Ancylostoma duodenale, Ancylostoma ceylanicum,

Acylostoma braziliensis, Ancylostoma spp., Ascaris lubricoides, Ascaris spp., Brugia malayi, Brugia timori, Bunostomum spp., Chabertia spp., Clonorchis spp., Cooperia spp., Dicrocoelium spp., Dictyocaulus filaria, Diphyllobothrium latum, Dracunculus me- dinensis, Echinococcus granulosus, Echinococcus multilocularis, Enterobius vermicu- laris, Faciola spp., Haemonchus spp. such as Haemonchus contortus; Heterakis spp., Hymenolepis nana, Hyostrongulus spp., Loa Loa, Nematodirus spp., Oesophagosto- mum spp., Opisthorchis spp., Onchocerca volvulus, Ostertagia spp., Paragonimus spp., Schistosomen spp., Strongyloides fuelleborni, Strongyloides stercora lis, Strony- loides spp., Taenia saginata, Taenia solium, Trichinella spiralis, Trichinella nativa, Trichinella britovi, Trichinella nelsoni, Trichinella pseudopsiralis, Trichostrongulus spp., Trichuris trichuria, Wuchereria bancrofti; from the order of the Isopoda, for example, Armadillidium vulgare, Oniscus asellus, Porcellio scaber; from the order of the Symphy- la, for example, Scutigerella immaculata; Further examples of pest species which may be controlled by compounds of formula (I) include: Anisoplia austriaca, Apamea spp., Austroasca viridigrisea, Baliothrips biformis, Caenorhabditis elegans, Cephus spp., Ceutorhynchus napi, Chaetocnema aridula, Chilo auricilius, Chilo indicus , Chilo polychrysus, Chortiocetes terminifera, Cnaphalo- croci medinalis, Cnaphalocrosis spp., Colias eurytheme, Collops spp., Cornitermes cumulans, Creontiades spp., Cyclocephala spp., Dalbulus maidis, Deraceras reticula- tum , Diatrea saccharalis, Dichelops furcatus, Dicladispa armigera , Diloboderus spp. such as Diloboderus abderus; Edessa spp., Epinotia spp., Formicidae, Geocoris spp., Globitermes sulfureus, Gryllotalpidae, Halotydeus destructor, Hipnodes bicolor, Hydrel- lia philippina, Julus spp., Laodelphax spp., Leptocorsia acuta , Leptocorsia oratorius , Liogenys fuscus, Lucillia spp., Lyogenys fuscus, Mahanarva spp., Maladera matrida, Marasmia spp., Mastotermes spp., Mealybugs, Megascelis ssp, Metamasius hemipter- us, Microtheca spp., Mocis latipes, Murgantia spp., Mythemina separata , Neo- capritermes opacus, Neocapritermes parvus, Neomegalotomus spp., Neotermes spp., Nymphula depunctalis, Oebalus pugnax, Orseolia spp. such as Orseolia oryzae; Ox- ycaraenus hyalinipennis, Plusia spp., Pomacea canaliculata, Procornitermes ssp, Pro- cornitermes triacifer , Psylloides spp., Rachiplusia spp., Rhodopholus spp., Scaptocoris castanea, Scaptocoris spp., Scirpophaga spp. such as Scirpophaga incertulas , Scirpophaga innotata; Scotinophara spp. such as Scotinophara coarctata; Sesamia spp. such as Sesamia inferens, Sogaella frucifera, Solenapsis geminata, Spissistilus spp., Stalk borer, Stenchaetothrips biformis, Steneotarsonemus spinki, Sylepta deroga- ta, Telehin licus, Trichostrongylus spp..

The compounds of the present invention, including their salts, stereoisomers and tau- tomers, are particularly useful for controlling insects, preferably sucking or piercing and chewing and biting insects such as insects from the genera Lepidoptera, Coleoptera and Hemiptera, in particular Lepidoptera, Coleoptera and true bugs.

The compounds of the present invention, including their salts, stereoisomers and tau- tomers, are moreover useful for controlling insects of the orders Thysanoptera, Diptera (especially flies, mosquitos), Hymenoptera (especially ants) and Isoptera (especially termites.

The compounds of the present invention, including their salts, stereoisomers and tau- tomers, are particularly useful for controlling insects of the orders Lepidoptera and Col- eoptera.

The invention also relates to agrochemical compositions comprising an auxiliary and at least one compound I according to the invention. An agrochemical composition comprises a pesticidally effective amount of a compound I. The term "effective amount" denotes an amount of the composition or of the compounds I, which is sufficient for controlling harmful fungi on cultivated plants or in the protection of materials and which does not result in a substantial damage to the treated plants. Such an amount can vary in a broad range and is dependent on various factors, such as the species to be controlled, the treated cultivated plant or material, the climatic conditions and the specific compound I used.

The compounds I, their N-oxides and salts can be converted into customary types of agrochemical compositions, e.g. solutions, emulsions, suspensions, dusts, powders, pastes, granules, pressings, capsules, and mixtures thereof. Examples for composition types are suspensions (e.g. SC, OD, FS), emulsifiable concentrates (e.g. EC), emulsions (e.g. EW, EO, ES, ME), capsules (e.g. CS, ZC), pastes, pastilles, wettable powders or dusts (e.g. WP, SP, WS, DP, DS), pressings (e.g. BR, TB, DT), granules (e.g. WG, SG, GR, FG, GG, MG), insecticidal articles (e.g. LN), as well as gel formulations for the treatment of plant propagation materials such as seeds (e.g. GF). These and further compositions types are defined in the "Catalogue of pesticide formulation types and international coding system", Technical Monograph No. 2, 6 ^th Ed. May 2008, CropLife International.

The compositions are prepared in a known manner, such as described by Mollet and Grubemann, Formulation technology, Wiley VCH, Weinheim, 2001 ; or Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F In- forma, London, 2005. Suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, dis- persants, emulsifiers, wetters, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, anti-freezing agents, anti-foaming agents, colorants, tackifiers and binders.

Suitable solvents and liquid carriers are water and organic solvents, such as mineral oil fractions of medium to high boiling point, e.g. kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, e.g. toluene, paraffin, tetra- hydronaphthalene, alkylated naphthalenes; alcohols, e.g. ethanol, propanol, butanol, benzylalcohol, cyclohexanol; glycols; DMSO; ketones, e.g. cyclohexanone; esters, e.g. lactates, carbonates, fatty acid esters, gamma-butyrolactone; fatty acids; phospho- nates; amines; amides, e.g. N-methylpyrrolidone, fatty acid dimethylamides; and mixtures thereof. Suitable solid carriers or fillers are mineral earths, e.g. silicates, silica gels, talc, kaolins, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharides, e.g. cellulose, starch; fertilizers, e.g. ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas; products of vegetable origin, e.g. cereal meal, tree bark meal, wood meal, nutshell meal, and mixtures thereof.

Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and mixtures thereof. Such surfactants can be used as emusifier, dispersant, solubilizer, wetter, penetration enhancer, protective colloid, or adjuvant. Examples of surfactants are listed in

McCutcheon's, Vol.1 : Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.).

Suitable anionic surfactants are alkali, alkaline earth or ammonium salts of sulfonates, sulfates, phosphates, carboxylates, and mixtures thereof. Examples of sulfonates are alkylarylsulfonates, diphenylsulfonates, alpha-olefin sulfonates, lignine sulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of alkoxylated arylphenols, sulfonates of condensed naphthalenes, sulfonates of dodecyl- and tridecylbenzenes, sulfonates of naphthalenes and alkylnaphthalenes, sulfosuccin- ates or sulfosuccinamates. Examples of sulfates are sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols, or of fatty acid esters. Examples of phosphates are phosphate esters. Examples of carboxylates are alkyl carboxylates, and carboxylated alcohol or alkylphenol ethoxylates. Suitable nonionic surfactants are alkoxylates, N-subsituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof. Examples of alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters which have been alkoxylated with 1 to 50 equivalents. Ethylene oxide and/or propylene oxide may be employed for the alkoxylation, preferably ethylene oxide. Examples of N-subsititued fatty acid amides are fatty acid glucamides or fatty acid alkanolamides. Examples of esters are fatty acid esters, glycerol esters or monoglycerides. Examples of sugar-based surfactants are sorbitans, ethoxylated sorbitans, sucrose and glucose esters or alkylpolyglucosides. Examples of polymeric surfactants are home- or copolymers of vinylpyrrolidone, vinyl- alcohols, or vinylacetate.

Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines. Suitable amphoteric surfactants are alkylbetains and imidazolines. Suitable block polymers are block polymers of the A-B or A-B-A type comprising blocks of polyethylene oxide and polypropylene oxide, or of the A-B-C type comprising alkanol, polyethylene oxide and polypropylene oxide. Suitable polyelectrolytes are polyacids or pol- ybases. Examples of polyacids are alkali salts of polyacrylic acid or polyacid comb polymers. Examples of polybases are polyvinylamines or polyethyleneamines.

Suitable adjuvants are compounds, which have a neglectable or even no pesticidal activity themselves, and which improve the biological performance of the compound I on the target. Examples are surfactants, mineral or vegetable oils, and other auxilaries. Further examples are listed by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5.

Suitable thickeners are polysaccharides (e.g. xanthan gum, carboxymethylcellulose), anorganic clays (organically modified or unmodified), polycarboxylates, and silicates. Suitable bactericides are bronopol and isothiazolinone derivatives such as alkylisothia- zolinones and benzisothiazolinones.

Suitable anti-freezing agents are ethylene glycol, propylene glycol, urea and glycerin. Suitable anti-foaming agents are silicones, long chain alcohols, and salts of fatty acids.

Suitable colorants (e.g. in red, blue, or green) are pigments of low water solubility and water-soluble dyes. Examples are inorganic colorants (e.g. iron oxide, titan oxide, iron hexacyanoferrate) and organic colorants (e.g. alizarin-, azo- and phthalocyanine colorants).

Suitable tackifiers or binders are polyvinylpyrrolidons, polyvinylacetates, polyvinyl alcohols, polyacrylates, biological or synthetic waxes, and cellulose ethers.

Examples for composition types and their preparation are:

i) Water-soluble concentrates (SL, LS)

10-60 wt% of a compound I according to the invention and 5-15 wt% wetting agent (e.g. alcohol alkoxylates) are dissolved in water and/or in a water-soluble solvent (e.g. alcohols) ad 100 wt%. The active substance dissolves upon dilution with water.

ii) Dispersible concentrates (DC)

5-25 wt% of a compound I according to the invention and 1 -10 wt% dispersant (e.g. polyvinylpyrrolidone) are dissolved in organic solvent (e.g. cyclohexanone) ad

100 wt%. Dilution with water gives a dispersion.

iii) Emulsifiable concentrates (EC)

15-70 wt% of a compound I according to the invention and 5-10 wt% emulsifiers (e.g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in water- insoluble organic solvent (e.g. aromatic hydrocarbon) ad 100 wt%. Dilution with water gives an emulsion.

iv) Emulsions (EW, EO, ES)

5-40 wt% of a compound I according to the invention and 1 -10 wt% emulsifiers (e.g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in 20-40 wt% water-insoluble organic solvent (e.g. aromatic hydrocarbon). This mixture is introduced into water ad 100 wt% by means of an emulsifying machine and made into a homoge- neous emulsion. Dilution with water gives an emulsion.

v) Suspensions (SC, OD, FS)

In an agitated ball mill, 20-60 wt% of a compound I according to the invention are comminuted with addition of 2-10 wt% dispersants and wetting agents (e.g. sodium lignosulfonate and alcohol ethoxylate), 0,1 -2 wt% thickener (e.g. xanthan gum) and water ad 100 wt% to give a fine active substance suspension. Dilution with water gives a stable suspension of the active substance. For FS type composition up to 40 wt% binder (e.g. polyvinylalcohol) is added.

vi) Water-dispersible granules and water-soluble granules (WG, SG)

50-80 wt% of a compound I according to the invention are ground finely with addition of dispersants and wetting agents (e.g. sodium lignosulfonate and alcohol ethoxylate) ad 100 wt%and prepared as water-dispersible or water-soluble granules by means of technical appliances (e.g. extrusion, spray tower, fluidized bed). Dilution with water gives a stable dispersion or solution of the active substance.

vii) Water-dispersible powders and water-soluble powders (WP, SP, WS)

50-80 wt% of a compound I according to the invention are ground in a rotor-stator mill with addition of 1 -5 wt% dispersants (e.g. sodium lignosulfonate), 1 -3 wt% wetting agents (e.g. alcohol ethoxylate) and solid carrier (e.g. silica gel) ad 100 wt%. Dilution with water gives a stable dispersion or solution of the active substance.

viii) Gel (GW, GF)

In an agitated ball mill, 5-25 wt% of a compound I according to the invention are comminuted with addition of 3-10 wt% dispersants (e.g. sodium lignosulfonate), 1 -5 wt% thickener (e.g. carboxymethylcellulose) and water ad 100 wt% to give a fine suspension of the active substance. Dilution with water gives a stable suspension of the active substance.

iv) Microemulsion (ME)

5-20 wt% of a compound I according to the invention are added to 5-30 wt% organic solvent blend (e.g. fatty acid dimethylamide and cyclohexanone), 10-25 wt% surfactant blend (e.g. alkohol ethoxylate and arylphenol ethoxylate), and water ad 100 %. This mixture is stirred for 1 h to produce spontaneously a thermodynamically stable micro- emulsion.

iv) Microcapsules (CS)

An oil phase comprising 5-50 wt% of a compound I according to the invention, 0-40 wt% water insoluble organic solvent (e.g. aromatic hydrocarbon), 2-15 wt% acrylic monomers (e.g. methylmethacrylate, methacrylic acid and a di- or triacrylate) are dis- persed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). Radical polymerization initiated by a radical initiator results in the formation of

poly(meth)acrylate microcapsules. Alternatively, an oil phase comprising 5-50 wt% of a compound I according to the invention, 0-40 wt% water insoluble organic solvent (e.g. aromatic hydrocarbon), and an isocyanate monomer (e.g. diphenylmethene-4,4'- diisocyanatae) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). The addition of a polyamine (e.g. hexamethylenediamine) results in the formation of a polyurea microcapsules. The monomers amount to 1 -10 wt%. The wt% relate to the total CS composition.

ix) Dustable powders (DP, DS)

1 -10 wt% of a compound I according to the invention are ground finely and mixed intimately with solid carrier (e.g. finely divided kaolin) ad 100 wt%.

x) Granules (GR, FG)

0.5-30 wt% of a compound I according to the invention is ground finely and associated with solid carrier (e.g. silicate) ad 100 wt%. Granulation is achieved by extrusion, spray-drying or the fluidized bed. xi) Ultra-low volume liquids (UL)

1 -50 wt% of a compound I according to the invention are dissolved in organic solvent (e.g. aromatic hydrocarbon) ad 100 wt%. The compositions types i) to xi) may optionally comprise further auxiliaries, such as 0,1 -1 wt% bactericides, 5-15 wt% anti-freezing agents, 0,1 -1 wt% anti-foaming agents, and 0,1 -1 wt% colorants.

The agrochemical compositions generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, and in particular between 0.5 and 75%, by weight of active substance. The active substances are employed in a purity of from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum).

Solutions for seed treamtent (LS), Suspoemulsions (SE), flowable concentrates (FS), powders for dry treatment (DS), water-dispersible powders for slurry treatment (WS), water-soluble powders (SS), emulsions (ES), emulsifiable concentrates (EC) and gels (GF) are usually employed for the purposes of treatment of plant propagation materials, particularly seeds. The compositions in question give, after two-to-tenfold dilution, active substance concentrations of from 0.01 to 60% by weight, preferably from 0.1 to 40% by weight, in the ready-to-use preparations. Application can be carried out before or during sowing. Methods for applying compound I and compositions thereof, respectively, on to plant propagation material, especially seeds include dressing, coating, pelleting, dusting, soaking and in-furrow application methods of the propagation material. Preferably, compound I or the compositions thereof, respectively, are applied on to the plant propagation material by a method such that germination is not induced, e.g. by seed dressing, pelleting, coating and dusting.

When employed in plant protection, the amounts of active substances applied are, depending on the kind of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05 to 0.9 kg per ha, and in particular from 0.1 to 0.75 kg per ha.

In treatment of plant propagation materials such as seeds, e.g. by dusting, coating or drenching seed, amounts of active substance of from 0.1 to 1000 g, preferably from 1 to 1000 g, more preferably from 1 to 100 g and most preferably from 5 to 100 g, per 100 kilogram of plant propagation material (preferably seeds) are generally required. When used in the protection of materials or stored products, the amount of active substance applied depends on the kind of application area and on the desired effect.

Amounts customarily applied in the protection of materials are 0.001 g to 2 kg, preferably 0.005 g to 1 kg, of active substance per cubic meter of treated material. Various types of oils, wetters, adjuvants, fertilizer, or micronutrients, and further pesticides (e.g. herbicides, insecticides, fungicides, growth regulators, safeners) may be added to the active substances or the compositions comprising them as premix or, if appropriate not until immediately prior to use (tank mix). These agents can be admixed with the compositions according to the invention in a weight ratio of 1 :100 to 100:1 , preferably 1 :10 to 10:1.

The user applies the composition according to the invention usually from a predosage device, a knapsack sprayer, a spray tank, a spray plane, or an irrigation system. Usual- ly, the agrochemical composition is made up with water, buffer, and/or further auxiliaries to the desired application concentration and the ready-to-use spray liquor or the agrochemical composition according to the invention is thus obtained. Usually, 20 to 2000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of agricultural useful area.

According to one embodiment, individual components of the composition according to the invention such as parts of a kit or parts of a binary or ternary mixture may be mixed by the user himself in a spray tank and further auxiliaries may be added, if appropriate. In a further embodiment, either individual components of the composition according to the invention or partially premixed components, e.g. components comprising compounds I and/or active substances from the groups M) or F) (see below), may be mixed by the user in a spray tank and further auxiliaries and additives may be added, if appropriate. In a further embodiment, either individual components of the composition according to the invention or partially premixed components, e. g. components comprising compounds I and/or active substances from the groups M.1 to M.UN.X or F.I to F.XII, can be applied jointly (e.g. after tank mix) or consecutively. The following list M of pesticides, grouped according the Mode of Action Classification of the Insecticide Resistance Action Committee (IRAC), together with which the compounds according to the invention can be used and with which potential synergistic effects might be produced, is intended to illustrate the possible combinations, but not to impose any limitation:

M.1 Acetylcholine esterase (AChE) inhibitors from the class of

M.1A carbamates, for example aldicarb, alanycarb, bendiocarb, benfuracarb, butocar- boxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pi- rimicarb, propoxur, thiodicarb, thiofanox, trimethacarb, XMC, xylylcarb and triazamate; or from the class of

M.1 B organophosphates, for example acephate, azamethiphos, azinphos-ethyl, az- inphosmethyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos/ DDVP, dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion, ethopro- phos, famphur, fenamiphos, fenitrothion, fenthion, fosthiazate, heptenophos, imicyafos, isofenphos, isopropyl O- (methoxyaminothio-phosphoryl) salicylate, isoxathion, mala- thion, mecarbam, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, parathion, parathion-methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimiphos- methyl, profenofos, prope- tamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, trichlorfon and vami- dothion;

M.2. GABA-gated chloride channel antagonists such as:

M.2A cyclodiene organochlorine compounds, as for example endosulfan or chlordane; or

M.2B fiproles (phenylpyrazoles), as for example ethiprole, fipronil, flufiprole, pyra- fluprole and pyriprole;

M.3 Sodium channel modulators from the class of

M.3A pyrethroids, for example acrinathrin, allethrin, d-cis-trans allethrin, d-trans alle- thrin, bifenthrin, bioallethrin, bioallethrin S-cylclopentenyl, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cyper- methrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta- cypermethrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau-fluvalinate, halfenprox, imipro- thrin, meperfluthrin,metofluthrin, momfluorothrin, permethrin, phenothrin, prallethrin, profluthrin, pyrethrin (pyrethrum), resmethrin, silafluofen, tefluthrin, tetramethylfluthrin, tetramethrin, tralomethrin and transfluthrin; or

M.3B sodium channel modulators such as DDT or methoxychlor;

M.4 Nicotinic acetylcholine receptor agonists (nAChR) from the class of

M.4A neonicotinoids, for example acteamiprid, chlothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam; or the compounds

M.4A.1 : 1 -[(6-chloro-3-pyridinyl)methyl]-2,3,5,6,7,8-hexahydro-9-nitr o-(5S,8R)-5,8- Epoxy-1 H-imidazo[1 ,2-a]azepine; or

M.4A.2: 1 -[(6-chloro-3-pyridyl)methyl]-2-nitro-1 -[(E)-pentylideneamino]guanidine; or M4.A.3: 1 -[(6-chloro-3-pyridyl)methyl]-7-methyl-8-nitro-5-propoxy-3,5 ,6,7-tetrahydro- 2H-imidazo[1 ,2-a]pyridine;

or M.4B nicotine. M.5 Nicotinic acetylcholine receptor allosteric activators from the class of spinosyns, for example spinosad or spinetoram;

M.6 Chloride channel activators from the class of avermectins and milbemycins, for example abamectin, emamectin benzoate, ivermectin, lepimectin or milbemectin;

M.7 Juvenile hormone mimics, such as

M.7A juvenile hormone analogues as hydroprene, kinoprene and methoprene; or others as M.7B fenoxycarb or M.7C pyriproxyfen; M.8 miscellaneous non-specific (multi-site) inhibitors, for example

M.8A alkyl halides as methyl bromide and other alkyl halides, or

M.8B chloropicrin, or M.8C sulfuryl fluoride, or M.8D borax, or M.8E tartar emetic;

M.9 Selective homopteran feeding blockers, for example

M.9B pymetrozine, or M.9C flonicamid;

M.10 Mite growth inhibitors, for example

M.10A clofentezine, hexythiazox and diflovidazin, or M.10B etoxazole; M.1 1 Microbial disruptors of insect midgut membranes, for example bacillus thuringiensis or bacillus sphaericus and the insecticdal proteins they produce such as bacillus thuringiensis subsp. israelensis, bacillus sphaericus, bacillus thuringiensis subsp. aizawai, bacillus thuringiensis subsp. kurstaki and bacillus thuringiensis subsp. tenebri- onis, or the Bt crop proteins: CrylAb, CrylAc, Cryl Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb and Cry34/35Ab1 ;

M.12 Inhibitors of mitochondrial ATP synthase, for example

M.12A diafenthiuron, or

M.12B organotin miticides such as azocyclotin, cyhexatin or fenbutatin oxide, or M.12C propargite, or M.12D tetradifon;

M.13 Uncouplers of oxidative phosphorylation via disruption of the proton gradient, for example chlorfenapyr, DNOC or sulfluramid; M.14 Nicotinic acetylcholine receptor (nAChR) channel blockers, for example nereis- toxin analogues as bensultap, cartap hydrochloride, thiocyclam or thiosultap sodium;

M.15 Inhibitors of the chitin biosynthesis type 0, such as benzoylureas as for example bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron or triflumuron;

M.16 Inhibitors of the chitin biosynthesis type 1 , as for example buprofezin; M.17 Moulting disruptors, Dipteran, as for example cyromazine;

M.18 Ecdyson receptor agonists such as diacylhydrazines, for example methoxyfeno- zide, tebufenozide, halofenozide, fufenozide or chromafenozide; M.19 Octopamin receptor agonists, as for example amitraz;

M.20 Mitochondrial complex III electron transport inhibitors, for example

M.20A hydramethylnon, or M.20B acequinocyl, or M.20C fluacrypyrim; M.21 Mitochondrial complex I electron transport inhibitors, for example

M.21 A METI acaricides and insecticides such as fenazaquin, fenpyroximate, pyrimidif- en, pyridaben, tebufenpyrad or tolfenpyrad, or M.21 B rotenone;

M.22 Voltage-dependent sodium channel blockers, for example

M.22A indoxacarb, or M.22B metaflumizone, or M.22C 1 -[(E)-[2-(4-cyanophenyl)-1 -[3- (trifluoromethyl)phenyl]ethylidene]amino]-3-[4-(difluorometh oxy)phenyl]urea;

M.23 Inhibitors of the of acetyl CoA carboxylase, such as Tetronic and Tetramic acid derivatives, for example spirodiclofen, spiromesifen or spirotetramat;

M.24 Mitochondrial complex IV electron transport inhibitors, for example

M.24A phosphine such as aluminium phosphide, calcium phosphide, phosphine or zinc phosphide, or M.24B cyanide. M.25 Mitochondrial complex II electron transport inhibitors, such as beta-ketonitrile derivatives, for example cyenopyrafen or cyflumetofen;

M.28 Ryanodine receptor-modulators from the class of diamides, as for example flubendiamide, chlorantraniliprole (rynaxypyr®), cyantraniliprole (cyazypyr®), or the phthalamide compounds M.28.1 : (R)-3-Chlor-N1 -{2-methyl-4-[1 , 2,2,2 - tetrafluor-1 -(trifluormethyl)ethyl]phenyl}- N2-(1 -methyl-2-methylsulfonylethyl)phthalamid and

M.28.2: (S)-3-Chlor-N1 -{2-methyl-4-[1 ,2,2,2 - tetrafluor-1 -(trifluormethyl)ethyl]phenyl}- N2-(1 -methyl-2-methylsulfonylethyl)phthalamid, or the compound

M.28.3: 3-bromo-N-{2-bromo-4-chloro-6-[(1 -cyclopropylethyl)carbamoyl]phenyl}-1 -(3- chlorpyridin-2-yl)-1 H-pyrazole-5-carboxamide (proposed ISO name: cyclaniliprole), or the compound

M.28.4: methyl-2-[3,5-dibromo-2-({[3-bromo-1 -(3-chlorpyridin-2-yl)-1 H-pyrazol-5- yl]carbonyl}amino)benzoyl]-1 ,2-dimethylhydrazinecarboxylate; or a compound selected from M.28.5a) to M.28.5I):

M.28.5a) N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl ]-phenyl]-2-(3- chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;

M.28.5b) N-[4-chloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-6- methyl-phenyl]-

2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carb oxamide;

M.28.5c) N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl ]-6-methyl- phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3 -carboxamide;

M.28.5d) N-[4,6-dichloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carba moyl]-phenyl]-2-

(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carbox amide;

M.28.5e) N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl ]-phenyl]-2-(3- chloro-2-pyridyl)-5-(difluoromethyl)pyrazole-3-carboxamide;

M.28.5f) N-[4,6-dibromo-2-[(di-2-propyl-lambda-4-sulfanylidene)carbam oyl]-phenyl]-2-

(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carbox amide;

M.28.5g) N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl ]-6-cyano- phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3 -carboxamide;

M.28.5h) N-[4,6-dibromo-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl] -phenyl]-2-(3- chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;

Μ.28.5Ϊ) N-[2-(5-amino-1 ,3,4-thiadiazol-2-yl)-4-chloro-6-methyl-phenyl]-5-bromo-2-(3 - chloro-2-pyridyl)pyrazole-3-carboxamide;

M.28.5j) 5-chloro-2-(3-chloro-2-pyridyl)-N-[2,4-dichloro-6-[(1 -cyano-1 -methyl- ethyl)carbamoyl]phenyl]pyrazole-3-carboxamide;

M.28.5k) 5-bromo-N-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-2-(3,5-di chloro-2- pyridyl)pyrazole-3-carboxamide;

M.28.5I) N-[2-(tert-butylcarbamoyl)-4-chloro-6-methyl-phenyl]-2-(3-ch loro-2-pyridyl)-5- (fluoromethoxy)pyrazole-3-carboxamide; or a compound selected from

M.28.6 N2-(1 -cyano-1 -methyl-ethyl)-N1 -(2,4-dimethylphenyl)-3-iodo-phthalamide; or M.28.7 3-chloro-N2-(1 -cyano-1 -methyl-ethyl)-N1 -(2,4-dimethylphenyl)phthalamide;

M.UN.X insecticidal active compounds of unknown or uncertain mode of action, as for example azadirachtin, amidoflumet, benzoximate, bifenazate, bromopropylate, chi- nomethionat, cryolite, dicofol, flufenerim, flometoquin, fluensulfone, flupyradifurone, piperonyl butoxide, pyridalyl, pyrifluquinazon, sulfoxaflor, pyflubumide or the compounds

M.UN.X.1 : 4-[5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-iso xazol-3-yl]-2- methyl-N-[(2,2,2-trifluoro-ethylcarbamoyl)-methyl]-benzamide , or the compound M.UN.X.2: cyclopropaneacetic acid, l .l '- S^R^aR.eS.eaS.^R.^aS.^bSH-^- cyclopropylacetyl)oxy]methyl]-1 ,3,4,4a,5,6,6a,12,12a,12b-decahydro-12-hydroxy- 4,6a, 12b-trimethyl-1 1 -oxo-9-(3-pyridinyl)-2H , 1 1 H-naphtho[2, 1 -b]pyrano[3,4-e]pyran- 3,6-diyl] ester, or the compound

M.UN.X.3: 1 1 -(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1 ,4-dioxa-9- azadispiro[4.2.4.2]-tetradec-1 1 -en-10-one, or the compound

M.UN.X.4: 3-(4' -fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1 - azaspiro[4.5]dec-3-en-2-one, or the compound

M.UN.X.5: 1 -[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl ]-3- (trifluoromethyl)-l H-1 ,2,4-triazole-5-amine, or actives on basis of bacillus firmus (Voti- vo, 1-1582); or

M.UN.X.6; a compound selected from the group of

M.UN.X.6a) (E/Z)-N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluor o- acetamide;

M.UN.X.6b) (E/Z)-N-[1 -[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2 - trifluoro-acetamide;

M.UN.X.6c) (E/Z)-2,2,2-trifluoro-N-[1 -[(6-fluoro-3-pyridyl)methyl]-2- pyridylidene]acetamide;

M.UN.X.6d) (E/Z)-N-[1 -[(6-bromo-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro - acetamide;

M.UN.X.6e) (E/Z)-N-[1 -[1 -(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2-trifluoro- acetamide;

M.UN.X.6†) (E/Z)-N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro- acetamide;

M.UN.X.6g) (E/Z)-2-chloro-N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro- acetamide;

M.UN.X.6h) (E/Z)-N-[1 -[(2-chloropyrimidin-5-yl)methyl]-2-pyridylidene]-2,2,2-trif luoro- acetamide and

M.UN.X.6i) (E/Z)-N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,3,3,3-pent afluoro- propanamide.); or the compounds

M.UN.X.7: 3-[3-chloro-5-(trifluoromethyl)phenyl]-4-oxo-1 -(pyrimidin-5- ylmethyl)pyrido[1 ,2-a]pyrimidin-1 -ium-2-olate; or

M.UN.X.8: 8-chloro-N-[2-chloro-5-methoxyphenyl)sulfonyl]-6-trifluorome thyl)- imidazo[1 ,2-a]pyridine-2-carboxamide; or

M.UN.X.9: 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3- yl]-2-methyl-N-(1 - oxothietan-3-yl)benzamide; or M.UN.X.10: 5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy]propoxy]- 1 H-pyrazole; or M.UN.X.1 1 : 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3- yl]-2-methyl-N- [2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]benzamide; or

M.UN.X.12: 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl )-4H-isoxazol-3- yl]-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene- 1 -carboxamide.

The commercially available compounds of the group M listed above may be found in The Pesticide Manual, 15th Edition, C. D. S. Tomlin, British Crop Protection Council (201 1 ) among other publications.

The quinoline derivative flometoquin is shown in WO2006/013896. The aminofuranone compounds flupyradifurone is known from WO 2007/1 15644. The sulfoximine compound sulfoxaflor is known from WO2007/149134. The acaricide pyflubumide is known from WO2007/020986. The isoxazoline compounds have been described: M.UN.X.1 in WO2005/085216, M.UN.X.9 in WO2013/050317, M.UN.X.1 1 in WO2005/085216 and M.UN.X. in WO2009/002809 and in WO201 1/149749 . The pyripyropene derivative M.UN.X.2 has been described in WO 2006/129714. The spiroketal-substituted cyclic ketoenol derivative M.UN.X.3 is known from WO2006/089633 and the biphenyl- substituted spirocyclic ketoenol derivative M.UN.X.4 from WO2008/06791 1. Finally triazoylphenylsulfide like M.UN.X.5 have been described in WO2006/043635 and biological control agents on basis of bacillus firmus in WO2009/124707. The neonico- tionids 4A.1 is known from WO20120/069266 and WO201 1/06946, the M.4.A.2 from WO2013/003977, the M4.A.3.from WO2010/069266. The Metaflumizone analogue M.22C is described in CN 10171577. The phthalamides M.28.1 and M.28.2 are both known from WO 2007/101540. The anthranilamide M.28.3 has been described in WO2005/077934. The hydrazide compound M.28.4 has been described in WO 2007/043677. The anthranilamides M.28.5a) to M.28.5h) can be prepared as described in WO 2007/006670, WO2013/024009 and WO2013/024010, the anthranilamide Μ.28.5Ϊ) is described in WO201 1/085575, the M.28.5j) in

WO2008/134969, the M.28.5k) in US201 1/046186 and the M.28.5I) in

WO2012/034403. The diamide compounds M.28.6 and M.28.7 can be found in CN102613183.

The compounds M.UN.X.6a) to M.UN.X.6i) listed in M.UN.X.6 have been described in WO2012/029672. The mesoionic antagonist compound M.UN.X.7 was described in WO2012/0921 15, the nematicide M.UN.X.8 in WO2013/055584and the Pyridalyl-type analogue M.UN.X.10 in WO2010/060379.

Preferred additional pesticidally active ingredients are those selected from the IRAC group 1 , the Acetylcholinesterase (AChE) inhibitors, herein from the group 1 A (Car- bamtes) Thiodicarb, Methomyl and Carbaryl, and from the group

1 B(Organophosphates), especially Acephate, Chlorpyriphos and Dimethoate, from the group 2B, the fiproles, here especially ethiprole and fipronil, from the group 3, the pyrethroids, here especially lambda-cyhalothrin, alpha-cypermethrin or deltametrin, and from the group 4A, the neonicotinoids, here especially acetamiprid, clothianidin, dinote- furan, imidacloprid, nitenpyram, thiacloprid or thiomethoxam.

Especially combinations of compounds of the invention with fiproles, neonictinoids or pyrethroids may possibly exhibit synergistic control of stinkbugs (according to the Colby formula), in particular Euschistus, e.g. Euschistus heros.

The following list F of active substances, in conjunction with which the compounds according to the invention can be used, is intended to illustrate the possible combinations but does not limit them:

F.I) Respiration Inhibitors

F.1-1 ) Inhibitors of complex III at Qo site:

strobilurins: azoxystrobin, coumethoxystrobin, coumoxystrobin, dimoxystrobin, ene- stroburin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, pyribencarb, triclopy- ricarb/chlorodincarb, trifloxystrobin, 2-[2-(2,5-dimethyl-phenoxymethyl)-phenyl]-3- methoxy-acrylic acid methyl ester and 2 (2-(3-(2,6-dichlorophenyl)-1 -methyl- allylideneaminooxymethyl)-phenyl)-2-methoxyimino-N methyl-acetamide;

oxazolidinediones and imidazolinones: famoxadone, fenamidone;

F.I-2) Inhibitors of complex II (e.g. carboxamides):

carboxanilides: benodanil, benzovindiflupyr, bixafen, boscalid, carboxin, fenfuram, fenhexamid, fluopyram, flutolanil, furametpyr, isopyrazam, isotianil, mepronil, oxycar- boxin, penflufen, penthiopyrad, sedaxane, tecloftalam, thifluzamide, tiadinil, 2-amino-4 methyl-thiazole-5-carboxanilide, N-(3',4',5' trifluorobiphenyl-2 yl)-3-difluoromethyl-1 - methyl-1 H-pyrazole-4 carboxamide (fluxapyroxad), N-(4'-trifluoromethylthiobiphenyl-2- yl)-3 difluoromethyl-1 -methyl-1 H pyrazole-4-carboxamide, N-(2-(1 ,3,3-trimethyl-butyl)- phenyl)-1 ,3-dimethyl-5 fluoro-1 H-pyrazole-4 carboxamide, 3-(difluoromethyl)-1 -methyl- N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1 -methyl-Nil ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide, 1 ,3-dimethyl-N-(1 ,1 ,3- trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1 ,5-dimethyl-N-(1 ,1 ,3- trimethylindan-4-yl)pyrazole-4-carboxamide, 3-(difluoromethyl)-1 ,5-dimethyl-N-(1 ,1 ,3- trimethylindan-4-yl)pyrazole-4-carboxamide, 1 ,3,5-trimethyl-N-(1 ,1 ,3-trimethylindan-4- yl)pyrazole-4-carboxamide, 3-(difluoromethyl)-1 -methyl-N-(1 ,1 ,3-trimethylindan-4- yl)pyrazole-4-carboxamide, 3-(trifluoromethyl)-1 -methyl-N-(1 ,1 ,3-trimethylindan-4- yl)pyrazole-4-carboxamide, 1 ,3-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4- carboxamide, 3-(trifluoromethyl)-1 ,5-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4- carboxamide, 3-(difluoromethyl)-1 ,5-dimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4- carboxamide, 1 ,3,5-trimethyl-N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide; F.I-3) Inhibitors of complex III at Qi site: cyazofamid, amisulbrom, [(3S,6S,7R,8R)-8- benzyl-3-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]-6- methyl-4,9-dioxo-1 ,5-di- oxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4- methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl]

2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[(3-isobutoxycarbonyloxy-4-methoxy - pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate, [(3S,6S,7R,8R)-8-benzyl-3-[[3-(1 ,3-benzodioxol-5-ylmethoxy)-4-methoxy-pyridine-2- carbonyl]amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate,

3S,6S,7R,8R)-3-[[(3-hydroxy-4-methoxy-2-pyridinyl)carbonyl]a mino]-6-methyl-4,9- dioxo-8-(phenylmethyl)-1 ,5-dioxonan-7-yl 2-methylpropanoate;

F.I-4) Other respiration inhibitors (complex I, uncouplers) diflumetorim; (5,8-difluoro- quinazolin-4-yl)-{2-[2-fluoro-4-(4-trifluoromethylpyridin-2- yloxy)-phenyl]-ethyl}-amine; tecnazen; ametoctradin; silthiofam; nitrophenyl derivates: binapacryl, dinobuton, di- nocap, fluazinam, ferimzone, nitrthal-isopropyl,

and including organometal compounds: fentin salts, such as fentin-acetate, fentin chloride or fentin hydroxide;

F.ll) Sterol biosynthesis inhibitors (SBI fungicides)

F.II-1 ) C14 demethylase inhibitors (DMI fungicides, e.g. triazoles, imidazoles) triazoles: azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, fenbuconazole, fluquinconazole, flusi- lazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobuta- nil, paclobutrazole, penconazole, propiconazole, prothioconazole, simeconazole, tebu- conazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole, 1 -[re/- (2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylme thyl]-5-thiocyanato-1 H- [1 ,2,4]triazole, 2-[re/-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxi ranylmethyl]- 2H-[1 ,2,4]triazole-3-thiol;

imidazoles: imazalil, pefurazoate, oxpoconazole, prochloraz, triflumizole;

pyrimidines, pyridines and piperazines: fenarimol, nuarimol, pyrifenox, triforine, 1 -[rel- (2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylme thyl]-5-thiocyanato-1 H- [1 ,2,4]triazole, 2-[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxi ranylmethyl]- 2H-[1 ,2,4]triazole-3-thiol;

F.II-2) Delta14-reductase inhitors (Amines, e.g. morpholines, piperidines)

morpholines: aldimorph, dodemorph, dodemorph-acetate, fenpropimorph, tridemorph; piperidines: fenpropidin, piperalin; spiroketalamines: spiroxamine;

F.II-3) Inhibitors of 3-keto reductase: hydroxyanilides: fenhexamid;

F.lll) Nucleic acid synthesis inhibitors

F.III-1 ) RNA, DNA synthesis phenylamides or acyl amino acid fungicides: benalaxyl, benalaxyl-M, kiralaxyl, met- alaxyl, metalaxyl-M (mefenoxam), ofurace, oxadixyl;

isoxazoles and iosothiazolones: hymexazole, octhilinone;

F.III-2) DNA topisomerase inhibitors: oxolinic acid;

F.III-3) Nucleotide metabolism (e.g. adenosin-deaminase), hydroxy (2-amino)- pyrimidines: bupirimate;

F.IV) Inhibitors of cell division and or cytoskeleton

F.IV-1 ) Tubulin inhibitors: benzimidazoles and thiophanates: benomyl, carbendazim, fuberidazole, thiabendazole, thiophanate-methyl;

triazolopyrimidines: 5-chloro-7 (4-methylpiperidin-1 -yl)-6-(2,4,6-trifluorophenyl)- [1 ,2,4]triazolo[1 ,5 a]pyrimidine;

F.IV-2) Other cell division inhibitors

benzamides and phenyl acetamides: diethofencarb, ethaboxam, pencycuron, fluopico- lide, zoxamide;

F.IV-3) Actin inhibitors: benzophenones: metrafenone, pyriofenone;

F.V) Inhibitors of amino acid and protein synthesis

F.V-1 ) Methionine synthesis inhibitors (anilino-pyrimidines)

anilino-pyrimidines: cyprodinil, mepanipyrim, nitrapyrin, pyrimethanil;

F.V-2) Protein synthesis inhibitors (anilino-pyrimidines)

antibiotics: blasticidin-S, kasugamycin, kasugamycin hydrochloride-hydrate, mildiomy- cin, streptomycin, oxytetracyclin, polyoxine, validamycin A;

F.VI) Signal transduction inhibitors

F.VI-1 ) MAP / Histidine kinase inhibitors (e.g. anilino-pyrimidines)

dicarboximides: fluoroimid, iprodione, procymidone, vinclozolin;

phenylpyrroles: fenpiclonil, fludioxonil;

F.VI-2) G protein inhibitors: quinolines: quinoxyfen;

F.VI I) Lipid and membrane synthesis inhibitors

F.VI 1-1 ) Phospholipid biosynthesis inhibitors

organophosphorus compounds: edifenphos, iprobenfos, pyrazophos;

dithiolanes: isoprothiolane;

F.VII-2) Lipid peroxidation: aromatic hydrocarbons: dicloran, quintozene, tecnazene, tolclofos-methyl, biphenyl, chloroneb, etridiazole;

F.VII-3) Carboxyl acid amides (CAA fungicides)

cinnamic or mandelic acid amides: dimethomorph, flumorph, mandiproamid, pyrimorph; valinamide carbamates: benthiavalicarb, iprovalicarb, pyribencarb, valifenalate and N- (1 -(1 -(4-cyano-phenyl)ethanesulfonyl)-but-2-yl) carbamic acid-(4-fluorophenyl) ester; F.VII-4) Compounds affecting cell membrane permeability and fatty acids:

1 -[4-[4-[5-(2,6-difluorophenyl)-4,5-dihydro-3-isoxazolyl]-2-t hiazolyl]-1 -piperidinyl]-2-[5- methyl-3-(trifluoromethyl)-1 H-pyrazol-1 -yl]ethanone, carbamates: propamocarb, pro- pamocarb-hydrochlorid, F.VII-5) fatty acid amide hydrolase inhibitors: 1 -[4-[4-[5-(2,6-difluorophenyl)-4,5- dihydro-3-isoxazolyl]-2-thiazolyl]-1 -piperidinyl]-2-[5-methyl-3-(trifluoromethyl)-1 H- pyrazol-1 -yl]ethanone;

F.VIII) Inhibitors with Multi Site Action

F.VIII-1 ) Inorganic active substances: Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur;

F.VIII-2) Thio- and dithiocarbamates: ferbam, mancozeb, maneb, metam,

methasulphocarb, metiram, propineb, thiram, zineb, ziram;

F.VIII-3) Organochlorine compounds (e.g. phthalimides, sulfamides, chloronitriles): anilazine, chlorothalonil, captafol, captan, folpet, dichlofluanid, dichlorophen, flusulfa- mide, hexachlorobenzene, pentachlorphenole and its salts, phthalide, tolylfluanid, N-(4- chloro-2-nitro-phenyl)-N-ethyl-4-methyl-benzenesulfonamide;

F.VIII-4) Guanidines and other: guanidine, dodine, dodine free base, guazatine, guaza- tine-acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris(albesilate), 2,6- dimethyl-1 H,5H-[1 ,4]dithiino[2,3-c:5,6-c']dipyrrole-1 ,3,5,7(2H,6H)-tetraone;

F.VIII-5) Ahtraquinones: dithianon;

F.IX) Cell wall synthesis inhibitors

F.IX-1 ) Inhibitors of glucan synthesis: validamycin, polyoxin B;

F.IX-2) Melanin synthesis inhibitors: pyroquilon, tricyclazole, carpropamide, dicyclomet, fenoxanil;

F.X) Plant defence inducers

F.X-1 ) Salicylic acid pathway: acibenzolar-S-methyl;

F.X-2) Others: probenazole, isotianil, tiadinil, prohexadione-calcium;

phosphonates: fosetyl, fosetyl-aluminum, phosphorous acid and its salts;

F.XI) Unknown mode of action:bronopol, chinomethionat, cyflufenamid, cymoxanil, dazomet, debacarb, diclomezine, difenzoquat, difenzoquat-methylsulfate, diphenyla- min, fenpyrazamine, flumetover, flusulfamide, flutianil, methasulfocarb, nitrapyrin, ni- trothal-isopropyl, oxathiapiprolin, oxin-copper, proquinazid, tebufloquin, tecloftalam, triazoxide, 2-butoxy-6-iodo-3-propylchromen-4-one, N-(cyclopropylmethoxyimino-(6- difluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenyl acetamide, N'-(4-(4-chloro-3- trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N methyl formamidine, N' (4-(4- fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-eth yl-N-methyl formamidine, N'-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanyl-propoxy )-phenyl)-N-ethyl-N-methyl formamidine, N'-(5-difluoromethyl-2 methyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N- ethyl-N-methyl formamidine, 2-{1 -[2-(5-methyl-3-trifluoromethyl-pyrazole-1 -yl)-acetyl]- piperidin-4-yl}-thiazole-4-carboxylic acid methyl-(1 ,2,3,4-tetrahydro-naphthalen-1 -yl)- amide, 2-{1 -[2-(5-methyl-3-trifluoromethyl-pyrazole-1 -yl)-acetyl]-piperidin-4-yl}-thiazole- 4-carboxylic acid methyl-(R)-1 ,2,3,4-tetrahydro-naphthalen-1 -yl-amide, methoxy-acetic acid 6-tert-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester and N-Methyl-2-{1 -[(5-methyl- 3-trifluoromethyl-1 H-pyrazol-1 -yl)-acetyl]-piperidin-4-yl}-N-[(1 R)-1 ,2,3,4- tetrahydronaphthalen-1 -yl]-4-thiazolecarboxamide, 3-[5-(4-chloro-phenyl)-2,3-dimethyl- isoxazolidin-3 yl]-pyridine, pyrisoxazole, 5-amino-2-isopropyl-3-oxo-4-ortho-tolyl-2,3- dihydro-pyrazole-1 carbothioic acid S-allyl ester, N-(6-methoxy-pyridin-3-yl) cyclopro- panecarboxylic acid amide, 5-chloro-1 (4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1 H- benzoimidazole, 2-(4-chloro-phenyl)-N-[4-(3,4-dimethoxy-phenyl)-isoxazol-5-y l]-2-prop- 2-ynyloxy-acetamide,.

F.XII) Growth regulators: abscisic acid, amidochlor, ancymidol, 6-benzylaminopurine, brassinolide, butralin, chlormequat (chlormequat chloride), choline chloride, cyclanilide, daminozide, dikegulac, dimethipin, 2,6-dimethylpuridine, ethephon, flumetralin, flur- primidol, fluthiacet, forchlorfenuron, gibberellic acid, inabenfide, indole-3-acetic acid, maleic hydrazide, mefluidide, mepiquat (mepiquat chloride), naphthaleneacetic acid, N 6-benzyladenine, paclobutrazol, prohexadione (prohexadione-calcium), prohydro- jasmon, thidiazuron, triapenthenol, tributyl phosphorotrithioate, 2,3,5 tri iodobenzoic acid, trinexapac-ethyl and uniconazole;

F.XII I) Biological control agents

Ampelomyces quisqualis (e.g. AQ 10 ^® from Intrachem Bio GmbH & Co. KG, Germany), Aspergillus flavus (e.g. AFLAGUARD ^® from Syngenta, CH), Aureobasidium pullulans (e.g. BOTECTOR ^® from bio-ferm GmbH, Germany), Bacillus pumilus (e.g. NRRL Accession No. B-30087 in SONATA ^® and BALLAD ^® Plus from AgraQuest Inc., USA), Ba- alius subtilis (e.g. isolate NRRL-Nr. B-21661 in RHAPSODY ^® , SERENADE ^® MAX and SERENADE ^® ASO from AgraQuest Inc., USA), Bacillus subtilis var. amyloliquefaciens FZB24 (e.g. TAEGRO ^® from Novozyme Biologicals, Inc., USA), Candida oleophila I-82 (e.g. ASPIRE ^® from Ecogen Inc., USA), Candida saitoana (e.g. BIOCURE ^® (in mixture with lysozyme) and BIOCOAT ^® from Micro Flo Company, USA (BASF SE) and Arysta), Chitosan (e.g. ARMOUR-ZEN from BotriZen Ltd., NZ), Clonostachys rosea f. catenula- ta, also named Gliocladium catenulatum (e.g. isolate J 1446: PRESTOP ^® from Verdera, Finland), Coniothyrium minitans (e.g. CONTANS ^® from Prophyta, Germany),

Cryphonectria parasitica (e.g. Endothia parasitica from CNICM, France), Cryptococcus albidus (e.g. YIELD PLUS ^® from Anchor Bio-Technologies, South Africa), Fusarium oxysporum (e.g. BIOFOX ^® from S.I.A.P.A., Italy, FUSACLEAN ^® from Natural Plant Protection, France), Metschnikowia fructicola (e.g. SHEMER ^® from Agrogreen, Israel), Microdochium dimerum (e.g. ANTIBOT ^® from Agrauxine, France), Phlebiopsis gigantea (e.g. ROTSOP ^® from Verdera, Finland), Pseudozyma flocculosa (e.g. SPORODEX ^® from Plant Products Co. Ltd., Canada), Pythium oligandrum DV74 (e.g. POLYVER- SUM ^® from Remeslo SSRO, Biopreparaty, Czech Rep.), Reynoutria sachlinensis (e.g. REGALIA ^® from Marrone Biolnnovations, USA), Talaromyces f/avus VH 7b (e.g. PRO- TUS ^® from Prophyta, Germany), Trichoderma asperellum SKT-1 (e.g. ECO-HOPE ^® from Kumiai Chemical Industry Co., Ltd., Japan), T. atroviride LC52 (e.g. SENTINEL ^® from Agrimm Technologies Ltd, NZ), T. harzianum T-22 (e.g. PLANTSHIELD ^® der Fir- ma BioWorks Inc., USA), T. harzianum TH 35 (e.g. ROOT PRO ^® from Mycontrol Ltd., Israel), T. harzianum T-39 (e.g. TRICHODEX ^® and TRICHODERMA 2000 ^® from My- control Ltd., Israel and Makhteshim Ltd., Israel), T. harzianum and T. viride (e.g. TRI- CHOPEL from Agrimm Technologies Ltd, NZ), T. harzianum ICC012 and T. viride ICC080 (e.g. REMEDIER ^® WP from Isagro Ricerca, Italy), T. polysporum and T. harzi- anum (e.g. BINAB ^® from BINAB Bio-Innovation AB, Sweden), T. stromaticum (e.g. TRICOVAB ^® from C.E.P.L.A.C., Brazil), T. virens GL-21 (e.g. SOILGARD ^® from Certis LLC, USA), T. viride {e.g. TRIECO ^® from Ecosense Labs. (India) Pvt. Ltd., Indien, BIO- CURE ^® F from T. Stanes & Co. Ltd., Indien), T. viride TV1 (e.g. T. viride TV1 from Ag- ribiotec srl, Italy), Ulocladium oudemansii HRU3 (e.g. BOTRY-ZEN ^® from Botry-Zen Ltd, NZ).

The commercially available compounds II of the group F listed above may be found in The Pesticide Manual, 15th Edition, C. D. S. Tomlin, British Crop Protection Council (201 1 ) among other publications. Their preparation and their activity against harmful fungi is known (cf.: http://www.alanwood.net/pesticides/); these substances are commercially available. The compounds described by lUPAC nomenclature, their preparation and their fungicidal activity are also known (cf. Can. J. Plant Sci. 48(6), 587-94, 1968; EP A 141 317; EP-A 152 031 ; EP-A 226 917; EP A 243 970; EP A 256 503; EP- A 428 941 ; EP-A 532 022; EP-A 1 028 125; EP-A 1 035 122; EP A 1 201 648; EP A 1 122 244, JP 2002316902; DE 19650197; DE 10021412; DE 102005009458; US

3,296,272; US 3,325,503; WO 98/46608; WO 99/14187; WO 99/24413; WO 99/27783; WO 00/29404; WO 00/46148; WO 00/65913; WO 01/54501 ; WO 01/56358; WO 02/22583; WO 02/40431 ; WO 03/10149; WO 03/1 1853; WO 03/14103; WO 03/16286; WO 03/53145; WO 03/61388; WO 03/66609; WO 03/74491 ; WO 04/49804; WO 04/83193; WO 05/120234; WO 05/123689; WO 05/123690; WO 05/63721 ; WO

05/87772; WO 05/87773; WO 06/15866; WO 06/87325; WO 06/87343; WO 07/82098; WO 07/90624, WO 1 1/028657).

The compounds of the invention may be mixed with soil, peat or other rooting media for the protection of plants against seed-borne, soil-borne or foliar fungal diseases.

Examples of suitable synergists for use in the compositions include piperonyl butoxide, sesamex, safroxan and dodecyl imidazole. Suitable herbicides and plant-growth regulators for inclusion in the compositions will depend upon the intended target and the effect required.

An example of a rice selective herbicide which may be included is propanil. An example of a plant growth regulator for use in cotton is PIX™. Some mixtures may comprise active ingredients which have significantly different physical, chemical or biological properties such that they do not easily lend themselves to the same The invertebrate pest (also referred to as "animal pest"), i.e. the insects, arachnids and nematodes, the plant, soil or water in which the plant is growing or may grow can be contacted with the compounds of the present invention or composition(s) comprising them by any application method known in the art. As such, "contacting" includes both direct contact (applying the compounds/compositions directly on the invertebrate pest or plant - typically to the foliage, stem or roots of the plant) and indirect contact (applying the compounds/compositions to the locus of the invertebrate pest or plant).

The compounds of the present invention or the pesticidal compositions comprising them may be used to protect growing plants and crops from attack or infestation by animal pests, especially insects, acaridae or arachnids by contacting the plant/crop with a pesticidally effective amount of compounds of the present invention. The term "crop" refers both to growing and harvested crops.

The compounds of the present invention and the compositions comprising them are particularly important in the control of a multitude of insects on various cultivated plants, such as cereal, root crops, oil crops, vegetables, spices, ornamentals, for ex- ample seed of durum and other wheat, barley, oats, rye, maize (fodder maize and sugar maize / sweet and field corn), soybeans, oil crops, crucifers, cotton, sunflowers, bananas, rice, oilseed rape, turnip rape, sugarbeet, fodder beet, eggplants, potatoes, grass, lawn, turf, fodder grass, tomatoes, leeks, pumpkin/squash, cabbage, iceberg lettuce, pepper, cucumbers, melons, Brassica species, melons, beans, peas, garlic, onions, carrots, tuberous plants such as potatoes, sugar cane, tobacco, grapes, petunias, geranium/pelargoniums, pansies and impatiens.

The compounds of the present invention are employed as such or in form of compositions by treating the insects or the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms to be protected from insecticidal attack with an insec- ticidally effective amount of the active compounds. The application can be carried out both before and after the infection of the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms by the insects.

Moreover, invertebrate pests may be controlled by contacting the target pest, its food supply, habitat, breeding ground or its locus with a pesticidally effective amount of compounds of the present invention. As such, the application may be carried out before or after the infection of the locus, growing crops, or harvested crops by the pest.

The compounds of the present invention can also be applied preventively to places at which occurrence of the pests is expected. The compounds of the present invention may be also used to protect growing plants from attack or infestation by pests by contacting the plant with a pesticidally effective amount of compounds of the present invention. As such, "contacting" includes both direct contact (applying the compounds/compositions directly on the pest and/or plant - typically to the foliage, stem or roots of the plant) and indirect contact (applying the compounds/compositions to the locus of the pest and/or plant).

"Locus" means a habitat, breeding ground, plant, seed, soil, area, material or environment in which a pest or parasite is growing or may grow. In general, "pesticidally effective amount" means the amount of active ingredient needed to achieve an observable effect on growth, including the effects of necrosis, death, retardation, prevention, and removal, destruction, or otherwise diminishing the occurrence and activity of the target organism. The pesticidally effective amount can vary for the various compounds/compositions used in the invention. A pesticidally effective amount of the compositions will also vary according to the prevailing conditions such as desired pesticidal effect and duration, weather, target species, locus, mode of application, and the like.

In the case of soil treatment or of application to the pests dwelling place or nest, the quantity of active ingredient ranges from 0.0001 to 500 g per 100 m ² , preferably from 0.001 to 20 g per 100 m ² .

Customary application rates in the protection of materials are, for example, from 0.01 g to 1000 g of active compound per m ² treated material, desirably from 0.1 g to 50 g per m ² .

Insecticidal compositions for use in the impregnation of materials typically contain from 0.001 to 95 weight %, preferably from 0.1 to 45 weight %, and more preferably from 1 to 25 weight % of at least one repellent and/or insecticide.

For use in treating crop plants, the rate of application of the active ingredients of this invention may be in the range of 0.1 g to 4000 g per hectare, desirably from 5 g to 500 g per hectare, more desirably from 5 g to 200 g per hectare.

The compounds of the present invention are effective through both contact (via soil, glass, wall, bed net, carpet, plant parts or animal parts), and ingestion (bait, or plant part).

The compounds of the present invention may also be applied against non-crop insect pests, such as ants, termites, wasps, flies, mosquitos, crickets, or cockroaches. For use against said non-crop pests, compounds of the present invention are preferably used in a bait composition.

The bait can be a liquid, a solid or a semisolid preparation (e.g. a gel). Solid baits can be formed into various shapes and forms suitable to the respective application e.g. granules, blocks, sticks, disks. Liquid baits can be filled into various devices to ensure proper application, e.g. open containers, spray devices, droplet sources, or evaporation sources. Gels can be based on aqueous or oily matrices and can be formulated to particular necessities in terms of stickyness, moisture retention or aging characteristics. The bait employed in the composition is a product, which is sufficiently attractive to incite insects such as ants, termites, wasps, flies, mosquitos, crickets etc. or cockroaches to eat it. The attractiveness can be manipulated by using feeding stimulants or sex pheromones. Food stimulants are chosen, for example, but not exclusively, from animal and/or plant proteins (meat-, fish- or blood meal, insect parts, egg yolk), from fats and oils of animal and/or plant origin, or mono-, oligo- or polyorganosaccharides, especially from sucrose, lactose, fructose, dextrose, glucose, starch, pectin or even molasses or honey. Fresh or decaying parts of fruits, crops, plants, animals, insects or specific parts thereof can also serve as a feeding stimulant. Sex pheromones are known to be more insect specific. Specific pheromones are described in the literature and are known to those skilled in the art.

For use in bait compositions, the typical content of active ingredient is from 0.001 weight % to 15 weight %, desirably from 0.001 weight % to 5% weight % of active ingredient.

Formulations of compounds of the present invention as aerosols (e.g in spray cans), oil sprays or pump sprays are highly suitable for the non-professional user for controlling pests such as flies, fleas, ticks, mosquitos or cockroaches. Aerosol recipes are preferably composed of the active compound, solvents such as lower alcohols (e.g. methanol, ethanol, propanol, butanol), ketones (e.g. acetone, methyl ethyl ketone), paraffin hydrocarbons (e.g. kerosenes) having boiling ranges of approximately 50 to 250°C, dimethylformamide, N-methylpyrrolidone, dimethyl sulfoxide, aromatic hydrocarbons such as toluene, xylene, water, furthermore auxiliaries such as emulsifiers such as sorbitol monooleate, oleyl ethoxylate having 3-7 mol of ethylene oxide, fatty alcohol ethox- ylate, perfume oils such as ethereal oils, esters of medium fatty acids with lower alcohols, aromatic carbonyl compounds, if appropriate stabilizers such as sodium benzo- ate, amphoteric surfactants, lower epoxides, triethyl orthoformate and, if required, propellents such as propane, butane, nitrogen, compressed air, dimethyl ether, carbon dioxide, nitrous oxide, or mixtures of these gases.

The oil spray formulations differ from the aerosol recipes in that no propellants are used.

For use in spray compositions, the content of active ingredient is from 0.001 to 80 weights %, preferably from 0.01 to 50 weight % and most preferably from 0.01 to 15 weight %. The compounds of the present invention and its respective compositions can also be used in mosquito and fumigating coils, smoke cartridges, vaporizer plates or long-term vaporizers and also in moth papers, moth pads or other heat-independent vaporizer systems.

Methods to control infectious diseases transmitted by insects (e.g. malaria, dengue and yellow fever, lymphatic filariasis, and leishmaniasis) with compounds of the present invention and its respective compositions also comprise treating surfaces of huts and houses, air spraying and impregnation of curtains, tents, clothing items, bed nets, tsetse-fly trap or the like. Insecticidal compositions for application to fibers, fabric, knit- goods, nonwovens, netting material or foils and tarpaulins preferably comprise a mixture including the insecticide, optionally a repellent and at least one binder. Suitable repellents for example are Ν,Ν-Diethyl-meta-toluamide (DEET),

Ν,Ν-diethylphenylacetamide (DEPA), 1 -(3-cyclohexan-1 -yl-carbonyl)-2-methylpiperine, (2-hydroxymethylcyclohexyl) acetic acid lactone, 2-ethyl-1 ,3-hexandiol, indalone, Me- thylneodecanamide (MNDA), a pyrethroid not used for insect control such as {(+/-)-3- allyl-2-methyl-4-oxocyclopent-2-(+)-enyl-(+)-trans-chrysante mate (Esbiothrin), a repellent derived from or identical with plant extracts like limonene, eugenol, (+)-Eucamalol (1 ), (-)-l -epi-eucamalol or crude plant extracts from plants like Eucalyptus maculata, Vitex rotundifolia, Cymbopogan martinii, Cymbopogan citratus (lemon grass), Cy- mopogan nartdus (citronella). Suitable binders are selected for example from polymers and copolymers of vinyl esters of aliphatic acids (such as such as vinyl acetate and vinyl versatate), acrylic and methacrylic esters of alcohols, such as butyl acrylate, 2- ethylhexylacrylate, and methyl acrylate, mono- and di-ethylenically unsaturated hydrocarbons, such as styrene, and aliphatic diens, such as butadiene.

The impregnation of curtains and bednets is done in general by dipping the textile material into emulsions or dispersions of the insecticide or spraying them onto the nets. The compounds of the present invention and their compositions can be used for protecting wooden materials such as trees, board fences, sleepers, etc. and buildings such as houses, outhouses, factories, but also construction materials, furniture, leath- ers, fibers, vinyl articles, electric wires and cables etc. from ants and/or termites, and for controlling ants and termites from doing harm to crops or human being (e.g. when the pests invade into houses and public facilities). The compounds of the present invention are applied not only to the surrounding soil surface or into the under-floor soil in order to protect wooden materials but it can also be applied to lumbered articles such as surfaces of the under-floor concrete, alcove posts, beams, plywoods, furniture, etc., wooden articles such as particle boards, half boards, etc. and vinyl articles such as coated electric wires, vinyl sheets, heat insulating material such as styrene foams, etc. In case of application against ants doing harm to crops or human beings, the ant con- trailer of the present invention is applied to the crops or the surrounding soil, or is directly applied to the nest of ants or the like.

The compounds of the present invention are also suitable for the treatment of plant propagation material, especially seeds, in order to protect them from insect pest, in particular from soil-living insect pests and the resulting plant's roots and shoots against soil pests and foliar insects.

The compounds of the present invention are particularly useful for the protection of the seed from soil pests and the resulting plant's roots and shoots against soil pests and foliar insects. The protection of the resulting plant's roots and shoots is preferred. More preferred is the protection of resulting plant's shoots from piercing and sucking insects, wherein the protection from aphids is most preferred.

The present invention therefore comprises a method for the protection of seeds from insects, in particular from soil insects and of the seedlings' roots and shoots from in- sects, in particular from soil and foliar insects, said method comprising contacting the seeds before sowing and/or after pregermination with a compound of the present invention, including a salt thereof. Particularly preferred is a method, wherein the plant' s roots and shoots are protected, more preferably a method, wherein the plants shoots are protected form piercing and sucking insects, most preferably a method, wherein the plants shoots are protected from aphids.

The term seed embraces seeds and plant propagules of all kinds including but not limited to true seeds, seed pieces, suckers, corms, bulbs, fruit, tubers, grains, cuttings, cut shoots and the like and means in a preferred embodiment true seeds.

The term seed treatment comprises all suitable seed treatment techniques known in the art, such as seed dressing, seed coating, seed dusting, seed soaking and seed pelleting.

The present invention also comprises seeds coated with or containing the active compound.

The term "coated with and/or containing" generally signifies that the active ingredient is for the most part on the surface of the propagation product at the time of application, although a greater or lesser part of the ingredient may penetrate into the propagation product, depending on the method of application. When the said propagation product is (re)planted, it may absorb the active ingredient.

Suitable seed is seed of cereals, root crops, oil crops, vegetables, spices, ornamentals, for example seed of durum and other wheat, barley, oats, rye, maize (fodder maize and sugar maize / sweet and field corn), soybeans, oil crops, crucifers, cotton, sunflowers, bananas, rice, oilseed rape, turnip rape, sugarbeet, fodder beet, eggplants, potatoes, grass, lawn, turf, fodder grass, tomatoes, leeks, pumpkin/squash, cabbage, iceberg lettuce, pepper, cucumbers, melons, Brassica species, melons, beans, peas, garlic, onions, carrots, tuberous plants such as potatoes, sugar cane, tobacco, grapes, petunias, geranium/pelargoniums, pansies and impatiens.

In addition, the active compound may also be used for the treatment seeds from plants, which tolerate the action of herbicides or fungicides or insecticides owing to breeding, including genetic engineering methods.

For example, the active compound can be employed in treatment of seeds from plants, which are resistant to herbicides from the group consisting of the sulfonylureas, imid- azolinones, glufosinate-ammonium or glyphosate-isopropylammonium and analogous active substances (see for example, EP-A 242 236, EP-A 242 246) (WO 92/00377) (EP-A 257 993, U.S. 5,013,659) or in transgenic crop plants, for example cotton, with the capability of producing Bacillus thuringiensis toxins (Bt toxins) which make the plants resistant to certain pests (EP-A 142 924, EP-A 193 259),

Furthermore, the active compound can be used also for the treatment of seeds from plants, which have modified characteristics in comparison with existing plants consist, which can be generated for example by traditional breeding methods and/or the generation of mutants, or by recombinant procedures). For example, a number of cases have been described of recombinant modifications of crop plants for the purpose of modifying the starch synthesized in the plants (e.g. WO 92/1 1376, WO 92/14827, WO

91/19806) or of transgenic crop plants having a modified fatty acid composition (WO 91/13972).

The seed treatment application of the active compound is carried out by spraying or by dusting the seeds before sowing of the plants and before emergence of the plants. Compositions which are especially useful for seed treatment are e.g.:

A Soluble concentrates (SL, LS)

D Emulsions (EW, EO, ES)

E Suspensions (SC, OD, FS)

F Water-dispersible granules and water-soluble granules (WG, SG)

G Water-dispersible powders and water-soluble powders (WP, SP, WS)

H Gel-Formulations (GF)

I Dustable powders (DP, DS)

Conventional seed treatment formulations include for example flowable concentrates FS, solutions LS, powders for dry treatment DS, water dispersible powders for slurry treatment WS, water-soluble powders SS and emulsion ES and EC and gel formulation GF. These formulations can be applied to the seed diluted or undiluted. Application to the seeds is carried out before sowing, either directly on the seeds or after having pregerminated the latter.

In a preferred embodiment a FS formulation is used for seed treatment. Typcially, a FS formulation may comprise 1 -800 g/l of active ingredient, 1 -200 g/l Surfactant, 0 to 200 g/l antifreezing agent, 0 to 400 g/l of binder, 0 to 200 g/l of a pigment and up to 1 liter of a solvent, preferably water.

Especially preferred FS formulations of compounds of the present invention for seed treatment usually comprise from 0.1 to 80% by weight (1 to 800 g/l) of the active ingredient, from 0.1 to 20% by weight (1 to 200 g/l) of at least one surfactant, e.g. 0.05 to 5% by weight of a wetter and from 0.5 to 15% by weight of a dispersing agent, up to 20% by weight, e.g. from 5 to 20% of an anti-freeze agent, from 0 to 15% by weight, e.g. 1 to 15% by weight of a pigment and/or a dye, from 0 to 40% by weight, e.g. 1 to 40% by weight of a binder (sticker /adhesion agent), optionally up to 5% by weight, e.g. from 0.1 to 5% by weight of a thickener, optionally from 0.1 to 2% of an anti-foam agent, and optionally a preservative such as a biocide, antioxidant or the like, e.g. in an amount from 0.01 to 1 % by weight and a filler/vehicle up to 100% by weight.

Seed Treatment formulations may additionally also comprise binders and optionally colorants.

Binders can be added to improve the adhesion of the active materials on the seeds after treatment. Suitable binders are homo- and copolymers from alkylene oxides like ethylene oxide or propylene oxide, polyvinylacetate, polyvinylalcohols, polyvinylpyrrolidones, and copolymers thereof, ethylene-vinyl acetate copolymers, acrylic homo- and copolymers, polyethyleneamines, polyethyleneamides and polyethyleneimines, polysaccharides like celluloses, tylose and starch, polyolefin homo- and copolymers like olefin/maleic anhydride copolymers, polyurethanes, polyesters, polystyrene homo and copolymers.

Optionally, also colorants can be included in the formulation. Suitable colorants or dyes for seed treatment formulations are Rhodamin B, C.I. Pigment Red 1 12, C.I. Solvent Red 1 , pigment blue 15:4, pigment blue 15:3, pigment blue 15:2, pigment blue 15:1 , pigment blue 80, pigment yellow 1 , pigment yellow 13, pigment red 1 12, pigment red 48:2, pigment red 48:1 , pigment red 57:1 , pigment red 53:1 , pigment orange 43, pigment orange 34, pigment orange 5, pigment green 36, pigment green 7, pigment white 6, pigment brown 25, basic violet 10, basic violet 49, acid red 51 , acid red 52, acid red 14, acid blue 9, acid yellow 23, basic red 10, basic red 108.

Examples of a gelling agent is carrageen (Satiagel ^® )

In the treatment of seed, the application rates of the compounds of the present invention are generally from 0.01 g to 10 kg per 100 kg of seed, preferably from 0.05 g to 5 kg per 100 kg of seed, more preferably from 0.1 g to 1000 g per 100 kg of seed and in particular from 0.1 g to 200 g per 100 kg of seed.

The invention therefore also relates to seed comprising a compound of the present invention, including an agriculturally useful salt of it, as defined herein. The amount of the compound of the present invention, including an agriculturally useful salt thereof will in general vary from 0.01 g to 10 kg per 100 kg of seed, preferably from 0.05 g to 5 kg per 100 kg of seed, in particular from 0.1 g to 1000 g per 100 kg of seed. For specific crops such as lettuce the rate can be higher. Methods which can be employed for treating the seed are, in principle, all suitable seed treatment and especially seed dressing techniques known in the art, such as seed coating (e.g. seed pelleting), seed dusting and seed imbibition (e.g. seed soaking). Here, "seed treatment" refers to all methods that bring seeds and the compounds of the present invention into contact with each other, and "seed dressing" to methods of seed treatment which provide the seeds with an amount of the compounds of the present invention, i.e. which generate a seed comprising a compound of the present invention. In principle, the treatment can be applied to the seed at any time from the harvest of the seed to the sowing of the seed. The seed can be treated immediately before, or during, the planting of the seed, for example using the "planter's box" method. However, the treatment may also be carried out several weeks or months, for example up to 12 months, before planting the seed, for example in the form of a seed dressing treatment, without a substantially reduced efficacy being observed.

Expediently, the treatment is applied to unsown seed. As used herein, the term "un- sown seed" is meant to include seed at any period from the harvest of the seed to the sowing of the seed in the ground for the purpose of germination and growth of the plant.

Specifically, a procedure is followed in the treatment in which the seed is mixed, in a suitable device, for example a mixing device for solid or solid/liquid mixing partners, with the desired amount of seed treatment formulations, either as such or after previous dilution with water, until the composition is distributed uniformly on the seed. If appropriate, this is followed by a drying step. The compounds of the present invention, including their stereoisomers, veterinarily acceptable salts or N-oxides, are in particular also suitable for being used for combating parasites in and on animals. An object of the present invention is therefore also to provide new methods to control parasites in and on animals. Another object of the invention is to provide safer pesticides for animals. Another object of the invention is further to provide pesticides for animals that may be used in lower doses than existing pesticides. And another object of the invention is to provide pesticides for animals, which provide a long residual control of the parasites.

The invention also relates to compositions comprising a parasiticidally effective amount of compounds of the present invention, including their stereoisomers, veterinarily acceptable salts or N-oxides, and an acceptable carrier, for combating parasites in and on animals.

The present invention also provides a method for treating, controlling, preventing and protecting animals against infestation and infection by parasites, which comprises orally, topically or parenterally administering or applying to the animals a parasiticidally effective amount of a compound of the present invention, including its stereoisomers, veterinarily acceptable salts or N-oxides, or a composition comprising it.

The invention also provides the use of a compound of the present invention, including its stereoisomers, veterinarily acceptable salts or N-oxides, for treating or protecting an animal from infestation or infection by invertebrate pests.

The invention also provides a process for the preparation of a composition for treating, controlling, preventing or protecting animals against infestation or infection by parasites which comprises a parasiticidally effective amount of a compound of the present invention, including its stereoisomers, veterinarily acceptable salts or N-oxides, or a composition comprising it.

Activity of compounds against agricultural pests does not suggest their suitability for control of endo- and ectoparasites in and on animals which requires, for example, low, non-emetic dosages in the case of oral application, metabolic compatibility with the animal, low toxicity, and a safe handling.

Surprisingly it has now been found that compounds of formula (I) and their stereoisomers, veterinarily acceptable salts, tautomers and N-oxides, are suitable for combating endo- and ectoparasites in and on animals.

The compounds of the present invention, especially compounds of formula (I) and their stereoisomers, veterinarily acceptable salts, tautomers and N-oxides, and compositions comprising them are preferably used for controlling and preventing infestations of and infections in animals including warm-blooded animals (including humans) and fish. They are for example suitable for controlling and preventing infestations and infections in mammals such as cattle, sheep, swine, camels, deer, horses, pigs, poultry, rabbits, goats, dogs and cats, water buffalo, donkeys, fallow deer and reindeer, and also in fur- bearing animals such as mink, chinchilla and raccoon, birds such as hens, geese, turkeys and ducks and fish such as fresh- and salt-water fish such as trout, carp and eels. Compounds of the present invention, including their stereoisomers, veterinarily acceptable salts or N-oxides, and compositions comprising them are preferably used for controlling and preventing infestations and infections in domestic animals, such as dogs or cats.

Infestations in warm-blooded animals and fish include, but are not limited to, lice, biting lice, ticks, nasal bots, keds, biting flies, muscoid flies, flies, myiasitic fly larvae, chig- gers, gnats, mosquitoes and fleas.

The compounds of the present invention, including their stereoisomers, veterinarily acceptable salts or N-oxides, and compositions comprising them are suitable for systemic and/or non-systemic control of ecto- and/or endoparasites. They are active against all or some stages of development.

The compounds of the present invention are especially useful for combating parasites of the following orders and species, respectively:

fleas (Siphonaptera), e.g. Ctenocephalides felis, Ctenocephalides canis, Xenopsylla cheopis, Pulex irritans, Tunga penetrans, and Nosopsyllus fasciatus,

cockroaches (Blattaria - Blattodea), e.g. Blattella germanica, Blattella asahinae, Peri- planeta americana, Periplaneta japonica, Periplaneta brunnea, Periplaneta fuligginosa, Periplaneta australasiae, and Blatta orientalis,

flies, mosquitoes (Diptera), e.g. Aedes aegypti, Aedes albopictus, Aedes vexans, Anas- trepha ludens, Anopheles maculipennis, Anopheles crucians, Anopheles albimanus, Anopheles gambiae, Anopheles freeborni, Anopheles leucosphyrus, Anopheles minimus, Anopheles quadrimaculatus, Calliphora vicina, Chrysomya bezziana, Chrysomya hominivorax, Chrysomya macellaria, Chrysops discalis, Chrysops silacea, Chrysops atlanticus, Cochliomyia hominivorax, Cordylobia anthropophaga, Culicoides furens, Culex pipiens, Culex nigripalpus, Culex quinquefasciatus, Culex tarsalis, Culiseta inor- nata, Culiseta melanura, Dermatobia hominis, Fannia canicularis, Gasterophilus intes- tinalis, Glossina morsitans, Glossina palpalis, Glossina fuscipes, Glossina tachinoides, Haematobia irritans, Haplodiplosis equestris, Hippelates spp., Hypoderma lineata, Lep- toconops torrens, Lucilia caprina, Lucilia cuprina, Lucilia sericata, Lycoria pectoralis, Mansonia spp., Musca domestica, Muscina stabulans, Oestrus ovis, Phlebotomus ar- gentipes, Psorophora columbiae, Psorophora discolor, Prosimulium mixtum, Sarcoph- aga haemorrhoidalis, Sarcophaga sp., Simulium vittatum, Stomoxys calcitrans, Taba- nus bovinus, Tabanus atratus, Tabanus lineola, and Tabanus similis,

lice (Phthiraptera), e.g. Pediculus humanus capitis, Pediculus humanus corporis, Pthirus pubis, Haematopinus eurysternus, Haematopinus suis, Linognathus vituli, Bo- vicola bovis, Menopon gallinae, Menacanthus stramineus and Solenopotes capillatus. ticks and parasitic mites (Parasitiformes): ticks (Ixodida), e.g. Ixodes scapularis, Ixodes holocyclus, Ixodes pacificus, Rhiphicephalus sanguineus, Dermacentor andersoni, Dermacentor variabilis, Amblyomma americanum, Ambryomma maculatum, Ornithodo- rus hermsi, Ornithodorus turicata and parasitic mites (Mesostigmata), e.g. Ornithonys- sus bacoti and Dermanyssus gallinae,

Actinedida (Prostigmata) und Acaridida (Astigmata) e.g. Acarapis spp., Cheyletiella spp., Ornithocheyletia spp., Myobia spp., Psorergates spp., Demodex spp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp., Pterolichus spp., Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedres spp.,Knemidocoptes spp., Cytodites spp., and Laminosioptes spp., Bugs (Heteropterida): Cimex lectularius, Cimex hemipterus, Reduvius senilis, Triatoma spp., Rhodnius ssp., Panstrongylus ssp. and Arilus critatus,

Anoplurida, e.g. Haematopinus spp., Linognathus spp., Pediculus spp., Phtirus spp., and Solenopotes spp,

Mallophagida (suborders Arnblycerina and Ischnocerina), e.g. Trimenopon spp., Me- nopon spp., Trinoton spp., Bovicola spp., Werneckiella spp., Lepikentron spp., Tricho- dectes spp., and Felicola spp,

Roundworms Nematoda:

Wipeworms and Trichinosis (Trichosyringida), e.g. Trichinellidae (Trichinella spp.), (Tri- churidae) Trichuris spp., Capillaria spp,

Rhabditida, e.g. Rhabditis spp, Strongyloides spp., Helicephalobus spp,

Strongylida, e.g. Strongylus spp., Ancylostoma spp., Necator americanus, Bunosto- mum spp. (Hookworm), Trichostrongylus spp., Haemonchus contortus., Ostertagia spp., Cooperia spp., Nematodirus spp., Dictyocaulus spp., Cyathostoma spp., Oe- sophagostomum spp., Stephanurus dentatus, Ollulanus spp., Chabertia spp., Stepha- nurus dentatus, Syngamus trachea, Ancylostoma spp., Uncinaria spp., Globocephalus spp., Necator spp., Metastrongylus spp., Muellerius capillaris, Protostrongylus spp., Angiostrongylus spp., Parelaphostrongylus spp. Aleurostrongylus abstrusus, and Dioc- tophyma renale,

Intestinal roundworms (Ascaridida), e.g. Ascaris lumbricoides, Ascaris suum, Ascaridia galli, Parascaris equorum, Enterobius vermicularis (Threadworm), Toxocara canis, Toxascaris leonine, Skrjabinema spp., and Oxyuris equi,

Camallanida, e.g. Dracunculus medinensis (guinea worm)

Spirurida, e.g. Thelazia spp. Wuchereria spp., Brugia spp., Onchocerca spp., Dirofilari spp. a, Dipetalonema spp., Setaria spp., Elaeophora spp., Spirocerca lupi, and Habro- nema spp.,

Thorny headed worms (Acanthocephala), e.g. Acanthocephalus spp.,

Macracanthorhynchus hirudinaceus and Oncicola spp., Planarians (Plathelminth.es):

Flukes (Trematoda), e.g. Faciola spp., Fascioloides magna, Paragonimus spp., Dicro- coelium spp., Fasciolopsis buski, Clonorchis sinensis, Schistosoma spp., Trichobilhar- zia spp., Alaria alata, Paragonimus spp., and Nanocyetes spp.,

Cercomeromorpha, in particular Cestoda (Tapeworms), e.g. Diphyllobothrium spp., Tenia spp., Echinococcus spp., Dipylidium caninum, Multiceps spp., Hymenolepis spp., Mesocestoides spp., Vampirolepis spp., Moniezia spp., Anoplocephala spp., Sirometra spp., Anoplocephala spp., and Hymenolepis spp. The present invention relates to the therapeutic and the non-therapeutic use of compounds of the present invention and compositions comprising them for controlling and/or combating parasites in and/or on animals. The compounds of the present invention and compositions comprising them may be used to protect the animals from attack or infestation by parasites by contacting them with a parasiticidally effective amount of compounds of the present invention and compositions containing them.

The compounds of the present invention and compositions comprising them can be effective through both contact (via soil, glass, wall, bed net, carpet, blankets or animal parts) and ingestion (e.g. baits). As such, "contacting" includes both direct contact (applying the pesticidal mixtures/compositions containing the compounds of the present invention directly on the parasite, which may include an indirect contact at its locus-P, and optionally also administrating the pesticidal mixtures/composition directly on the animal to be protected) and indirect contact (applying the compounds/compositions to the locus of the parasite). The contact of the parasite through application to its locus is an example of a non-therapeutic use of compounds of the present invention. "Locus-P" as used above means the habitat, food supply, breeding ground, area, material or environment in which a parasite is growing or may grow outside of the animal.

In general, "parasiticidally effective amount" means the amount of active ingredient needed to achieve an observable effect on growth, including the effects of necrosis, death, retardation, prevention, and removal, destruction, or otherwise diminishing the occurrence and activity of the target organism. The parasiticidally effective amount can vary for the various compounds/compositions of the present invention. A parasiticidally effective amount of the compositions will also vary according to the prevailing conditions such as desired parasiticidal effect and duration, target species, mode of application, and the like.

The compounds of the present invention can also be applied preventively to places at which occurrence of the pests or parasites are expected.

Administration can be carried out both prophylactically and therapeutically. Administration of the active compounds is carried out directly or in the form of suitable preparations, orally, topically/dermally or parenterally.

The isothiazoline compounds of the present invention are less persistent, bioaccumula- tive and/or toxic than the compounds of the prior art, and especially the isoxazoline insecticides of the prior art, which show a high persistency in the soil and thus accumulate there.

Examples

The present invention is now illustrated in further details by the following examples, without imposing any limitation thereto.

I. Preparation Examples

Compounds can be characterized e.g. by coupled High Performance Liquid Chromatography / mass spectrometry (HPLC/MS), by ¹ H-NMR and/or by their melting points. Analytical HPLC column:

Method A: Analytical UPLC column: Phenomenex Kinetex 1 ,7 μηι XB-C18 100A; 50 x 2.1 mm from Phenomenex, Germany. Elution: acetonitrile + 0.1 % trifluoroacetic acid (TFA) / water + 0.1 % trifluoroacetic acid (TFA) in a ratio from 5:95 to 100:0 in 1.5 min at 60 °C. Flow: 0.8 mL/min to 1 mL/min in 1.5 min. MS-method: ESI positive.

1H-NMR: The signals are characterized by chemical shift (ppm, δ [delta]) vs. tetrame- thylsilane, respectively CDC for ¹³ C-NMR, by their multiplicity and by their integral (relative number of hydrogen atoms given). The following abbreviations are used to characterize the multiplicity of the signals: m = multiplett, q = quartett, t = triplett, d = doublet and s = singulett.

Abbreviations used are: h for hour(s), min for minute(s), r.t./room temperature for 20- 25°C, THF for tetrahydrofuran, t-BuOH for tert-butanol, MTBE for methyl-tert- butylether, OAc for acetate, BuLi for n-butyl lithium, DMF for dimethyl formamide.

C.1 Compound examples 1

Compound examples 1 -1 to 1 -16 correspond to compounds of formula C.1 :

wherein R ^2a , R ^2b , R ^2c , R ^4b and Y of each synthesized compound is defined in one row of table C.1 below.

The compounds were synthesized in analogy to Synthesis Example S.1 or S.2.

Table d

Ex. R2a, R2b, R4b Y HPLC-MS:

R2c Method, Rt (min) & [M+H] ⁺

1H-NMR

1-1 CI, CI, CI CH ₃ OC(CH ₃ ) ₃ Ή NMR (400 MHz,CDCI ₃ ): δ 7.4 (m,

2H), 7.1 (s, 1H), 4.1 (d, 1H), 3.8 (d, 1H), 2.5 (s, 3H), 1.6 (s, 9H).

1-2 CI, CI, CI CH ₃ OH H NMR (400 MHz, de-DMSO): δ 7.8

(s, 2H), 7.5 (s, 1H), 4.5 (d, 1H), 4.3 (d, 1H), 2.5 (s, 3H).

1-3 CI, CI, CI CH ₃ NHCH ₂ C(=0)-NHCH ₂ CF ₃ A 1.416 613.7

1-4 CI, CI, CI CH ₃ NHCH ₂ -(2-pyridyl) A 1.233 565.7

1-5 CI, CI, CI CH ₃ NHCH ₂ -(2-thiazolyl) A 1.423 571.8

1-6 CI, CI, CI CH ₃ NHCH ₂ -(2-pyrimidinyl) A 1.397 566.7

1-7 CI, CI, CI CH ₃ NHCH ₂ CF ₃ A 1.531 557

1-8 CI, CI, CI CH ₃ NH-(1,1-dioxo-thiethan-3- H NMR (400 MHz, de-DMSO): δ 8.9 yi) (m, 1H), 7.8 (s, 2H), 7.5 (s, 1H), 4.6- 4.5 (m, 4H), 4.4-4.2 (m, 3H), 2.5 (s, 3H).

1-9 CI, F, CI CF ₃ OH Ή NMR (400 MHz, CDCIs): δ 7.4 (s,

1H), 7.3 (m, 2H), 4.2 (d, 1H), 3.85 (d, 1H).

1-10 CI, F, CI CF ₃ NHCH ₂ -(2-pyridyl) A 1.264 602.2

1-11 CI, F, CI CF ₃ NHCH ₂ C(=0)-NHCH ₂ CF ₃ A 1.433 650.2

1-12 CI, F, CI CF ₃ NHCH ₂ -(2-pyrimidinyl) A 1.439 603.2

1-13 CI, F, CI CF ₃ NH-(1,1-dioxo-thiethan-3- A 1.370 614.7

yi) Ex. R2a, R2b, R4b Y HPLC-MS:

R2c Method, Rt (min) & [M+H] ⁺

or

1H-NMR

1-14 CI, F, CI CF ₃ NH-(3-thiethanyl) A 1.486 582.7

1-15 CI, F, CI CF ₃ NHCH2(cyclopropyl) A 1.501 564.8

1-16 CI, F, CI CF ₃ OCH ₃ Ή NMR (400 MHz, CDC ): δ 7.55 (s,

1 H), 7.4-7.35 (m, 2H), 4.2 (d, 1 H), 3.95 (s, 3H), 3.85 (d, 1 H).

Synthesis Example S.1

3-Methyl-5-[5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl) -4H-isothiazol-3-yl]-N-(2,2,2- trifluoroethyl)thiophene-2-carboxamide

(Compound example 1 -7; compound of formula IA, wherein R ^2a , R ^2b and R ^2c are CI, R ^4a is H, R ^4b is CH ₃ , and A is A ² = -C(=0)NHCH ₂ CF ₃ )

Step 1 : tert-Butyl 5-bromo-3-methyl-thiophene-2-carboxylate

To a solution of 5-bromo-3-methyl-thiophene-2-carboxylic acid (168 g, CAS 38239-45- 1 ) and (Boc) ₂ 0 (250 g) in t-BuOH/THF (500 mL/500 mL) was added N,N-dimethyl-4- aminopyridine ("DMAP", 10 g) and the mixture was stirred overnight at 80°C. Then, the reaction was concentrated and water (500 mL) was added. The aqueous layer was extracted with MTBE (2x 500 mL). The combined organic layers were dried (Na2S0 ₄ ), filtered and concentrated to give a residue which was purified by flash chromatography on silica gel to afford the title product (35 g, 17%). H NMR (400 MHz, CDCb): δ 6.8 (s, 1 H), 2.5 (s, 3H), 1 .5 (s, 9H).

Step 2: tert-Butyl 5-formyl-3-methyl-thiophene-2-carboxylate

To a solution of the product of step 1 (28 g) in THF (300 mL) at -78°C was added n- BuLi (2.5 M in hexanes, 50 mL) dropwise, and the reaction was stirred for 10 min at -78°C. 1 -Formylpiperidine (18 g, CAS 2591 -86-8) was added dropwise to the reaction, and the mixture was stirred for another 30 min at -78°C. The reaction was quenched with water and the aqueous layer was extracted with MTBE. The organic layers were dried (Na2S0 ₄ ), filtered and concentrated to give a residue which was purified by flash chromatography on silica gel (ethyl acetate/petroleum ether) to afford the title product (17 g, 74%). Step 3: tert-Butyl 5-acetyl-3-methyl-thiophene-2-carboxylate

A solution of the product of step 2 (17 g) in THF (200 ml.) at 0°C under N ₂ was treated with methyl magnesium bromide (27.5 ml_, 2.9 M solution in diethylether) over 15 min. The reaction was stirred at 0°C for another 30 min. Then, a saturated aqueous NH4CI solution was added and the aqueous layer was extracted with MTBE. The organic layer was dried (Na2S0 ₄ ), filtered and concentrated to afford the "crude alcohol" (20 g) which was used in the next step without any further purification.

The "crude alcohol" (20 g) in CH2CI2 was treated with pyridinium chlorochromate ("PCC", 35.5 g) and stirred at r.t. overnight. The reaction was filtered and the filtrate was concentrated to afford a residue which was purified by flash chromatography on silica gel (ethyl acetate/petroleum ether) to afford the title product (7 g, 40%). Step 4: tert-Butyl 3-methyl-5-[4,4,4-trifluoro-3-(3,4,5-trichlorophenyl)but-2- enoyl]thiophene-2-carboxylate

A solution of the product of step 3 (7 g) in a mixture of DMF (30 ml.) and THF (60 ml.) was treated with 2,2,2-trifluoro-1 -(3,4,5-trichlorophenyl)ethanone (8.8 g, CAS 158401 - 00-4). The reaction was stirred overnight at 70°C using a Dean-Stark apparatus to remove water. Then, the mixture was concentrated to give a residue which was purified by flash chromatography on silica gel (ethyl acetate/petroleum ether) to afford the title product (5.8 g, 47%). ¹ H NMR (400 MHz, CDC ): δ 7.45 (s, 1 H), 7.4-7.2 (m, 3H), 2.5 (s, 3H), 1 .6 (s, 9H).

Step 5: tert-Butyl 3-methyl-5-[4,4,4-trifluoro-3-sulfanyl-3-(3,4,5- trichlorophenyl)butanoyl]thiophene-2-carboxylate The product of step 4 (5.8 g, mixture of E/Z-isomers) in CH2CI2 (100 ml.) was treated with triethylamine (1 1 .7 g). At 0°C, gaseous hydrogen sulfide (H2S) was bubbled through the solution until the solution was saturated. The mixture was stirred for another 1 h at 0°C, and then diluted with CH2CI2 (200 ml_). The organic layer was washed with 10% aqueous hydrochloric acid solution (3x), dried (Na2S0 ₄ ), filtered, and concen- trated to afford the crude product (5.9 g, quant.), which was used in the next step without any further purification. H NMR (400 MHz, CDCI ₃ ): δ 7.7 (s, 2H), 7.5 (s, 1 H), 4.1 (d, 1 H), 3.8 (d, 1 H), 3.3 (s, 1 H (SH)), 2.5 (s, 3H), 1.6 (s, 9H).

Step 6: tert-Butyl 3-methyl-5-[5-(3,4,5-trichlorophenyl)-5-(tnfluoromethyl)-4H- isothiazol- 3-yl]thiophene-2-carboxylate

At -15°C, the product of step 5 (5.9 g) in CH2CI2 (100 mL) was treated with triethyla- mine (4.5 g) and with a solution of hydroxylamine-O-sulfonic acid ("HOSA", 1 .5 g) in water (5 mL). The reaction was warmed to 0°C and stirred at 0°C for 1 h, and then di- luted with CH2CI2 (300 mL). The organic layer was washed with saturated aqueous

NH4CI solution (3x), dried (Na2S0 ₄ ), and filtered. To the obtained solution, acid washed molecular sieves (AW 300, 150 g) were added and the mixture was stirred vigorously for 3 h at r.t. Then, the molecular sieves were filtered off over Celite, and the filtrate concentrated to afford the product (4.7 g, 80%), which was used in the next step with- out any further purification. H NMR (400 MHz, CDC ): δ 7.4 (m, 2H), 7.1 (s, 1 H), 4.1 (d, 1 H), 3.8 (d, 1 H), 2.5 (s, 3H), 1.6 (s, 9H). Step 7: 3-Methyl-5-[5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-4H -isothiazol-3- yl]thiophene-2-carboxylic acid

At 0°C, the product of step 6 (7.7 g) in CH2CI2 (100 mL) was treated with trifluoroacetic acid ("TFA", 50 mL), and the mixture stirred overnight at r.t. The reaction was concen- trated, and co-evaporated with CH2CI2 (5x) to afford the title product as a pale yellow solid (3.4 g, quant.) that was used in the next step without any further purification. H NMR (400 MHz, d ₆ -DMSO): δ 7.8 (s, 2H), 7.5 (s, 1 H), 4.5 (d, 1 H), 4.3 (d, 1 H), 2.5 (s, 3H).

Step 8: 3-Methyl-5-[5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-4H -isothiazol-3-yl]-N- (2,2,2-trifluoroethyl)thiophene-2-carboxamide

To a solution of the product of step 1 (0.3 g), 2,2,2-trifluoroethylamine (0.08 g) and bromotripyrrolidinophosphonium hexafluorophosphate ("PyBroP", 0.35 g) in CH2CI2 (40 mL) at r.t. was added A/,A/-diisopropylethylamine (0.26 g). The reaction was stirred at r.t. overnight, then concentrated to afford a residue that was purified by flash chroma- tography on silica gel (ethyl acetate/cyclohexane) to afford the title product (0.21 g, 60%).

HPLC-MS (method A): 1.531 min, M = 557.0.

Synthesis Example S.2

5-[5-(3,5-Dichloro-4-fluoro-phenyl)-5-(trifluoromethyl)-4 H-isothiazol-3-yl]-N-(pyrimidin-2- ylmethyl)-3-(trifluoromethyl)thiophene-2-carboxamide

(Compound example 1 -12; compound of formula IA, wherein R ^2a , and R ^2c are CI, R ^2b is F, R ^4a is H, R ^4b is CF ₃ , and A is A ² = -C(=0)NH-(pyrimidin-2-yl)

For the synthesis of methyl 5-formyl-3-(trifluoromethyl)thiophene-2-carboxylate (CAS 189756-77-2) , see US 2012/238569 (p. 34, paragraph [314]) or Helvetica Chimica Acta, 1997, Vol. 80, 531 -537.

Step 1 : Methyl 5-(1 -hydroxyethyl)-3-(trifluoromethyl)-thiophene-2-carboxylate

To a solution of methyl 5-formyl-3-(trifluoromethyl)-thiophene-2-carboxylate (8.5 g) in THF (370 mL) at 0°C was added a solution of methylmagnesium bromide (1 1.9 mL, 3 M in diethylether) and the mixture was stirred at 0°C for 1 h. Then, the reaction was quenched by the addition of saturated aqueous NH4CI solution (200 mL). The aqueous layer was extracted with ethyl acetate (2x 100 mL). The combined organic layers were dried (Na2S0 ₄ ), filtered and concentrated to give a residue which was purified by flash chromatography on silica gel (petroleum ether / ethyl acetate) to afford the title product (6 g, 66%). H NMR (400 MHz, CDC ): 5 7.19 (s, 1 H), 5.15 (q, 1 H), 3.92 (s, 3H), 1 .63 (d, 3H). Step 2: Methyl 5-acetyl-3-(trifluoromethyl)-thiophene-2-carboxylate

To a solution of the product of step 1 (6 g) in CH2CI2 (250 mL) at 0°C was added Dess- Martin periodane (15 g, CAS 87413-09-0), and the reaction was stirred at 0°C overnight. Then, a mixture of aqueous solutions of Na2SC"3 and NaHCC"3 was added drop- wise at 0°C. The aqueous layer was extracted with CH2C .The organic layers were combined, dried (Na2S0 ₄ ), filtered and concentrated to give a residue which was purified by flash chromatography on silica gel (ethyl acetate/petroleum ether) to afford the title product (3.5 g, 59%). H NMR (400 MHz, CDCI ₃ ): δ 7.82 (s, 1 H), 3.97 (s, 3H), 2.62 (s, 3H).

Step 3: Methyl 5-[3-(3,5-dichloro-4-fluoro-phenyl)-4,4,4-trifluoro-but-2-en oyl]-3- (trifluoromethyl)-thiophene-2-carboxylate

A solution of the product of step 2 (3.3 g) in a 1 ,2-dichloroethane ("DCE", 100 mL) was treated with 1 -(3,5-dichloro-4-fluoro-phenyl)-2,2,2-trifluoro-ethanone (5.2 g, CAS 1 190865-44-1 ), K2CO3 (1 .8 g), triethylamine (0.9 mL). The reaction was stirred over- night at 100°C. Then, the mixture was diluted with water and extracted with ethyl acetate. The organic layer was dried (Na2S0 ₄ ), filtered and concentrated to give a residue which was purified by flash chromatography on silica gel (ethyl acetate/petroleum ether) to afford the title product (2.4 g, 38%). ¹ H NMR (400 MHz, CDC ): δ 8.19 (s, 1 H), 7.78-7.72 (m, 1 H), 7.47 (m, 2H), 3.95 (s, 3H).

Step 4: Methyl 5-[3-(3,5-dichloro-4-fluoro-phenyl)-4,4,4-trifluoro-3-sulfan yl-butanoyl]-3- (trifluoromethyl)-thiophene-2-carboxylate

The product of step 3 (2.31 g, mixture of E/Z-isomers) in CH2CI2 (30 mL) was treated with N,N-diisopropylethylamine (3.6 g). At 0°C, gaseous hydrogen sulfide (H2S) was bubbled through the solution until the solution was saturated. The mixture was stirred for another 1 h at 0°C. Then, the pH was adjusted to pH 4-5 with aqueous 10% HCI solution) and the mixture diluted with CH2CI2 (200 mL). The organic layer was washed with 10% aqueous HCI solution (1 x) and water (2x), dried (Na2S0 ₄ ), filtered, and concentrated to afford the crude product (2.4 g, 97%), which was used in the next step without any further purification. ¹ H NMR (400 MHz, CDCI3): δ 7.9 (s, 1 H), 7.6 (m, 2H), 4.2 (d, 1 H), 4.0-3.8 (m, 4H), 3.2 (s, 1 H (SH)).

Step 5: Methyl 5-[5-(3,5-dichloro-4-fluoro-phenyl)-5-(trifluoromethyl)-4H-i sothiazol-3-yl]- 3-(trifluoromethyl)-thiophene-2-carboxylate (compound example 1 -16)

At -10°C, the product of step 4 (2.4 g) in CH2CI2 (30 mL) was treated with N,N- diisopropylethylamine (2.3 g) and with a solution of hydroxylamine-O-sulfonic acid ("HOSA", 0.62 g) in water (2 mL). The reaction was warmed to 0°C and stirred at 0°C for 2 h, and then diluted with CH2CI2 (300 mL). The organic layer was washed with saturated aqueous NH4CI solution (3x). Then, Na2S0 ₄ and para-toluenesulfonic acid (50 mg) were added, and the mixture was stirred at r.t. for 1 h. Then, the reaction was filtered and the organic layer was washed with 5% aqueous K2CO3 solution (2x), dried (Na2S0 ₄ ), filtered, and concentrated to afford the crude product (2.24 g, 94%), which was used in the next step without any further purification. H NMR (400 MHz, CDC ): δ 7.55 (s, 1 H), 7.4-7.35 (m, 2H), 4.2 (d, 1 H), 3.95 (s, 3H), 3.85 (d, 1 H).

Step 6: 5-[5-(3,5-Dichloro-4-fluoro-phenyl)-5-(trifluoromethyl)-4H-i sothiazol-3-yl]-3- (trifluoromethyl)-thiophene-2-carboxylic acid (compound example 1 -9)

At 0°C, the product of step 5 (2.2 g) in THF (60 mL) was treated with a solution of LiOH (0.6 g) in water (20 mL), and the mixture stirred overnight at r.t. Then, 10% aqueous HCI was added to adjust the pH of the reaction to pH 3-4. The aqueous layer was extracted with ethyl acetate (3x). The organic layers were combined, washed with brine (1 x), dried (Na2S0 ₄ ), filtered, and concentrated. The obtained residue was purified by trituration (petroleum ether/ethyl acetate 20:1 ) to afford the product (3.9 g, 93%). H NMR (400 MHz, CDCb): δ 7.4 (s, 1 H), 7.3 (m, 2H), 4.2 (d, 1 H), 3.85 (d, 1 H).

Step 7: 5-[5-(3,5-Dichloro-4-fluoro-phenyl)-5-(trifluoromethyl)-4H-i sothiazol-3-yl]-N- (pyrimidin-2-ylmethyl)-3-(trifluoromethyl)-thiophene-2-carbo xamide

To a solution of the product of step 6 (0.3 g), pyrimidin-2-ylmethanamine hydrochloride (0.1 g) and bromotripyrrolidinophosphonium hexafluorophosphate ("PyBroP", 0.33 g) in CH2CI2 (40 mL) at r.t. was added A/,A/-diisopropylethylamine (0.24 g). The reaction was stirred at r.t. overnight. Then, water was added and the layers separated. The organic layer was dried (Na2S0 ₄ ), filtered and concentrated to give a residue which was purified by flash chromatography on silica gel to afford the title product (0.14 g,40%). H NMR (400 MHz, CDCI3): δ 8.8 (m, 2H), 7.7 (br. s, 1 H), 7.4 (s, 1 H), 7.35 (m, 2H), 4.9 (m, 2H), 4.15 (d, 1 H), 3.85 (d, 1 H).

II. Evaluation of pesticidal activity: The activity of the compounds of formula I of the present invention can be

demonstrated and evaluated by the following biological test.

B.1 Diamond back moth (Plutella xylostella)

The active compound was dissolved at the desired concentration in a mixture of 1 :1 (vohvol) distilled water : aceteone. Surfactant (Kinetic HV) was added at a rate of 0.01 % (vol/vol). The test solution was prepared at the day of use. Leaves of cabbage were dipped in test solution and air-dried. Treated leaves were placed in petri dishes lined with moist filter paper and inoculated with ten 3 ^rd instar larvae. Mortality was recorded 72 hours after treatment. Feeding damages were also recorded using a scale of 0-100%. In this test, the compounds 1 -3, 1 -4, 1 -5, 1 -7, and 1 -8 at 500 ppm, respectively, showed a mortality of at least 75% in comparison with untreated controls.

B.2 Green Peach Aphid (Myzus persicae) For evaluating control of green peach aphid (Myzus persicae) through systemic means the test unit consisted of 96-well-microtiter plates containing liquid artificial diet under an artificial membrane.

The compounds were formulated using a solution containing 75% v/v water and 25% v/v DMSO. Different concentrations of formulated compounds were pipetted into the aphid diet, using a custom built pipetter, at two replications.

After application, 5 - 8 adult aphids were placed on the artificial membrane inside the microtiter plate wells. The aphids were then allowed to suck on the treated aphid diet and incubated at about 23 + 1 °C and about 50 + 5 % relative humidity for 3 days. Aphid mortality and fecundity was then visually assessed.

In this test, the compounds 1 -3, 1 -4, 1 -10, 1 -1 1 , 1 -12, 1 -13, 1 -14 and 1 -15 at 2500 ppm, respectively, showed a mortality of at least 75% in comparison with untreated controls. B.3 Mediterranean fruitfly (Ceratitis capitata)

For evaluating control of Mediterranean fruitfly (Ceratitis capitata) the test unit consisted of microtiter plates containing an insect diet and 50-80 C. capitata eggs. The compounds were formulated using a solution containing 75% v/v water and 25% v/v DMSO. Different concentrations of formulated compounds were sprayed onto the insect diet at 5 μΙ, using a custom built micro atomizer, at two replications.

After application, microtiter plates were incubated at about 28 + 1 °C and about 80 + 5 % relative humidity for 5 days. Egg and larval mortality was then visually assessed.

In this test, the compounds 1 -3, 1 -7, 1 -8, 1 -10, 1 -1 1 , 1 -12, 1 -13, 1 -14 and 1 -15 at 2500 ppm, respectively, showed a mortality of at least 75% in comparison with untreated controls.

B.4 Orchid thrips (dichromothrips corbetti)

Dichromothrips corbetti adults used for bioassay were obtained from a colony maintained continuously under laboratory conditions. For testing purposes, the test com- pound is diluted in a 1 :1 mixture of acetone:water (vohvol), plus Kinetic HV at a rate of 0.01 % v/v.

Thrips potency of each compound was evaluated by using a floral-immersion technique. All petals of individual, intact orchid flowers were dipped into treatment solution and allowed to dry in Petri dishes. Treated petals were placed into individual re- sealable plastic along with about 20 adult thrips. All test arenas were held under continuous light and a temperature of about 28°C for duration of the assay. After 3 days, the numbers of live thrips were counted on each petal. The percent mortality was recorded 72 hours after treatment.

In this test, the compounds 1 -3, and 1 -8 at 500 ppm, respectively, showed a mortality of at least 75% in comparison with untreated controls.

B.5 Southern armyworm (Spodoptera eridania)

The active compounds were formulated by a Tecan liquid handler in 100%

cyclohexanone as a 10,000 ppm solution supplied in tubes. The 10,000 ppm solution was serially diluted in 100% cyclohexanone to make interim solutions. These served as stock solutions for which final dilutions were made by the Tecan in 50% acetone:50% water (v/v) into 5 or 10ml glass vials. A nonionic surfactant (Kinetic®) was included in the solution at a volume of 0.01 % (v/v). The vials were then inserted into an automated electrostatic sprayer equipped with an atomizing nozzle for application to

plants/insects. Lima bean plants (variety Sieva) were grown 2 plants to a pot and selected for treatment at the 1 ^st true leaf stage. Test solutions were sprayed onto the foliage by an automated electrostatic plant sprayer equipped with an atomizing spray nozzle. The plants were dried in the sprayer fume hood and then removed from the sprayer. Each pot was placed into perforated plastic bags with a zip closure. About 10 to 1 1 armyworm larvae were placed into the bag and the bags zipped closed. Test plants were maintained in a growth room at about 25°C and about 20-40% relative humidity for 4 days, avoiding direct exposure to fluorescent light (24 hour photoperiod) to prevent trapping of heat inside the bags. Mortality and reduced feeding were assessed 4 days after treatment, compared to untreated control plants.

In this test, the compound 1 -1 at 300 ppm showed a mortality of at least 75% in comparison with untreated controls. B.6 Vetch aphid (Megoura viciae)

For evaluating control of vetch aphid (Megoura viciae) through contact or systemic means the test unit consisted of 24-well-microtiter plates containing broad bean leaf disks.

The compounds were formulated using a solution containing 75% v/v water and 25% v/v DMSO. Different concentrations of formulated compounds were sprayed onto the leaf disks at 2.5 μΙ, using a custom built micro atomizer, at two replications.

After application, the leaf disks were air-dried and 5 - 8 adult aphids placed on the leaf disks inside the microtiter plate wells. The aphids were then allowed to suck on the treated leaf disks and incubated at about 23 + 1 °C and about 50 + 5 % relative humidity for 5 days. Aphid mortality and fecundity was then visually assessed.

In this test, the compounds 1 -5, 1 -7, 1 -10, 1 -1 1 , 1 -12, 1 -13, 1 -14 and 1 -15 at 2500 ppm, respectively, showed a mortality of at least 75% in comparison with untreated controls.

B.7 Tobacco budworm (Heliothis virescens)

For evaluating control of tobacco budworm (Heliothis virescens) the test unit consisted of 96-well-microtiter plates containing an insect diet and 15-25 H. virescens eggs.

The compounds were formulated using a solution containing 75% v/v water and 25% v/v DMSO. Different concentrations of formulated compounds were sprayed onto the insect diet at 10 μΙ, using a custom built micro atomizer, at two replications.

After application, microtiter plates were incubated at about 28 + 1 °C and about 80 + 5 % relative humidity for 5 days. Egg and larval mortality was then visually assessed. In this test, the compounds 1-3, 1-4, 1-5, 1-7, 1-8, 1-9, 1-10, 1-11, 1-12, 1-13, 1-14 and 1-15 at 2500 ppm, respectively, showed a mortality of at least 75% in comparison with untreated controls.

B.8 Boll weevil (Anthonomus grandis)

For evaluating control of boll weevil (Anthonomus grandis) the test unit consisted of 96- well-microtiter plates containing an insect diet and 5-10 A. grandis eggs.

The compounds were formulated using a solution containing 75% v/v water and 25% v/v DMSO. Different concentrations of formulated compounds were sprayed onto the insect diet at 5 μΙ, using a custom built micro atomizer, at two replications.

After application, microtiter plates were incubated at about 25 + 1 °C and about 75 + 5 % relative humidity for 5 days. Egg and larval mortality was then visually assessed.

In this test, the compounds 1-3, 1-4, 1-5, 1-6, 1-7, 1-8, 1-9, 1-10, 1-11, 1-12, 1-13, 1-14 and 1-15 at 2500 ppm, respectively, showed a mortality of at least 75% in comparison with untreated controls.